data_2mpn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mpn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 64.22 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.05 110.935 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.833 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.31 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.124 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.2 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 63.24 111.14 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.43 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.42 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.2 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.136 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 75.51 110.831 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.43 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.1 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 73.51 111.139 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.51 111.126 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.899 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 55.43 112.494 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.24 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.098 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.24 111.153 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 64.43 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.2 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.903 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 71.4 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.52 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.54 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.13 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 62.13 111.102 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.52 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 72.34 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.53 110.981 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 74.53 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 72.14 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.04 111.128 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 61.25 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.21 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.32 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 65.32 111.086 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.43 110.939 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.878 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.849 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.76 0.314 . . . . 74.05 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 72.33 110.894 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.3 110.879 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.22 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.11 111.183 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.157 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.163 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 71.43 111.102 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 74.51 112.452 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 72.15 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 75.15 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.33 111.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.922 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 65.42 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 42.41 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 74.41 111.145 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 75.15 111.088 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 75.4 110.909 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.22 112.439 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.21 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.413 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.12 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.03 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.44 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.54 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.51 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.33 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 75.11 110.954 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.21 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 74.12 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.41 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.42 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.35 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 64.21 111.076 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 75.11 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.2 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.911 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.23 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.23 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.11 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 75.43 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.31 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.45 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.13 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.15 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.43 111.081 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.952 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.53 110.887 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.842 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 72.33 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.927 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 74.31 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.169 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 74.11 110.968 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.32 111.101 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.038 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.45 112.52 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.33 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.41 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 74.04 110.897 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 70.34 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 71.43 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 72.45 111.123 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.23 111.097 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 53.24 112.462 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.41 110.923 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.402 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 70.31 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.14 111.057 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.53 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 63.01 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 74.43 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 71.42 110.958 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.465 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 75.31 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 75.24 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 73.4 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.01 111.073 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.23 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 74.04 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.967 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.15 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 62.31 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 75.42 111.088 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 73.41 110.907 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.04 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 75.31 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.53 111.138 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 73.25 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 71.25 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.929 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 73.54 110.888 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.23 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 74.24 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.32 111.142 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.942 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.175 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.02 111.09 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.53 111.116 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 72.2 112.503 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 75.25 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.44 111.092 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.958 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 74.55 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 71.14 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 73.2 111.05 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.149 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 75.51 110.947 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.54 112.433 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 75.51 110.864 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.34 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 74.34 111.123 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.95 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.12 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.03 110.915 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 61.02 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.44 112.552 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 74.44 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 71.51 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 74.31 111.089 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 74.32 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 72.32 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.33 111.004 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.3 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 75.14 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.44 111.141 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 62.41 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 75.12 110.918 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.35 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 63.21 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.15 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 74.14 111.169 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.926 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.32 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 63.43 110.946 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.831 0.348 . . . . 64.42 110.914 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.836 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 75.21 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.145 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.891 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.13 111.156 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.33 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.149 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 60.41 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 43.21 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 74.44 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.22 111.217 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.949 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 75.12 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 72.52 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.33 111.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.132 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.04 110.945 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.14 112.543 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 75.52 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.2 111.155 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 72.02 111.075 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.14 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.21 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.851 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.14 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.04 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.33 111.077 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 73.2 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.925 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.14 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.13 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.24 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.11 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.2 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 72.34 110.916 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 71.51 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.13 112.482 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.44 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.05 111.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 75.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.963 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.849 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.841 0.353 . . . . 74.12 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.902 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.089 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 72.54 110.943 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.161 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.136 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.53 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.42 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.23 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.092 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 75.05 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 72.13 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 73.35 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.31 111.107 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.146 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.923 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.44 112.519 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.34 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.402 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.4 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.147 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.21 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.12 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.22 112.584 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.51 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 74.21 110.925 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.14 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.01 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 71.33 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 53.25 110.966 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.54 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 73.03 110.961 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.926 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.43 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.43 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.04 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 74.23 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.41 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.34 110.847 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.52 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 53.4 112.504 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.44 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 61.3 111.166 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.861 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.982 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.4 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.886 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.797 0.332 . . . . 75.32 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.869 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.02 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.11 111.158 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.13 111.111 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.23 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.119 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 72.0 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 73.32 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 74.13 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.01 110.978 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 74.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 65.4 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.55 111.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.097 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.89 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 74.45 110.934 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.53 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 74.03 111.089 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.2 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.01 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.44 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.15 110.891 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.13 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.05 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 75.3 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.1 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.43 111.173 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.1 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 75.32 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.975 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.1 110.877 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.41 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 74.41 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.11 111.09 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 71.24 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 71.54 110.88 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.31 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.35 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 51.22 111.074 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.874 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.35 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 63.13 110.956 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 74.53 110.925 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.777 0.322 . . . . 75.35 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.885 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.928 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 72.3 111.077 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 62.22 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.1 111.154 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 64.22 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.22 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 73.14 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 74.5 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.23 111.134 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.34 110.908 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 73.52 111.152 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.52 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 74.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 73.42 111.11 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.929 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.03 112.495 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.12 110.889 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.418 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 72.05 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.154 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.2 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.34 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.41 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.35 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.839 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 73.01 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.23 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.34 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.42 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.03 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 71.11 111.019 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.22 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.32 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.857 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.916 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.15 111.128 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.33 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 72.22 110.908 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 64.11 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.31 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.22 111.104 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.856 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 72.34 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.911 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.873 0.368 . . . . 71.22 110.948 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.928 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 74.1 110.953 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.55 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 72.5 111.171 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.126 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.22 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.4 111.162 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 62.13 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.01 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.33 111.149 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.31 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 65.11 111.087 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.134 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.862 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.55 112.459 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.33 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.11 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.43 111.105 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.52 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 54.31 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 74.54 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 75.02 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.909 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.35 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 75.44 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 75.23 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 71.22 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 64.42 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.41 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.22 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.4 110.913 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.41 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.54 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.2 111.091 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 73.4 110.875 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 74.31 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 75.04 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.131 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.851 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.886 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.862 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.82 0.343 . . . . 62.54 110.894 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.864 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 75.43 110.928 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.117 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.31 111.104 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.01 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.133 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.24 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 72.12 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.23 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.139 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.42 110.956 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.51 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.24 111.123 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.12 111.117 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.818 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.33 112.488 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 73.31 110.963 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.409 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.42 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 72.42 111.124 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.23 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 65.33 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.52 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 74.43 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 75.22 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.42 110.852 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.35 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.14 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.14 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 73.23 111.134 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 73.22 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.904 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.23 111.06 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.2 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 74.4 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.52 110.924 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.15 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.52 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.21 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 72.41 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.941 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.871 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.04 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.51 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.831 0.348 . . . . 62.32 110.948 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.1 110.895 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 63.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.42 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.11 111.144 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.998 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.118 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 75.41 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.02 111.112 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.01 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 73.43 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.121 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.909 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.44 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.21 111.123 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.14 111.133 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 73.11 110.969 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.478 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.44 110.892 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 75.1 111.189 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 75.12 111.131 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.44 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 74.12 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 71.1 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 71.24 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 75.42 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 54.32 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.54 111.085 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 74.43 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.22 110.923 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.23 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.43 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 74.1 111.18 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.11 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.04 110.924 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.11 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 73.4 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.3 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.24 111.105 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.856 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 73.31 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 75.33 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.786 0.327 . . . . 72.55 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 74.32 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.058 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.904 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.074 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.41 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.118 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.2 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 74.5 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.833 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.51 111.09 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.24 111.119 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.893 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.34 112.57 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 74.34 110.957 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.2 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 71.34 111.133 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.13 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 71.51 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.03 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 75.14 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.413 HD12 ' N ' ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 72.1 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.12 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 73.45 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.3 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.4 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.35 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.13 111.121 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 71.43 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 74.12 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.912 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.51 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 71.44 111.18 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 65.32 110.822 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.21 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 73.43 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 73.14 111.119 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.9 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 60.51 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.903 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.24 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.886 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.838 0.352 . . . . 74.1 110.905 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.888 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 74.3 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.51 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.098 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.34 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 72.43 111.043 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 65.24 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.24 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.35 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 73.12 111.11 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.882 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.13 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 74.14 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.14 111.053 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.076 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.839 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 41.22 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 73.02 110.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.31 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.085 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 65.13 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.44 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 52.3 112.532 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.1 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.15 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.03 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.926 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.13 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 74.55 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.24 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.31 111.048 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.21 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 74.24 111.095 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 74.1 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.889 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 71.11 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.51 111.104 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 72.34 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.52 112.529 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.43 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.32 111.076 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.4 110.852 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.935 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 63.34 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.24 110.915 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 70.3 111.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.186 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.31 111.136 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.51 112.46 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 74.24 110.942 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.948 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 73.11 111.116 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.14 111.151 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 71.54 111.099 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.95 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 72.44 112.49 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 72.31 110.899 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.428 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.14 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.186 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 75.05 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.23 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.52 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 73.42 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 63.12 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.31 110.931 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.23 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 73.34 111.114 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 74.22 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 75.35 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.972 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.22 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.32 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.51 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 52.31 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 75.31 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.51 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.139 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.872 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.54 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.921 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.42 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.12 110.864 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 74.52 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.879 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 75.41 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 62.54 111.141 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.51 110.936 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.147 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.34 111.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.25 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.3 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 73.24 111.119 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 71.34 110.893 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.51 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.03 111.099 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.087 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.55 110.821 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.509 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.31 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.52 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.113 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.865 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.35 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.12 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.927 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 63.41 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.22 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.44 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.2 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.44 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 63.4 111.129 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 74.4 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 75.42 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.922 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 72.41 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.31 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 64.13 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.21 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.22 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.03 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 75.3 110.886 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.53 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 63.22 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 75.21 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.12 111.11 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.04 110.896 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.921 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.798 0.332 . . . . 74.2 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.1 110.886 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 75.44 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 63.14 111.181 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.02 110.914 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 75.51 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.14 111.054 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.11 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 74.0 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 73.12 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 70.22 111.095 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.892 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.41 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.21 111.169 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.167 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 75.55 110.966 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 61.14 112.482 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.11 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.414 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.14 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.104 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.44 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.45 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 53.24 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.13 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.15 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.12 110.926 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 65.34 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 74.12 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.33 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.45 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 74.13 111.068 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 74.23 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.51 110.958 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.815 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.1 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 75.53 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.31 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 73.01 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 75.33 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 71.42 110.866 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.42 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 70.52 111.122 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.966 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 74.13 110.829 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.23 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.92 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.883 0.373 . . . . 75.33 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.53 110.965 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.187 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.02 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.42 111.091 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 74.25 111.057 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 63.13 111.112 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 44.53 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 65.34 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 75.42 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.107 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.32 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.02 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.4 111.15 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.089 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.917 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 72.42 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.03 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 71.43 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.15 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 71.21 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.2 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.43 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 73.42 110.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.23 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.34 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.35 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 63.31 111.068 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.42 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.14 110.999 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 71.2 110.924 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.34 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 64.32 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.54 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.2 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.52 110.84 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 74.41 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 64.25 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.32 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.24 111.149 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.872 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.32 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.881 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.917 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 72.54 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.87 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.44 110.864 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 71.15 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.093 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.45 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.114 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.12 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.12 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.147 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 74.45 110.858 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 74.33 111.072 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.146 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.24 112.5 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.02 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.171 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.42 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 72.32 112.429 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.43 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.53 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.923 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 73.31 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 52.04 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.43 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 72.22 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.52 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 53.23 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 74.5 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 74.1 110.975 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.896 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.42 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 72.32 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 74.53 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.34 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.22 110.872 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 54.14 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 63.15 111.143 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.91 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.896 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 61.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 64.04 110.867 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.427 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 73.53 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.084 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 70.03 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.24 111.087 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.23 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.42 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.44 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 72.51 111.156 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.5 110.894 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.14 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 72.34 111.136 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 75.43 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.869 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.43 112.439 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 74.24 110.985 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.178 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.44 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.54 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.14 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 74.44 110.924 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 70.45 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 74.34 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.21 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.3 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 72.1 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 72.35 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 75.44 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.15 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 71.43 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.41 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 70.01 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 75.22 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 74.53 110.866 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 53.32 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.43 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.34 111.08 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.53 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 61.12 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.14 110.902 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.832 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 71.54 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.787 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.41 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.4 111.066 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.427 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 71.53 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.12 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.35 111.106 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 62.44 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.02 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.21 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.14 111.163 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 72.25 110.898 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 64.32 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.2 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 75.13 111.169 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.2 111.12 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 72.42 110.935 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.42 112.497 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.31 111.094 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.161 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 74.45 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.41 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.14 110.901 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.12 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.24 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 71.11 111.109 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 64.32 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.03 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 75.23 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 73.24 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.1 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 72.44 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 74.2 110.855 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.55 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.31 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 64.31 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 75.14 111.09 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 73.23 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.4 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 74.34 110.905 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.856 0.36 . . . . 65.51 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -53.77 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.868 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -111.16 153.68 43.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 72.23 110.885 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 -8.93 24.84 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.625 2.216 . . . . 75.44 112.311 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.9 67.09 4.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.689 0.757 . . . . 74.11 110.865 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -171.07 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.646 2.23 . . . . 65.05 112.437 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.15 0.45 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 64.22 110.889 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.05 110.935 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.833 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.31 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.124 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 74.2 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 63.24 111.14 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.43 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.42 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.2 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.136 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 75.51 110.831 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.43 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.1 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 73.51 111.139 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.51 111.126 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.899 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 55.43 112.494 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.24 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.098 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.24 111.153 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 64.43 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.2 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.903 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 71.4 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.52 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.54 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.13 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 62.13 111.102 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.52 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 72.34 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.53 110.981 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 74.53 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 72.14 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.04 111.128 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 61.25 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.21 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.32 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 65.32 111.086 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.43 110.939 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.878 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.849 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.24 56.84 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.892 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.2 ttm -50.2 144.54 11.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.599 0.714 . . . . 72.25 110.944 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 48.24 0.63 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.73 2.287 . . . . 74.02 112.345 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -84.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.994 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -79.28 -2.56 41.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.45 110.934 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.5 -24.27 45.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.894 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -142.22 38.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.765 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 70.12 111.073 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.776 0.322 . . . . 73.43 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -53.6 10.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.832 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -111.61 153.33 44.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.572 0.701 . . . . 73.21 110.941 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -10.99 29.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.746 2.297 . . . . 73.23 112.304 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.12 67.66 3.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.592 0.711 . . . . 74.41 110.987 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.578 2.185 . . . . 71.25 112.455 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -113.59 1.04 14.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 74.05 110.902 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 72.33 110.894 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.3 110.879 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.22 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.11 111.183 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.157 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.163 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 71.43 111.102 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 74.51 112.452 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 72.15 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 75.15 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.33 111.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.922 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 65.42 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 42.41 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 74.41 111.145 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 75.15 111.088 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 75.4 110.909 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.22 112.439 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.21 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.413 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.12 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.03 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.44 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.54 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.51 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.33 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 75.11 110.954 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.21 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 74.12 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.41 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.42 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.35 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 64.21 111.076 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 75.11 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.2 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.911 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.23 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.23 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.11 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 75.43 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.31 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.45 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.13 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.15 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 72.43 111.081 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.53 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.952 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.53 110.887 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.16 58.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.842 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtm -49.61 143.95 10.07 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.21 110.903 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.9 48.11 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.744 2.296 . . . . 74.34 112.267 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.885 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -80.15 -2.02 42.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 71.32 110.873 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.48 -23.48 57.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.24 110.998 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -143.84 41.68 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.915 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 75.32 111.104 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.864 0.364 . . . . 74.34 110.882 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.92 -53.37 9.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 63.53 110.814 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -53.32 153.14 7.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.568 0.699 . . . . 73.11 110.959 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.58 -18.22 37.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.704 2.269 . . . . 74.31 112.42 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.24 68.07 3.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 75.02 110.934 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.0 11.67 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.72 2.28 . . . . 75.45 112.328 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 1.07 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.33 110.847 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.927 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 74.31 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.169 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 74.11 110.968 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.32 111.101 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.038 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.45 112.52 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.33 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.41 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.139 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 74.04 110.897 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 70.34 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 71.43 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 72.45 111.123 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.23 111.097 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.889 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 53.24 112.462 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.41 110.923 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.402 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 70.31 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.14 111.057 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.53 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 63.01 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 74.43 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 71.42 110.958 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.465 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 75.31 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 75.24 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 73.4 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.01 111.073 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.23 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 74.04 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.967 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.15 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 62.31 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 75.42 111.088 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 73.41 110.907 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.04 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 75.31 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.53 111.138 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 73.25 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 71.25 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.76 59.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.41 110.929 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 ptp -51.52 153.74 3.68 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.518 0.675 . . . . 71.22 110.866 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 53.56 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.601 2.201 . . . . 74.52 112.357 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -83.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.907 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -80.84 -1.21 42.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 74.51 110.925 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -95.02 23.47 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.885 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.89 64.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 63.43 110.838 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 73.23 111.07 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.743 0.306 . . . . 64.24 110.841 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -53.33 10.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 74.14 110.8 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -52.77 153.6 5.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.637 0.732 . . . . 73.41 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -21.72 32.71 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.585 2.19 . . . . 64.53 112.41 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.44 67.54 4.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 74.21 110.9 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 177.1 5.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.638 2.225 . . . . 74.22 112.381 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.15 0.97 10.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 73.54 110.888 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.23 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 74.24 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.32 111.142 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.942 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.175 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.02 111.09 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.53 111.116 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 72.2 112.503 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 75.25 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.44 111.092 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.958 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 74.55 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 71.14 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 73.2 111.05 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.149 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 75.51 110.947 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.54 112.433 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 75.51 110.864 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.42 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.34 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 74.34 111.123 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.41 110.95 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.12 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.03 110.915 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 61.02 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.44 112.552 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 74.44 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 71.51 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 74.31 111.089 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 74.32 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 72.32 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.33 111.004 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.3 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 75.14 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.44 111.141 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.5 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 62.41 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 75.12 110.918 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.35 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 63.21 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.15 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 74.14 111.169 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.926 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.32 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.42 60.37 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 63.43 110.946 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.3 ptp -52.01 153.62 4.49 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 73.12 110.865 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.87 53.5 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.613 2.209 . . . . 61.45 112.383 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.24 110.927 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -81.03 -1.09 42.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 73.42 110.938 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.98 23.42 5.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.914 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -25.69 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 65.42 111.114 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 73.32 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.73 11.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 72.45 110.9 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -131.71 153.79 81.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.31 110.932 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -7.8 22.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.62 2.213 . . . . 73.03 112.382 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.08 65.77 5.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.649 0.738 . . . . 72.51 110.961 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -173.13 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.653 2.235 . . . . 74.23 112.405 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.32 1.87 10.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 64.42 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.836 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 75.21 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.145 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.891 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.13 111.156 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.33 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.149 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 60.41 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 43.21 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 74.44 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.22 111.217 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.949 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 75.12 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 72.52 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.33 111.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.132 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.04 110.945 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.14 112.543 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 75.52 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.2 111.155 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 72.02 111.075 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.14 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.21 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.41 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.851 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.14 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.04 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.33 111.077 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 73.2 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.925 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.14 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.13 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 74.24 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.11 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.2 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 72.34 110.916 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 71.51 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.13 112.482 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.44 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.05 111.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 75.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.963 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -165.18 59.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.849 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 18.4 ptp -54.37 152.91 10.81 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.475 0.655 . . . . 75.15 110.924 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 50.97 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 74.14 112.304 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.927 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.83 -0.5 48.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.52 110.799 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.75 21.99 6.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.99 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.9 -25.06 59.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.869 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 73.54 111.019 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.802 0.334 . . . . 74.14 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -53.57 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -131.58 153.67 81.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.544 0.688 . . . . 74.44 110.851 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -11.97 31.94 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.695 2.263 . . . . 71.43 112.323 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp 56.2 65.45 4.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.54 0.686 . . . . 73.23 110.893 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -171.78 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.643 2.229 . . . . 74.52 112.322 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.1 1.34 10.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.902 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.089 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 72.54 110.943 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.161 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.136 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.53 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.42 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.23 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.092 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 75.05 110.92 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 72.13 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 73.35 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.31 111.107 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.146 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 72.22 110.923 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.44 112.519 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.34 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.402 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.4 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.21 111.147 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.21 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.12 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.22 112.584 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.51 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 74.21 110.925 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.14 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.01 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 71.33 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 53.25 110.966 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.54 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 73.03 110.961 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.926 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.43 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.43 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.04 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 74.23 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.41 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.34 110.847 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.52 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 53.4 112.504 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.44 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 61.3 111.166 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.861 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.982 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.4 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -165.51 60.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.886 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 18.8 ptp -53.8 152.77 9.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 75.01 110.834 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 51.15 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.75 2.3 . . . . 74.51 112.276 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.967 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -83.13 -0.52 49.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 75.23 110.822 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.47 22.03 6.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.874 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.52 -25.2 60.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.88 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 74.05 111.02 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.2 mttp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.861 0.363 . . . . 72.41 110.837 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -53.72 10.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 75.02 110.867 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -83.75 153.9 64.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.562 0.696 . . . . 74.23 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.78 -11.8 31.55 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.662 2.241 . . . . 72.24 112.284 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.55 67.3 4.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 72.42 110.925 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.67 2.247 . . . . 71.1 112.409 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.07 2.53 12.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.926 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.869 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.02 110.929 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.11 111.158 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.13 111.111 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.23 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.119 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 72.0 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 73.32 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 74.13 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.01 110.978 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 74.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 65.4 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.55 111.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.097 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.89 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 74.45 110.934 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.53 111.205 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 74.03 111.089 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.2 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.01 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.44 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.15 110.891 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.13 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.05 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 75.3 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.1 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.43 111.173 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.1 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 75.32 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.975 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.1 110.877 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.41 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 74.41 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.11 111.09 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 71.24 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 71.54 110.88 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.31 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.35 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 51.22 111.074 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.874 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.35 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 63.13 110.956 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -142.79 57.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 74.53 110.925 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.3 mtm -50.76 142.9 15.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.642 0.734 . . . . 65.33 110.837 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 48.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.256 . . . . 62.14 112.396 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.999 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.82 -7.82 50.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 73.43 110.932 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.17 23.52 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -26.13 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 73.42 110.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.054 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.6 mttp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.774 0.321 . . . . 64.51 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.01 -53.12 10.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 75.41 110.781 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -84.56 153.67 61.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.561 0.696 . . . . 72.11 110.851 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -12.28 32.68 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.695 2.263 . . . . 72.22 112.322 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.72 67.18 4.36 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 63.55 110.854 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.92 -169.17 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 75.13 112.306 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.63 1.62 14.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 75.35 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.885 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.928 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 72.3 111.077 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 62.22 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.1 111.154 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 64.22 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.22 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 73.14 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 74.5 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.23 111.134 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.34 110.908 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 73.52 111.152 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.52 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 74.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 73.42 111.11 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.929 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.03 112.495 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.12 110.889 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.418 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 72.05 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.154 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.2 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.34 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.41 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.35 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.839 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 73.01 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.23 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.34 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.42 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.03 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 71.11 111.019 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.22 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.32 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.857 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.916 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.15 111.128 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.33 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 72.22 110.908 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 64.11 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.31 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.22 111.104 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.856 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 72.34 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -139.92 57.69 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.911 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.2 mtm -49.62 143.36 10.85 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.582 0.706 . . . . 74.02 110.855 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 48.44 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 74.14 112.298 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 64.34 110.866 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -7.44 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 72.22 110.863 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.09 23.8 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 74.54 110.947 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -26.22 64.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 70.01 110.892 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.019 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 74.21 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -52.83 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 74.44 110.901 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.84 153.87 47.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 75.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 -11.36 30.77 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.259 . . . . 75.54 112.38 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.07 69.35 2.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.559 0.695 . . . . 75.23 110.918 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.24 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.675 2.25 . . . . 73.23 112.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.69 1.78 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.928 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 74.1 110.953 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.55 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 72.5 111.171 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.126 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.22 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.4 111.162 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 62.13 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.01 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.33 111.149 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.31 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 65.11 111.087 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.134 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.862 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.55 112.459 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.33 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.11 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.43 111.105 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.52 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 54.31 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 74.54 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 75.02 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.909 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.35 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 75.44 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 75.23 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 71.22 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 64.42 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.41 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.22 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.4 110.913 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.41 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.54 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.2 111.091 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 73.4 110.875 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 74.31 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 75.04 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.131 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.851 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.886 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.22 57.66 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.862 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.2 mtm -49.95 143.58 11.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.489 0.661 . . . . 75.34 110.92 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 48.03 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.682 2.255 . . . . 62.03 112.327 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -82.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 71.4 110.953 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -80.26 -1.9 42.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -54.74 -25.98 31.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.974 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 ptt85 -179.32 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.915 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.25 111.149 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.762 0.315 . . . . 75.04 110.849 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.48 -52.28 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.52 153.57 48.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 70.12 110.924 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.85 -11.92 31.68 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.643 2.229 . . . . 74.52 112.314 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.15 68.53 3.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.692 0.758 . . . . 64.12 110.935 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.89 -170.46 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.604 2.203 . . . . 73.54 112.368 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.02 1.48 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 62.54 110.894 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.864 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 75.43 110.928 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.117 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 74.51 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.31 111.104 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.01 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.133 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.24 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 72.12 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.23 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.139 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.42 110.956 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.51 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.24 111.123 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.12 111.117 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.818 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.33 112.488 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 73.31 110.963 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.409 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.42 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 72.42 111.124 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.23 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 65.33 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.52 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 74.43 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 75.22 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.42 110.852 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.35 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.14 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.14 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 73.23 111.134 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 73.22 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.904 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 54.12 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.23 111.06 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.2 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 74.4 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.52 110.924 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.15 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.52 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.21 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 72.41 111.115 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.52 110.941 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.871 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.04 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.19 58.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 75.51 110.921 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtm -50.26 144.24 11.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 64.11 110.844 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 48.18 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 74.35 112.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.953 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.56 -1.29 41.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 74.35 110.924 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -54.85 -25.97 32.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.905 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 ptt85 -179.66 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.854 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.5 111.154 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.716 0.294 . . . . 73.53 110.878 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -52.42 8.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 73.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 158.38 46.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.709 . . . . 74.5 110.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -11.57 31.27 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.612 2.208 . . . . 64.11 112.386 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt 59.37 68.92 1.43 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.597 0.713 . . . . 74.43 110.952 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -170.65 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 74.25 112.3 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.3 mp -113.13 1.24 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.948 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.1 110.895 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 63.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.42 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.11 111.144 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.998 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.118 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 75.41 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.02 111.112 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.01 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 73.43 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.121 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.909 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 74.35 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.44 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.21 111.123 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.14 111.133 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 73.11 110.969 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.478 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.44 110.892 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 75.1 111.189 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 75.12 111.131 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.44 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 74.12 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 71.1 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 71.24 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 75.42 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 54.32 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.54 111.085 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 74.43 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.22 110.923 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.23 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.43 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 74.1 111.18 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.11 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.04 110.924 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.11 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 73.4 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.3 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.24 111.105 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.856 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 73.31 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 75.33 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -153.22 56.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.4 mtm -48.76 142.58 8.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.572 0.701 . . . . 72.04 110.862 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.93 48.31 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.53 112.335 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 63.43 110.918 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -79.64 -2.27 41.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.907 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -57.3 -23.9 51.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.36 -39.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 72.4 110.895 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.13 111.102 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.797 0.332 . . . . 75.51 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 -52.33 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.805 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.44 158.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.524 0.678 . . . . 73.32 110.985 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -16.34 37.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.75 2.3 . . . . 74.01 112.292 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mt 63.81 68.2 0.89 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.7 . . . . 74.45 110.862 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.669 2.246 . . . . 73.21 112.323 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.2 mp -110.3 1.04 18.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 72.55 110.938 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 74.32 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.058 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.904 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.074 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.41 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.118 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.2 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 74.5 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.833 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.51 111.09 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.24 111.119 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.893 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.34 112.57 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 74.34 110.957 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.2 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 71.34 111.133 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.13 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 71.51 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.03 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 75.14 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.413 HD12 ' N ' ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 72.1 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.12 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 73.45 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.3 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.4 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.35 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.13 111.121 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 71.43 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 74.12 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.912 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.51 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 71.44 111.18 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 65.32 110.822 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.21 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 73.43 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 73.14 111.119 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.9 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 60.51 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.903 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.24 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -150.88 57.55 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.3 mtm -48.31 143.38 7.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.608 0.718 . . . . 74.14 110.819 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.87 48.87 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.537 2.158 . . . . 75.22 112.373 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -85.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.847 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -80.35 -2.2 44.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.13 110.863 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.74 -24.51 50.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.882 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.51 -37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 75.04 110.934 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 73.22 111.177 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.762 0.315 . . . . 70.44 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -50.88 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 61.22 110.759 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -52.08 157.18 2.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 74.13 110.948 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.48 31.87 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 70.44 112.35 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.23 68.24 3.62 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.581 0.705 . . . . 70.54 110.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -173.02 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 73.14 112.326 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.64 0.99 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 74.1 110.905 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.888 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 74.3 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.51 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 72.43 111.098 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.34 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 72.43 111.043 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 65.24 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.24 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.35 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 73.12 111.11 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.882 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.13 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 74.14 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.14 111.053 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.076 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.839 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 41.22 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 73.02 110.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.31 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.085 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 65.13 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.44 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 52.3 112.532 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.1 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.15 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.03 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.926 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.13 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 74.55 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.24 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.31 111.048 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.21 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 74.24 111.095 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 74.1 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.889 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 71.11 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.51 111.104 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 72.34 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.52 112.529 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.43 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.32 111.076 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.4 110.852 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.935 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.09 57.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.846 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.3 mtm -50.48 143.36 13.91 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.644 0.735 . . . . 73.51 110.811 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 48.25 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.648 2.232 . . . . 72.23 112.374 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.33 -82.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.917 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.75 -2.86 41.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.913 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.51 -24.16 44.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 72.11 111.001 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.39 59.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.818 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 64.04 111.086 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.784 0.326 . . . . 72.22 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -50.47 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.804 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -52.82 157.31 2.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 74.21 110.833 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.1 31.11 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.653 2.235 . . . . 70.12 112.379 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.3 67.7 4.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.647 0.737 . . . . 70.24 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 65.42 112.375 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.25 1.19 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.909 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.24 110.915 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 70.3 111.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.186 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.31 111.136 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.51 112.46 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 74.24 110.942 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.948 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 73.11 111.116 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.14 111.151 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 71.54 111.099 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.95 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 72.44 112.49 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 72.31 110.899 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.428 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.14 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.186 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 75.05 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.23 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.52 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 73.42 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 63.12 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.31 110.931 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.23 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 73.34 111.114 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 74.22 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 75.35 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.972 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.22 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.32 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.51 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 52.31 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 75.31 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.51 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.139 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.872 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.54 110.948 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.921 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.42 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.21 57.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.12 110.864 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.2 mtm -50.81 143.93 14.09 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.57 0.7 . . . . 73.41 110.851 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 48.46 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.643 2.229 . . . . 74.14 112.415 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.967 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -79.21 -2.63 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.839 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -24.43 48.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 61.35 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.24 59.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 64.32 110.848 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.24 111.056 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.835 0.35 . . . . 74.43 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -52.87 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 65.41 110.884 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -51.59 159.89 1.15 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.698 0.761 . . . . 62.31 110.833 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.62 -27.39 27.2 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.749 2.299 . . . . 72.32 112.358 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mp 49.63 67.58 4.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.565 0.698 . . . . 73.15 110.854 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -178.56 2.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.694 2.263 . . . . 75.12 112.381 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.29 -0.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.901 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.879 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 75.41 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 62.54 111.141 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.51 110.936 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.147 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.34 111.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.25 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.53 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.3 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 73.24 111.119 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 71.34 110.893 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.51 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.03 111.099 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.087 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 71.55 110.821 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.509 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.31 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.52 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.113 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.865 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.35 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.12 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.927 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 63.41 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.22 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.44 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.2 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.44 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 63.4 111.129 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 74.4 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 75.42 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.922 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 72.41 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.31 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 64.13 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.21 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.22 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.03 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 75.3 110.886 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.53 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 63.22 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 75.21 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.12 111.11 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.04 110.896 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -148.04 56.94 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.921 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.3 ttm -50.09 142.9 13.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 75.24 110.908 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.65 48.16 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.63 2.22 . . . . 64.31 112.369 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 75.3 110.821 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -9.69 54.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.909 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -96.28 22.98 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.834 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.07 -35.35 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.2 110.855 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 74.12 111.118 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.871 0.367 . . . . 75.33 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -53.12 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.876 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -52.7 159.56 1.71 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 73.13 110.908 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -28.36 25.3 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.685 2.257 . . . . 64.21 112.33 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp 49.61 65.54 6.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.589 0.709 . . . . 74.35 110.884 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 179.61 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.601 2.201 . . . . 63.42 112.352 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.23 0.07 10.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.1 110.886 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 75.44 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 63.14 111.181 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.02 110.914 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 75.51 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.14 111.054 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.11 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 74.0 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 73.12 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 70.22 111.095 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.892 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.41 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.21 111.169 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.167 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 75.55 110.966 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 61.14 112.482 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.11 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.414 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.14 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.104 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.44 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.45 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 53.24 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.13 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.15 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.12 110.926 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 65.34 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 74.12 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.33 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.45 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 74.13 111.068 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 74.23 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.51 110.958 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.815 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.1 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 75.53 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.31 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 73.01 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 75.33 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 71.42 110.866 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.42 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 70.52 111.122 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.966 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 74.13 110.829 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.23 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -133.78 57.31 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.92 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.2 ttm -51.58 143.81 19.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.64 0.733 . . . . 73.52 110.918 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 49.44 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 75.44 112.373 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 71.24 110.902 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -10.0 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.836 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -95.11 22.11 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.868 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -35.28 61.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.458 . . . . 74.03 110.887 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 63.53 111.067 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' N ' ' HZ3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 63.13 110.878 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -52.84 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 75.34 110.837 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -50.26 108.22 0.97 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.637 0.732 . . . . 73.01 110.919 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.07 1.71 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.717 2.278 . . . . 52.01 112.364 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.34 67.1 70.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.599 0.714 . . . . 75.2 110.961 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 154.8 67.3 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.735 2.29 . . . . 65.4 112.328 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt -84.12 0.71 47.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.921 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.53 110.965 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.187 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.02 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.42 111.091 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 74.25 111.057 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 63.13 111.112 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 44.53 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 65.34 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 75.42 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.107 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.32 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.02 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 72.4 111.15 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.089 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.917 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 72.42 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.03 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 71.43 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.15 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 71.21 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.2 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.43 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 73.42 110.932 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.23 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.34 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.35 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 63.31 111.068 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.42 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.14 110.999 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 71.2 110.924 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.34 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 64.32 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.54 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.2 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.52 110.84 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 74.41 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 64.25 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.32 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.24 111.149 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.872 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.32 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.881 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -161.12 60.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.6 ptp -48.49 153.81 1.28 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.575 0.703 . . . . 63.3 110.899 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 50.34 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 73.4 112.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -48.7 -86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.94 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.46 -0.5 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 65.24 110.869 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -54.65 -26.3 32.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 75.03 110.918 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -178.87 57.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.32 110.871 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 65.23 111.049 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.538 ' HZ3' ' N ' ' B' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.816 0.341 . . . . 71.01 110.931 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -52.79 9.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.862 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -51.85 109.91 1.62 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.636 0.731 . . . . 75.04 110.949 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -167.86 0.25 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.706 2.271 . . . . 73.04 112.337 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.68 64.68 37.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.616 0.722 . . . . 64.32 110.931 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.29 66.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.243 . . . . 71.32 112.348 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.5 0.4 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.894 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.87 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.44 110.864 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.12 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 71.15 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.093 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.45 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.114 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.12 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.12 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.147 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 74.45 110.858 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 61.11 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 74.33 111.072 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.146 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 71.54 110.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.24 112.5 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.02 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' B' ' 137' ' ' GLY . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.171 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.42 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 72.32 112.429 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.43 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.53 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.923 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 73.31 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 52.04 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.43 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 72.22 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.52 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 53.23 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 74.5 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 74.1 110.975 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.896 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.42 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 72.32 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 74.53 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.34 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.22 110.872 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 54.14 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 63.15 111.143 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.91 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -161.78 60.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.896 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ptp -48.58 153.88 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 71.23 110.833 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 50.89 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 73.12 112.344 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . 0.418 ' CD1' ' N ' ' B' ' 169' ' ' TRP . 0.0 OUTLIER -48.95 -85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 74.13 110.875 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.49 -0.11 44.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.869 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -55.13 -26.13 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 75.34 110.935 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -179.32 59.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.836 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 74.23 111.039 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.821 0.343 . . . . 74.43 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -52.73 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.832 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -95.91 155.53 38.25 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 51.42 110.901 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 -21.0 34.64 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.72 2.28 . . . . 64.03 112.382 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.3 mt 50.61 69.45 2.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.698 . . . . 72.1 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.634 2.223 . . . . 73.51 112.378 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.49 1.76 13.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 61.21 110.885 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 64.04 110.867 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.427 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 73.53 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.084 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 70.03 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.24 111.087 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.23 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.42 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.44 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 72.51 111.156 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.5 110.894 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.14 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 72.34 111.136 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 75.43 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.869 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.43 112.439 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 74.24 110.985 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.178 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.44 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.54 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.14 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 74.44 110.924 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 70.45 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 74.34 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.21 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.3 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 72.1 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 72.35 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 75.44 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.15 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 71.43 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.41 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 70.01 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 75.22 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 74.53 110.866 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 53.32 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.43 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.34 111.08 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.53 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 61.12 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.14 110.902 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.18 56.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.832 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.402 ' O ' ' CE2' ' A' ' 169' ' ' TRP . 2.4 mtm -48.8 143.1 8.5 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 74.04 110.84 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 49.03 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 71.23 112.334 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.402 ' CE2' ' O ' ' A' ' 167' ' ' MET . 0.0 OUTLIER -54.06 -80.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.01 110.872 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.48 -9.03 55.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 75.42 110.847 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.0 23.46 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 75.41 110.916 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -24.62 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 74.1 110.816 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 71.21 111.139 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.843 0.354 . . . . 75.34 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -52.85 8.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 74.15 110.915 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.95 156.59 37.82 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.574 0.702 . . . . 63.54 110.951 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -25.4 28.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.711 2.274 . . . . 75.44 112.372 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt 53.9 67.71 3.35 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.629 0.728 . . . . 70.54 110.986 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -169.43 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.67 2.247 . . . . 71.41 112.367 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.92 2.1 14.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 71.54 110.881 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.787 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.41 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.4 111.066 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.427 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 71.53 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.12 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.35 111.106 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 62.44 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.02 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.21 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.14 111.163 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 72.25 110.898 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 64.32 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.2 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 75.13 111.169 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.2 111.12 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 72.42 110.935 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.42 112.497 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.31 111.094 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.161 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 74.45 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.41 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.14 110.901 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.12 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 74.24 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 71.11 111.109 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 64.32 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.03 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 75.23 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 73.24 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.1 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 72.44 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 74.2 110.855 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.55 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.31 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 64.31 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 75.14 111.09 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 73.23 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.4 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 57.16 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 74.34 110.905 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.403 ' O ' ' CE2' ' B' ' 169' ' ' TRP . 2.3 mtm -48.75 142.92 8.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.491 0.663 . . . . 71.43 110.921 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 49.08 0.69 Allowed 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.72 2.28 . . . . 75.32 112.282 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' TRP . . . . . 0.403 ' CE2' ' O ' ' B' ' 167' ' ' MET . 0.0 OUTLIER -54.41 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.945 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -8.81 54.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.961 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.96 23.54 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.932 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -23.97 63.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 71.52 110.937 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 74.23 111.054 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 64.219999999999999 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.779 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.049999999999997 110.935 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.41 ' HD3' ' CB ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.833 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.239999999999995 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 54.030000000000001 111.124 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 62.409999999999997 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 62.149999999999999 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 42.219999999999999 111.14 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.430000000000007 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.420000000000002 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.200000000000003 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.459 ' CG2' HD22 ' B' ' 150' ' ' LEU . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 111.136 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.699 HD22 HG23 ' A' ' 129' ' ' VAL . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 65.409999999999997 110.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.019999999999996 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.099999999999994 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' B' ' 128' ' ' VAL . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.139 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 125' ' ' LEU . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.510000000000005 111.126 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.429 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 44.210000000000001 110.899 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 53.109999999999999 112.494 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.239999999999995 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.672 ' CB ' ' HB2' ' A' ' 147' ' ' ALA . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 111.098 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.554 HG12 ' HA2' ' A' ' 131' ' ' GLY . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 111.153 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 63.020000000000003 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 53.439999999999998 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.200000000000003 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.040000000000006 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.903 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 53.420000000000002 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.329999999999998 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.539999999999999 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.129999999999995 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 133' ' ' THR . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 43.119999999999997 111.102 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.420000000000002 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 30.329999999999998 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD13 HG22 ' A' ' 129' ' ' VAL . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.981 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 60.119999999999997 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.040000000000006 111.128 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 21.109999999999999 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.210000000000001 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.049999999999997 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 30.34 111.086 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 110.939 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.831 HD22 ' HB2' ' B' ' 113' ' ' MET . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 74.510000000000005 110.878 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CB ' ' HD3' ' A' ' 114' ' ' ARG . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.849 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.010000000000005 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.76 0.314 . . . . 65.019999999999996 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.831 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.129999999999995 110.894 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.682 ' NH1' HG23 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.299999999999997 110.879 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.219999999999999 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 30.149999999999999 111.183 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.682 HG23 ' NH1' ' B' ' 114' ' ' ARG . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 111.157 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.417 ' N ' HG13 ' B' ' 118' ' ' ILE . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 31.129999999999999 111.163 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 62.039999999999999 111.102 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.556 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 60.119999999999997 112.452 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 63.509999999999998 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 52.240000000000002 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 150' ' ' LEU . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.010000000000005 111.161 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.922 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 63.549999999999997 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 40.530000000000001 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 128' ' ' VAL . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 70.319999999999993 111.145 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 111.088 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.425 ' N ' HG12 ' B' ' 129' ' ' VAL . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 61.310000000000002 110.909 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.6 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.219999999999999 112.439 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.209999999999994 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.120000000000005 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.6 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 43.229999999999997 111.136 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.439999999999998 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.540000000000006 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.510000000000005 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 64.109999999999999 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 72.030000000000001 110.954 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.209999999999994 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 62.509999999999998 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.409999999999997 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.420000000000002 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.349999999999994 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.653 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 63.329999999999998 111.076 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 41.329999999999998 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.200000000000003 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.459 HD22 ' CG2' ' A' ' 124' ' ' ILE . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.230000000000004 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 54.409999999999997 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.109999999999999 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.310000000000002 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.450000000000003 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.140000000000001 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.130000000000003 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.120000000000005 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.666 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 111.081 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 61.310000000000002 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.349999999999994 110.952 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.530000000000001 110.887 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.842 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 72.299999999999997 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.705 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.329999999999998 110.927 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 53.030000000000001 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.709 HG11 ' CE1' ' B' ' 157' ' ' PHE . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 111.169 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.692 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.968 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.68 HG22 ' HG3' ' B' ' 117' ' ' GLN . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.209999999999994 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 118' ' ' ILE . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.319999999999993 111.101 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.038 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.583 ' HA2' HD11 ' B' ' 154' ' ' ILE . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.450000000000003 112.52 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.329999999999998 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.409999999999997 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.699 ' CG2' HD22 ' B' ' 150' ' ' LEU . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 111.139 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 71.049999999999997 110.897 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 62.119999999999997 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 62.229999999999997 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.788 HG11 HG22 ' B' ' 129' ' ' VAL . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 61.140000000000001 111.123 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.796 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.097 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.889 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 43.149999999999999 112.462 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 110.923 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.7 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 65.319999999999993 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.599 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.5 111.057 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.530000000000001 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.230000000000004 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 43.340000000000003 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.439999999999998 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 32.130000000000003 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 45.039999999999999 110.958 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.399999999999999 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 133' ' ' THR . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 70.010000000000005 112.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 71.329999999999998 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 61.109999999999999 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 64.340000000000003 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.7 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.010000000000005 111.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.230000000000004 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 61.340000000000003 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CG2' ' B' ' 124' ' ' ILE . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 110.967 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.150000000000006 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 52.100000000000001 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.564 HD11 ' HA2' ' B' ' 121' ' ' GLY . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 74.219999999999999 111.088 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.723 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 71.109999999999999 110.907 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 55.439999999999998 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.040000000000006 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 73.450000000000003 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.530000000000001 111.138 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' HD13 ' A' ' 118' ' ' ILE . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 61.130000000000003 110.867 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 62.43 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 61.200000000000003 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 72.129999999999995 110.929 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.401 ' O ' HG23 ' B' ' 116' ' ' VAL . 95.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 51.119999999999997 110.888 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.687 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.886 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 53.210000000000001 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.723 HG11 ' CE1' ' A' ' 157' ' ' PHE . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.319999999999993 111.142 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLN . . . . . 0.68 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 110.942 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.692 HG22 ' HG3' ' A' ' 117' ' ' GLN . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.510000000000005 111.175 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.413 ' N ' HD12 ' B' ' 118' ' ' ILE . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.019999999999996 111.09 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 154' ' ' ILE . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 65.400000000000006 112.503 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.099999999999994 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 70.430000000000007 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.68 ' CG2' HD22 ' A' ' 150' ' ' LEU . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.439999999999998 111.092 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.545 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.958 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 62.130000000000003 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.796 HG11 HG22 ' A' ' 129' ' ' VAL . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 54.450000000000003 111.05 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.788 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.219999999999999 111.149 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.443 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.947 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.540000000000006 112.433 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.5 ' CD2' HG12 ' A' ' 128' ' ' VAL . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 74.450000000000003 110.864 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.679 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 64.310000000000002 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 65.140000000000001 110.95 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.409999999999997 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.120000000000005 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 71.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 70.239999999999995 110.915 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 53.140000000000001 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' B' ' 133' ' ' THR . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.439999999999998 112.552 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 73.030000000000001 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 62.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 62.350000000000001 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.679 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 71.019999999999996 111.089 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 60.229999999999997 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.699 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 111.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.519999999999996 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.299999999999997 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 64.219999999999999 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.583 HD11 ' HA2' ' A' ' 121' ' ' GLY . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.439999999999998 111.141 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 61.210000000000001 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.709 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 72.439999999999998 110.918 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.349999999999994 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 60.229999999999997 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.150000000000006 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 52.420000000000002 111.169 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.631 ' HB2' HD13 ' B' ' 118' ' ' ILE . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.926 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 65.049999999999997 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.319999999999993 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.409999999999997 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.210000000000001 110.946 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.831 0.348 . . . . 42.32 110.914 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.578 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.836 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 71.209999999999994 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' B' ' 157' ' ' PHE . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 111.145 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 60.229999999999997 110.891 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 162' ' ' ARG . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 111.156 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.329999999999998 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 54.399999999999999 111.149 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 55.210000000000001 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 42.340000000000003 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 73.420000000000002 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.526 HG23 HD22 ' B' ' 150' ' ' LEU . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.219999999999999 111.217 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.540000000000006 110.949 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 70.030000000000001 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 62.030000000000001 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.918 HG11 HG22 ' B' ' 129' ' ' VAL . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.329999999999998 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 128' ' ' VAL . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.329999999999998 111.132 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.040000000000006 110.945 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.140000000000001 112.543 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.200000000000003 111.155 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.61 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 61.25 111.075 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.239999999999995 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 51.009999999999998 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.140000000000001 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.209999999999994 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.210000000000001 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.109999999999999 110.851 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.040000000000006 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 54.439999999999998 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.329999999999998 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.6 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.329999999999998 111.077 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.120000000000005 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 43.420000000000002 110.885 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 129' ' ' VAL . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.925 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 54.32 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 63.109999999999999 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.129999999999995 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 71.510000000000005 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.200000000000003 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' B' ' 116' ' ' VAL . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.916 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 53.299999999999997 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 163' ' ' LEU . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.129999999999995 112.482 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.439999999999998 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 51.439999999999998 111.128 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HB3' HD13 ' A' ' 118' ' ' ILE . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 110.88 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.963 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.869 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.299999999999997 110.849 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.841 0.353 . . . . 73.120000000000005 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 52.210000000000001 110.902 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.642 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.089 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLN . . . . . 0.526 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 54.420000000000002 110.943 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' B' ' 162' ' ' ARG . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 61.43 111.161 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 72.519999999999996 111.136 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.530000000000001 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.420000000000002 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.230000000000004 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.513 HG23 HD22 ' A' ' 150' ' ' LEU . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.319999999999993 111.092 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.626 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 63.32 110.92 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 63.039999999999999 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 50.140000000000001 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.911 HG11 HG22 ' A' ' 129' ' ' VAL . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 128' ' ' VAL . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.146 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.483 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 51.109999999999999 110.923 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.439999999999998 112.519 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.340000000000003 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.400000000000006 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.030000000000001 111.147 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.209999999999994 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.119999999999997 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.219999999999999 112.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.510000000000005 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.925 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 54.039999999999999 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.140000000000001 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.010000000000005 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 45.329999999999998 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.591 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 42.310000000000002 110.966 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.540000000000006 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' LEU . . . . . 0.568 ' O ' HD13 ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 62.25 110.961 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 124' ' ' ILE . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 110.926 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.430000000000007 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 70.329999999999998 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.040000000000006 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.310000000000002 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.340000000000003 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.409999999999997 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.584 ' CE1' HG21 ' A' ' 116' ' ' VAL . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.847 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.519999999999996 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.56 ' O ' HD12 ' B' ' 163' ' ' LEU . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 42.130000000000003 112.504 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.420000000000002 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 53.130000000000003 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.582 ' HB3' HD13 ' B' ' 118' ' ' ILE . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 110.928 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.56 HD12 ' O ' ' B' ' 159' ' ' GLY . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.861 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.982 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.400000000000006 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.886 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.797 0.332 . . . . 73.310000000000002 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.587 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.869 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' B' ' 161' ' ' ALA . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.019999999999996 110.929 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.681 HG11 ' CE1' ' B' ' 157' ' ' PHE . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 54.549999999999997 111.158 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.340000000000003 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.129999999999995 111.111 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.230000000000004 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 53.329999999999998 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 71.239999999999995 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 63.030000000000001 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.693 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.588 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 71.430000000000007 110.978 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 151' ' ' PHE . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 71.040000000000006 111.103 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 34.329999999999998 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 129' ' ' VAL . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.219999999999999 111.163 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.843 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.140000000000001 111.097 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' A' ' 129' ' ' VAL . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.89 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.524 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 73.329999999999998 110.934 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' A' ' 147' ' ' ALA . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.530000000000001 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 64.400000000000006 111.089 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.200000000000003 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 41.32 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.010000000000005 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.439999999999998 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.329999999999998 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.150000000000006 110.891 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.129999999999995 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.049999999999997 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 72.420000000000002 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.099999999999994 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' A' ' 133' ' ' THR . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.430000000000007 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.099999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 61.350000000000001 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.703 HD22 ' CG2' ' B' ' 124' ' ' ILE . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.975 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.586 ' HD1' HD11 ' A' ' 126' ' ' ILE . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 110.877 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.409999999999997 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 42.350000000000001 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 HD13 ' A' ' 125' ' ' LEU . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.109999999999999 111.09 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 62.420000000000002 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 62.25 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 64.450000000000003 110.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.310000000000002 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.349999999999994 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 43.509999999999998 111.074 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.654 ' HB3' HD13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.340000000000003 110.874 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.598 HD22 ' NH2' ' B' ' 114' ' ' ARG . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 62.340000000000003 110.956 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.109999999999999 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 54.030000000000001 110.925 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.777 0.322 . . . . 75.349999999999994 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 110.885 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.598 ' NH2' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 62.420000000000002 110.928 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 157' ' ' PHE . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 111.077 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 53.340000000000003 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 51.299999999999997 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.350000000000001 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.219999999999999 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 64.219999999999999 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 71.319999999999993 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.703 ' CG2' HD22 ' A' ' 150' ' ' LEU . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.230000000000004 111.134 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 65.409999999999997 110.908 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.556 HD11 ' HD1' ' B' ' 151' ' ' PHE . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 60.140000000000001 111.152 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.520000000000003 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.843 HG11 HG22 ' A' ' 129' ' ' VAL . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 53.420000000000002 111.17 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.823 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 111.11 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' B' ' 129' ' ' VAL . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.929 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.627 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.030000000000001 112.495 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.549 ' HD2' HG12 ' A' ' 128' ' ' VAL . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.120000000000005 110.889 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.722 HG21 ' N ' ' B' ' 147' ' ' ALA . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 71.430000000000007 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.627 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.420000000000002 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.200000000000003 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.340000000000003 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.409999999999997 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.349999999999994 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.839 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.120000000000005 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.340000000000003 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.420000000000002 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.030000000000001 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.722 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 70.010000000000005 111.019 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.219999999999999 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.200000000000003 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.693 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 110.857 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.556 ' HD1' HD11 ' B' ' 126' ' ' ILE . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.916 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 51.340000000000003 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 61.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.425 HG13 HD22 ' B' ' 125' ' ' LEU . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.150000000000006 111.128 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 63.450000000000003 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.329999999999998 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.681 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 65.430000000000007 110.908 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 61.240000000000002 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.310000000000002 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.219999999999999 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.621 ' HB3' HD13 ' B' ' 118' ' ' ILE . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.856 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 64.109999999999999 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.450000000000003 110.911 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.873 0.368 . . . . 71.219999999999999 110.948 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.585 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.439999999999998 110.928 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' CZ ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 70.010000000000005 110.953 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.549999999999997 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' B' ' 157' ' ' PHE . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 111.171 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.126 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.399999999999999 111.162 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 54.130000000000003 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.010000000000005 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 111.149 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 154' ' ' ILE . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.93 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.400000000000006 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.310000000000002 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' B' ' 128' ' ' VAL . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 55.140000000000001 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 150' ' ' LEU . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.319999999999993 111.134 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.200000000000003 110.862 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.611 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.549999999999997 112.459 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.329999999999998 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.69 HG21 ' N ' ' A' ' 147' ' ' ALA . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 60.149999999999999 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.611 HG12 ' HA2' ' A' ' 131' ' ' GLY . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 111.105 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.519999999999996 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 43.340000000000003 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 65.329999999999998 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.239999999999995 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.909 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.430000000000007 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.350000000000001 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 72.219999999999999 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 71.329999999999998 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 53.509999999999998 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.69 ' N ' HG21 ' A' ' 133' ' ' THR . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 24.32 111.189 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.409999999999997 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 129' ' ' VAL . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.400000000000006 110.913 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.409999999999997 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.539999999999999 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 111.091 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' B' ' 116' ' ' VAL . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 55.210000000000001 110.875 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 73.230000000000004 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 70.540000000000006 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 63.119999999999997 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 111.131 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.851 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.230000000000004 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.64 HD23 ' NH1' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.886 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.340000000000003 110.862 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.82 0.343 . . . . 53.210000000000001 110.894 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.49 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 53.140000000000001 110.864 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.64 ' NH1' HD23 ' A' ' 164' ' ' LEU . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 72.219999999999999 110.928 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.653 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 111.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.310000000000002 111.104 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.009999999999998 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 111.133 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.239999999999995 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 41.119999999999997 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.230000000000004 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.621 ' O ' HG23 ' B' ' 128' ' ' VAL . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 54.350000000000001 111.139 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.625 HD22 ' CB ' ' B' ' 154' ' ' ILE . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.420000000000002 110.956 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.510000000000005 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.230000000000004 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' A' ' 128' ' ' VAL . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.239999999999995 111.123 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.661 HG22 HD13 ' B' ' 150' ' ' LEU . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 53.049999999999997 111.117 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.46 ' N ' HG12 ' B' ' 129' ' ' VAL . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.818 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.329999999999998 112.488 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 128' ' ' VAL . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 63.329999999999998 110.963 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' B' ' 147' ' ' ALA . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 54.020000000000003 111.124 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 54.229999999999997 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.519999999999996 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 73.409999999999997 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.109999999999999 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 63.149999999999999 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.517 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 55.520000000000003 110.852 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.350000000000001 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.140000000000001 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.540000000000006 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.140000000000001 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 31.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.5 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.661 HD13 HG22 ' B' ' 129' ' ' VAL . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.239999999999995 110.904 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.129999999999995 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 34.409999999999997 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.625 ' CB ' HD22 ' B' ' 125' ' ' LEU . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.219999999999999 111.06 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.200000000000003 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 50.240000000000002 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 116' ' ' VAL . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.519999999999996 110.924 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.150000000000006 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.520000000000003 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.209999999999994 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 114' ' ' ARG . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 35.130000000000003 111.115 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.658 ' HB3' HD13 ' B' ' 118' ' ' ILE . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.871 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.039999999999999 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.430000000000007 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 116' ' ' VAL . 9.3 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.831 0.348 . . . . 53.509999999999998 110.948 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.574 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 70.310000000000002 110.895 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 51.130000000000003 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.420000000000002 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 112' ' ' LEU . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.109999999999999 111.144 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' B' ' 117' ' ' GLN . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.439999999999998 110.998 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.519999999999996 111.118 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 54.109999999999999 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.019999999999996 111.112 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.010000000000005 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.310000000000002 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 63.32 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.796 HG23 HD22 ' B' ' 150' ' ' LEU . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.768 HD13 HG13 ' A' ' 154' ' ' ILE . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 53.32 110.909 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 72.409999999999997 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.932 HG11 HG22 ' B' ' 129' ' ' VAL . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.209999999999994 111.123 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.944 HG22 HG11 ' B' ' 128' ' ' VAL . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.133 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 129' ' ' VAL . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 70.340000000000003 110.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.109999999999999 112.478 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD2' HG12 ' B' ' 128' ' ' VAL . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.439999999999998 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 70.140000000000001 111.189 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 43.149999999999999 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 45.009999999999998 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.439999999999998 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 72.329999999999998 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.340000000000003 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.530000000000001 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 45.240000000000002 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 61.350000000000001 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 43.329999999999998 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.400000000000006 111.085 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 52.450000000000003 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 54.439999999999998 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.802 HD22 HG23 ' B' ' 124' ' ' ILE . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.219999999999999 110.923 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.430000000000007 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.768 HG13 HD13 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 72.219999999999999 111.18 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.150000000000006 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.109999999999999 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' B' ' 116' ' ' VAL . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.040000000000006 110.924 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.109999999999999 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 63.130000000000003 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.299999999999997 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.239999999999995 111.105 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.659 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.549999999999997 110.856 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 54.0 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.909 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 116' ' ' VAL . 9.2 mp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.786 0.327 . . . . 62.020000000000003 110.938 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 62.240000000000002 110.857 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 63.229999999999997 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 112' ' ' LEU . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.058 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 117' ' ' GLN . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.904 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' B' ' 162' ' ' ARG . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 111.074 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.409999999999997 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.118 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.200000000000003 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 73.049999999999997 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.802 HG23 HD22 ' A' ' 150' ' ' LEU . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.844 HD13 HG13 ' B' ' 154' ' ' ILE . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.833 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 129' ' ' VAL . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.510000000000005 111.09 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 128' ' ' VAL . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.239999999999995 111.119 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.413 ' N ' HG12 ' B' ' 129' ' ' VAL . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.129999999999995 110.893 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.63 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.340000000000003 112.57 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 73.109999999999999 110.957 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.120000000000005 111.2 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.63 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 65.239999999999995 111.133 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 70.109999999999999 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 61.030000000000001 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.030000000000001 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 70.530000000000001 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 44.350000000000001 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.120000000000005 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 63.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.299999999999997 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 61.140000000000001 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.349999999999994 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.673 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.129999999999995 111.121 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 54.299999999999997 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 71.310000000000002 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.796 HD22 HG23 ' A' ' 124' ' ' ILE . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 70.219999999999999 110.912 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.439999999999998 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.510000000000005 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ILE . . . . . 0.844 HG13 HD13 ' B' ' 125' ' ' LEU . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 44.450000000000003 111.18 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.319999999999993 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 116' ' ' VAL . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 54.240000000000002 110.822 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 51.530000000000001 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.210000000000001 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 64.530000000000001 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 72.450000000000003 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' B' ' 118' ' ' ILE . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.9 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 54.509999999999998 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.477 HD13 ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.903 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.230000000000004 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.886 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.7 mp . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.838 0.352 . . . . 54.140000000000001 110.905 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.654 ' CG ' HD22 ' B' ' 164' ' ' LEU . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 110.888 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.510000000000005 111.113 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.583 HD13 ' CB ' ' A' ' 162' ' ' ARG . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 63.030000000000001 111.098 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.140000000000001 111.043 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 55.520000000000003 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.240000000000002 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.349999999999994 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.424 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 64.049999999999997 111.11 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 129' ' ' VAL . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.882 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.129999999999995 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 53.32 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' B' ' 132' ' ' TYR . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.140000000000001 111.053 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 125' ' ' LEU . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 111.076 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 134' ' ' VAL . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 43.25 110.839 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 24.309999999999999 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' B' ' 128' ' ' VAL . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 60.409999999999997 110.93 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.310000000000002 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 130' ' ' LEU . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.420000000000002 111.085 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 60.109999999999999 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.439999999999998 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 42.25 112.532 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.099999999999994 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.150000000000006 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.030000000000001 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 61.450000000000003 110.926 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.130000000000003 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 64.420000000000002 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 141' ' ' LEU . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.048 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.209999999999994 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 42.509999999999998 111.095 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.409999999999997 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 70.319999999999993 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 129' ' ' VAL . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.889 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 65.329999999999998 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.439999999999998 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.340000000000003 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.510000000000005 111.104 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 63.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.200000000000003 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.519999999999996 112.529 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.430000000000007 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.319999999999993 111.076 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.583 ' CB ' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.400000000000006 110.852 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 159' ' ' GLY . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 110.935 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.7 HD22 ' CG ' ' B' ' 113' ' ' MET . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 110.883 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.150000000000006 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 62.32 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.7 ' CG ' HD22 ' A' ' 164' ' ' LEU . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 110.915 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 161' ' ' ALA . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.129999999999995 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 55.219999999999999 111.11 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' B' ' 162' ' ' ARG . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 111.186 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.136 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.618 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.510000000000005 112.46 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.439999999999998 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 126' ' ' ILE . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 70.140000000000001 110.942 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.618 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' B' ' 123' ' ' LEU . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.219999999999999 111.116 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.319999999999993 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.502 HG23 ' CD2' ' A' ' 132' ' ' TYR . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.140000000000001 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 111.099 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.426 ' N ' HG12 ' B' ' 129' ' ' VAL . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 64.129999999999995 110.95 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.53 ' CD2' HG23 ' A' ' 128' ' ' VAL . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 53.310000000000002 110.899 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.612 ' CB ' ' HB2' ' B' ' 147' ' ' ALA . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' B' ' 131' ' ' GLY . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 111.186 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.099999999999994 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.230000000000004 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.519999999999996 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 62.039999999999999 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 52.399999999999999 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' B' ' 145' ' ' VAL . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.931 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 73.299999999999997 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.120000000000005 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.230000000000004 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' VAL . . . . . 0.478 ' HB ' HD11 ' B' ' 141' ' ' LEU . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.2 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 72.230000000000004 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' B' ' 133' ' ' THR . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 70.439999999999998 111.114 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 65.319999999999993 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 70.5 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 124' ' ' ILE . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.450000000000003 110.972 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.219999999999999 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.319999999999993 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 34.149999999999999 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 65.510000000000005 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.433 ' O ' HD13 ' B' ' 163' ' ' LEU . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.510000000000005 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 111.139 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.585 ' CB ' HD13 ' B' ' 118' ' ' ILE . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.872 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.433 HD13 ' O ' ' B' ' 159' ' ' GLY . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 110.948 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.654 HD22 ' CG ' ' A' ' 113' ' ' MET . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.450000000000003 110.921 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.420000000000002 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.120000000000005 110.864 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.694 ' HG3' HD13 ' B' ' 164' ' ' LEU . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.879 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG21 ' CE1' ' B' ' 157' ' ' PHE . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 54.009999999999998 111.141 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.57 ' HG2' HG22 ' B' ' 118' ' ' ILE . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.510000000000005 110.936 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 111.147 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 50.439999999999998 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.340000000000003 111.094 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.219999999999999 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 50.439999999999998 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.299999999999997 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.536 HG23 HD22 ' B' ' 150' ' ' LEU . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.549999999999997 111.119 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 64.319999999999993 110.893 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.509999999999998 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.924 HG11 HG22 ' B' ' 129' ' ' VAL . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.030000000000001 111.099 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 128' ' ' VAL . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 53.439999999999998 111.087 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' ' 129' ' ' VAL . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 52.32 110.821 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.310000000000002 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.519999999999996 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.010000000000005 110.865 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.129999999999995 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.349999999999994 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.120000000000005 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.927 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 53.420000000000002 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.219999999999999 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.439999999999998 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.200000000000003 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.439999999999998 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 62.119999999999997 111.129 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 64.040000000000006 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 63.310000000000002 110.877 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 129' ' ' VAL . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 44.409999999999997 110.922 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 71.530000000000001 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.200000000000003 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 62.530000000000001 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.209999999999994 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.219999999999999 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.030000000000001 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 71.219999999999999 110.886 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.530000000000001 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 54.219999999999999 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.119999999999997 111.11 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 118' ' ' ILE . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.934 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.714 HD13 ' HG3' ' B' ' 113' ' ' MET . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.040000000000006 110.896 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.329999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.109999999999999 110.921 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.798 0.332 . . . . 74.200000000000003 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.714 ' HG3' HD13 ' A' ' 164' ' ' LEU . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.099999999999994 110.886 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 61.140000000000001 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 64.530000000000001 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.702 HG21 ' CE1' ' A' ' 157' ' ' PHE . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.181 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLN . . . . . 0.592 ' HG2' HG22 ' A' ' 118' ' ' ILE . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.019999999999996 110.914 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.57 HG22 ' HG2' ' A' ' 117' ' ' GLN . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 63.109999999999999 111.054 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.109999999999999 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 70.319999999999993 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 61.140000000000001 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 150' ' ' LEU . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 54.240000000000002 111.095 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.632 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.349999999999994 110.892 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.439999999999998 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.409999999999997 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 129' ' ' VAL . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.209999999999994 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.924 HG22 HG11 ' A' ' 128' ' ' VAL . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.167 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.477 ' N ' HG12 ' B' ' 129' ' ' VAL . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.966 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 44.210000000000001 112.482 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.109999999999999 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.140000000000001 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 65.230000000000004 111.104 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.439999999999998 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.450000000000003 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 50.350000000000001 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.129999999999995 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.150000000000006 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.52 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 70.310000000000002 110.926 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.009999999999998 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.540000000000006 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.450000000000003 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 71.219999999999999 111.068 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 24.309999999999999 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' LEU . . . . . 0.573 ' O ' HD13 ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.510000000000005 110.958 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' B' ' 147' ' ' ALA . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 110.815 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 52.350000000000001 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.310000000000002 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 72.109999999999999 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 72.310000000000002 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.627 ' CE1' HG21 ' A' ' 116' ' ' VAL . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 60.329999999999998 110.866 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.140000000000001 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.349999999999994 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.420000000000002 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 52.140000000000001 111.122 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.51 ' HB2' HD13 ' B' ' 118' ' ' ILE . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.966 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 110.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.694 HD13 ' HG3' ' A' ' 113' ' ' MET . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 110.829 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.230000000000004 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.92 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.883 0.373 . . . . 73.510000000000005 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.54 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 45.210000000000001 110.965 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 111.187 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 61.420000000000002 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 162' ' ' ARG . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 118' ' ' ILE . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 65.540000000000006 111.057 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 52.340000000000003 111.112 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 43.049999999999997 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 63.200000000000003 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 53.439999999999998 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.621 HG23 HD22 ' B' ' 150' ' ' LEU . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.107 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 110.908 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.319999999999993 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.019999999999996 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.909 HG11 HG22 ' B' ' 129' ' ' VAL . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.219999999999999 111.15 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.87 HG22 HG11 ' B' ' 128' ' ' VAL . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.089 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 129' ' ' VAL . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.030000000000001 110.917 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 61.009999999999998 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.030000000000001 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 42.340000000000003 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.130000000000003 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.150000000000006 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 61.200000000000003 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.200000000000003 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 72.239999999999995 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.530000000000001 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 71.430000000000007 110.932 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 52.210000000000001 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.019999999999996 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.350000000000001 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 62.229999999999997 111.068 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.420000000000002 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 149' ' ' LEU . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.140000000000001 110.999 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 129' ' ' VAL . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 63.020000000000003 110.924 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.310000000000002 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 53.530000000000001 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.209999999999994 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 64.340000000000003 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.200000000000003 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' B' ' 116' ' ' VAL . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.84 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 71.209999999999994 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 55.229999999999997 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.319999999999993 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 111.149 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' HD12 ' A' ' 118' ' ' ILE . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.519999999999996 110.872 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 54.109999999999999 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' B' ' 113' ' ' MET . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.881 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.917 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 72.540000000000006 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 64.200000000000003 110.87 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 64.420000000000002 111.12 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 61.409999999999997 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 162' ' ' ARG . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 111.093 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.450000000000003 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.114 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.120000000000005 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.219999999999999 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.120000000000005 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.591 HG23 HD22 ' A' ' 150' ' ' LEU . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.030000000000001 111.147 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.65 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 52.25 110.858 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 55.43 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 0.87 HG11 HG22 ' A' ' 129' ' ' VAL . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 73.200000000000003 111.072 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 128' ' ' VAL . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 111.146 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.489 ' N ' HG12 ' B' ' 129' ' ' VAL . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 65.230000000000004 110.965 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.239999999999995 112.5 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.019999999999996 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.439999999999998 111.171 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.420000000000002 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 61.43 112.429 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.430000000000007 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.530000000000001 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 61.340000000000003 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.349999999999994 110.923 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 72.049999999999997 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 51.299999999999997 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.430000000000007 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 63.409999999999997 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.519999999999996 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' B' ' 150' ' ' LEU . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 51.229999999999997 111.147 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 60.310000000000002 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' LEU . . . . . 0.572 HD23 ' O ' ' B' ' 149' ' ' LEU . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 53.119999999999997 110.975 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 124' ' ' ILE . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 110.896 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 72.129999999999995 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 60.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 61.030000000000001 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 72.299999999999997 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.340000000000003 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.219999999999999 110.872 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 52.229999999999997 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 62.009999999999998 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.436 ' HB3' HD12 ' B' ' 118' ' ' ILE . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.9 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.420000000000002 110.91 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.340000000000003 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 110.896 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 61.210000000000001 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.838 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.219999999999999 110.867 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.445 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 61.399999999999999 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.349999999999994 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG21 ' CE1' ' B' ' 157' ' ' PHE . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.230000000000004 111.084 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 52.509999999999998 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.239999999999995 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.229999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.420000000000002 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.439999999999998 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 128' ' ' VAL . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 42.409999999999997 111.156 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.495 HD22 HG23 ' A' ' 129' ' ' VAL . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.894 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.140000000000001 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' B' ' 128' ' ' VAL . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 62.43 111.136 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 147' ' ' ALA . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.159 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.419 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.869 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.430000000000007 112.439 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' B' ' 128' ' ' VAL . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 61.549999999999997 110.985 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 61.340000000000003 111.178 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.095 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.439999999999998 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.539999999999999 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.140000000000001 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.030000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.924 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.230000000000004 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 45.43 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.299999999999997 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 71.549999999999997 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 71.219999999999999 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 71.420000000000002 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 70.129999999999995 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 65.540000000000006 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 64.140000000000001 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 71.200000000000003 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 73.450000000000003 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 43.539999999999999 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.430000000000007 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.340000000000003 111.08 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 54.549999999999997 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.140000000000001 110.902 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.010000000000005 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 110.832 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 71.540000000000006 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' MET . . . . . 0.765 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.787 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.409999999999997 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.0 111.066 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.445 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 52.439999999999998 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.120000000000005 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.349999999999994 111.106 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 44.130000000000003 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.019999999999996 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.210000000000001 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.65 ' O ' HG23 ' B' ' 128' ' ' VAL . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 70.109999999999999 111.163 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.489 HD22 HG23 ' B' ' 129' ' ' VAL . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 64.209999999999994 110.898 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 61.439999999999998 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.200000000000003 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' A' ' 128' ' ' VAL . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 45.240000000000002 111.169 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.200000000000003 111.12 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.435 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 65.030000000000001 110.935 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.409999999999997 112.497 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 128' ' ' VAL . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.310000000000002 111.094 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 42.439999999999998 111.161 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.439999999999998 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 72.129999999999995 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.540000000000006 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 110.901 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.219999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.120000000000005 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 70.420000000000002 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.400000000000006 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 70.420000000000002 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 54.420000000000002 111.109 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 53.109999999999999 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.349999999999994 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 63.210000000000001 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 70.439999999999998 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 61.439999999999998 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 116' ' ' VAL . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 73.420000000000002 110.855 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.310000000000002 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 61.149999999999999 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 70.25 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 71.540000000000006 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.329999999999998 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 62.340000000000003 110.877 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.399999999999999 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 61.32 110.905 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.856 0.36 . . . . 63.210000000000001 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -53.77 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 72.120000000000005 110.868 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -111.16 153.68 43.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 72.230000000000004 110.885 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 -8.93 24.84 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.625 2.216 . . . . 55.240000000000002 112.311 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.744 HD23 ' CB ' ' A' ' 166' ' ' LYS . 1.0 OUTLIER 50.9 67.09 4.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.689 0.757 . . . . 74.109999999999999 110.865 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -171.07 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.646 2.23 . . . . 62.299999999999997 112.437 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.15 0.45 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 64.219999999999999 110.889 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.779 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.049999999999997 110.935 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.41 ' HD3' ' CB ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.833 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.239999999999995 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 54.030000000000001 111.124 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 62.409999999999997 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 62.149999999999999 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 42.219999999999999 111.14 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.430000000000007 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.420000000000002 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.200000000000003 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.459 ' CG2' HD22 ' B' ' 150' ' ' LEU . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 111.136 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.699 HD22 HG23 ' A' ' 129' ' ' VAL . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 65.409999999999997 110.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.019999999999996 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.099999999999994 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' B' ' 128' ' ' VAL . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 61.329999999999998 111.139 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 125' ' ' LEU . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.510000000000005 111.126 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.429 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 44.210000000000001 110.899 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 53.109999999999999 112.494 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.239999999999995 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.672 ' CB ' ' HB2' ' A' ' 147' ' ' ALA . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 111.098 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.554 HG12 ' HA2' ' A' ' 131' ' ' GLY . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.099999999999994 111.153 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 63.020000000000003 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 53.439999999999998 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.200000000000003 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.040000000000006 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.903 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 53.420000000000002 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.329999999999998 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.539999999999999 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.129999999999995 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 133' ' ' THR . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 43.119999999999997 111.102 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.420000000000002 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 30.329999999999998 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD13 HG22 ' A' ' 129' ' ' VAL . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.981 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 60.119999999999997 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.040000000000006 111.128 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 21.109999999999999 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.409999999999997 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.210000000000001 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.049999999999997 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 30.34 111.086 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.569 HD23 ' HG2' ' A' ' 167' ' ' MET . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 110.939 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.831 HD22 ' HB2' ' B' ' 113' ' ' MET . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 74.510000000000005 110.878 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CB ' ' HD3' ' A' ' 114' ' ' ARG . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.849 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.744 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -132.24 56.84 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.010000000000005 110.892 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.569 ' HG2' HD23 ' A' ' 163' ' ' LEU . 2.2 ttm -50.2 144.54 11.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.599 0.714 . . . . 72.25 110.944 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.7 Cg_endo -69.83 48.24 0.63 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.73 2.287 . . . . 63.25 112.345 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -84.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.994 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -79.28 -2.56 41.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.350000000000001 110.934 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.5 -24.27 45.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 110.894 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -142.22 38.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.765 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 52.439999999999998 111.073 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.776 0.322 . . . . 73.430000000000007 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -53.6 10.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.832 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -111.61 153.33 44.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.572 0.701 . . . . 73.209999999999994 110.941 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -10.99 29.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.746 2.297 . . . . 61.020000000000003 112.304 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.9 OUTLIER 52.12 67.66 3.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.592 0.711 . . . . 74.239999999999995 110.987 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.578 2.185 . . . . 71.25 112.455 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -113.59 1.04 14.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 65.019999999999996 110.902 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.831 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.129999999999995 110.894 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.682 ' NH1' HG23 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.299999999999997 110.879 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.219999999999999 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 30.149999999999999 111.183 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.682 HG23 ' NH1' ' B' ' 114' ' ' ARG . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 111.157 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.417 ' N ' HG13 ' B' ' 118' ' ' ILE . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 31.129999999999999 111.163 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 62.039999999999999 111.102 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.556 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 60.119999999999997 112.452 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 63.509999999999998 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 52.240000000000002 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 150' ' ' LEU . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.010000000000005 111.161 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.219999999999999 110.922 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 63.549999999999997 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 40.530000000000001 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 128' ' ' VAL . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 70.319999999999993 111.145 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 111.088 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.425 ' N ' HG12 ' B' ' 129' ' ' VAL . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 61.310000000000002 110.909 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.6 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.219999999999999 112.439 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.209999999999994 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.120000000000005 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.6 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 43.229999999999997 111.136 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.439999999999998 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.540000000000006 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.510000000000005 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 64.109999999999999 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 72.030000000000001 110.954 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.209999999999994 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 62.509999999999998 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.409999999999997 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.420000000000002 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.349999999999994 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.653 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 63.329999999999998 111.076 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 41.329999999999998 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.200000000000003 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.459 HD22 ' CG2' ' A' ' 124' ' ' ILE . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.230000000000004 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 54.409999999999997 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.109999999999999 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.310000000000002 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.450000000000003 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.140000000000001 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.130000000000003 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.120000000000005 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.666 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 64.109999999999999 111.081 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 61.310000000000002 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' B' ' 167' ' ' MET . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.349999999999994 110.952 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.530000000000001 110.887 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.716 ' CB ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -141.16 58.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.842 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.496 ' HG2' HD23 ' B' ' 163' ' ' LEU . 2.1 mtm -49.61 143.95 10.07 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 73.409999999999997 110.903 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.0 Cg_endo -69.9 48.11 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.744 2.296 . . . . 74.340000000000003 112.267 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 74.219999999999999 110.885 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -80.15 -2.02 42.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 71.319999999999993 110.873 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.48 -23.48 57.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.239999999999995 110.998 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -143.84 41.68 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 110.915 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 111.104 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.54 ' HZ2' ' N ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.882 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.92 -53.37 9.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 63.530000000000001 110.814 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -53.32 153.14 7.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.568 0.699 . . . . 73.109999999999999 110.959 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.58 -18.22 37.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.704 2.269 . . . . 74.310000000000002 112.42 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.24 68.07 3.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 75.019999999999996 110.934 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.0 11.67 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.72 2.28 . . . . 75.450000000000003 112.328 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 1.07 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.299999999999997 110.847 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.705 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.329999999999998 110.927 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 53.030000000000001 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.709 HG11 ' CE1' ' B' ' 157' ' ' PHE . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 111.169 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.692 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.968 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.68 HG22 ' HG3' ' B' ' 117' ' ' GLN . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.209999999999994 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 118' ' ' ILE . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.319999999999993 111.101 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.038 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.583 ' HA2' HD11 ' B' ' 154' ' ' ILE . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.450000000000003 112.52 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.329999999999998 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.409999999999997 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.699 ' CG2' HD22 ' B' ' 150' ' ' LEU . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 111.139 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 71.049999999999997 110.897 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 62.119999999999997 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 62.229999999999997 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.788 HG11 HG22 ' B' ' 129' ' ' VAL . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 61.140000000000001 111.123 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.796 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.097 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.889 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 43.149999999999999 112.462 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.409999999999997 110.923 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.7 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 65.319999999999993 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.599 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.5 111.057 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.530000000000001 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.230000000000004 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 43.340000000000003 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.439999999999998 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 32.130000000000003 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 45.039999999999999 110.958 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.399999999999999 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 133' ' ' THR . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 70.010000000000005 112.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 71.329999999999998 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 61.109999999999999 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 64.340000000000003 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.7 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.010000000000005 111.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.230000000000004 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 61.340000000000003 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CG2' ' B' ' 124' ' ' ILE . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 110.967 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.150000000000006 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 52.100000000000001 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.564 HD11 ' HA2' ' B' ' 121' ' ' GLY . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 74.219999999999999 111.088 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.723 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 71.109999999999999 110.907 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 55.439999999999998 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.040000000000006 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 73.450000000000003 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.530000000000001 111.138 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' HD13 ' A' ' 118' ' ' ILE . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 61.130000000000003 110.867 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 62.43 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.239999999999995 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 61.200000000000003 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.76 59.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 72.129999999999995 110.929 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 ptp -51.52 153.74 3.68 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.518 0.675 . . . . 71.219999999999999 110.866 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 53.56 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.601 2.201 . . . . 74.519999999999996 112.357 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -83.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 75.120000000000005 110.907 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -80.84 -1.21 42.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 61.43 110.925 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -95.02 23.47 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.885 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.89 64.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 63.43 110.838 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 71.420000000000002 111.07 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.518 ' N ' ' HZ2' ' B' ' 106' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.743 0.306 . . . . 53.43 110.841 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -53.33 10.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 74.140000000000001 110.8 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -52.77 153.6 5.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.637 0.732 . . . . 73.409999999999997 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -21.72 32.71 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.585 2.19 . . . . 64.530000000000001 112.41 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.44 67.54 4.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 110.9 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 177.1 5.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.638 2.225 . . . . 63.420000000000002 112.381 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.401 ' O ' HG23 ' B' ' 116' ' ' VAL . 95.3 mt -120.15 0.97 10.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 51.119999999999997 110.888 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.687 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.886 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 53.210000000000001 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.723 HG11 ' CE1' ' A' ' 157' ' ' PHE . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.319999999999993 111.142 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLN . . . . . 0.68 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 110.942 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.692 HG22 ' HG3' ' A' ' 117' ' ' GLN . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.510000000000005 111.175 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.413 ' N ' HD12 ' B' ' 118' ' ' ILE . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.019999999999996 111.09 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 154' ' ' ILE . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 65.400000000000006 112.503 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.099999999999994 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 70.430000000000007 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.68 ' CG2' HD22 ' A' ' 150' ' ' LEU . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.439999999999998 111.092 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.545 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.958 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 62.130000000000003 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.796 HG11 HG22 ' A' ' 129' ' ' VAL . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 54.450000000000003 111.05 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.788 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.219999999999999 111.149 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.443 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.947 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.540000000000006 112.433 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.5 ' CD2' HG12 ' A' ' 128' ' ' VAL . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 74.450000000000003 110.864 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.679 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.219999999999999 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 64.310000000000002 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 65.140000000000001 110.95 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.519999999999996 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.409999999999997 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.120000000000005 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 71.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 70.239999999999995 110.915 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 53.140000000000001 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' B' ' 133' ' ' THR . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.439999999999998 112.552 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 73.030000000000001 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 62.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 62.350000000000001 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.679 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 71.019999999999996 111.089 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 60.229999999999997 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.699 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 111.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.519999999999996 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.299999999999997 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 64.219999999999999 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.583 HD11 ' HA2' ' A' ' 121' ' ' GLY . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.439999999999998 111.141 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 61.210000000000001 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.709 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 72.439999999999998 110.918 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.349999999999994 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 60.229999999999997 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.150000000000006 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 52.420000000000002 111.169 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.631 ' HB2' HD13 ' B' ' 118' ' ' ILE . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.926 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 65.049999999999997 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.319999999999993 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.409999999999997 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.42 60.37 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.210000000000001 110.946 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.3 ptp -52.01 153.62 4.49 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 70.140000000000001 110.865 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.87 53.5 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.613 2.209 . . . . 61.450000000000003 112.383 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 62.509999999999998 110.927 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -81.03 -1.09 42.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.938 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.98 23.42 5.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.914 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -25.69 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 65.420000000000002 111.114 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 73.319999999999993 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.73 11.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 42.140000000000001 110.9 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -131.71 153.79 81.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.310000000000002 110.932 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -7.8 22.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.62 2.213 . . . . 64.430000000000007 112.382 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 166' ' ' LYS . 1.0 OUTLIER 52.08 65.77 5.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.649 0.738 . . . . 64.030000000000001 110.961 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -173.13 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.653 2.235 . . . . 61.539999999999999 112.405 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.32 1.87 10.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 42.32 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.578 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.836 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 71.209999999999994 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' B' ' 157' ' ' PHE . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 111.145 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 60.229999999999997 110.891 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 162' ' ' ARG . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 111.156 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.329999999999998 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 54.399999999999999 111.149 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 55.210000000000001 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 42.340000000000003 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 73.420000000000002 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.526 HG23 HD22 ' B' ' 150' ' ' LEU . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.219999999999999 111.217 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.540000000000006 110.949 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 70.030000000000001 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 62.030000000000001 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.918 HG11 HG22 ' B' ' 129' ' ' VAL . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.329999999999998 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 128' ' ' VAL . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.329999999999998 111.132 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.040000000000006 110.945 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.140000000000001 112.543 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.200000000000003 111.155 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.61 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 61.25 111.075 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.239999999999995 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 51.009999999999998 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.140000000000001 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.209999999999994 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.210000000000001 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.109999999999999 110.851 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.140000000000001 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.040000000000006 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 54.439999999999998 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.329999999999998 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.6 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.329999999999998 111.077 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.120000000000005 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 43.420000000000002 110.885 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 129' ' ' VAL . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.925 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 54.32 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 63.109999999999999 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.129999999999995 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 71.510000000000005 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.200000000000003 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' B' ' 116' ' ' VAL . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.916 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 53.299999999999997 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 163' ' ' LEU . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.129999999999995 112.482 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.439999999999998 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 51.439999999999998 111.128 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HB3' HD13 ' A' ' 118' ' ' ILE . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 110.88 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 167' ' ' MET . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.963 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.869 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.746 ' HB2' HD23 ' A' ' 110' ' ' LEU . 9.1 ptmt -165.18 59.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.299999999999997 110.849 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 163' ' ' LEU . 18.4 ptp -54.37 152.91 10.81 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.475 0.655 . . . . 75.150000000000006 110.924 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 50.97 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 71.310000000000002 112.304 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 75.209999999999994 110.927 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.83 -0.5 48.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.519999999999996 110.799 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.75 21.99 6.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 62.25 110.99 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.9 -25.06 59.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 75.340000000000003 110.869 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 64.450000000000003 111.019 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.802 0.334 . . . . 51.009999999999998 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -53.57 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.129999999999995 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -131.58 153.67 81.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.544 0.688 . . . . 74.439999999999998 110.851 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -11.97 31.94 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.695 2.263 . . . . 64.239999999999995 112.323 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.83 HD23 ' HB2' ' B' ' 166' ' ' LYS . 1.1 mp 56.2 65.45 4.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.54 0.686 . . . . 61.32 110.893 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -171.78 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.643 2.229 . . . . 70.329999999999998 112.322 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.1 1.34 10.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 52.210000000000001 110.902 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.642 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.089 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLN . . . . . 0.526 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 54.420000000000002 110.943 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' B' ' 162' ' ' ARG . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 61.43 111.161 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 72.519999999999996 111.136 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.530000000000001 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.420000000000002 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.230000000000004 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.513 HG23 HD22 ' A' ' 150' ' ' LEU . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.319999999999993 111.092 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.626 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 63.32 110.92 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 63.039999999999999 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 50.140000000000001 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.911 HG11 HG22 ' A' ' 129' ' ' VAL . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 128' ' ' VAL . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.146 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.483 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 51.109999999999999 110.923 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.439999999999998 112.519 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.340000000000003 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.400000000000006 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.030000000000001 111.147 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.209999999999994 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.119999999999997 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.219999999999999 112.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.510000000000005 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.925 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 54.039999999999999 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.140000000000001 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.010000000000005 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 45.329999999999998 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.591 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 42.310000000000002 110.966 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.540000000000006 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' LEU . . . . . 0.568 ' O ' HD13 ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 62.25 110.961 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 124' ' ' ILE . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 110.926 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.430000000000007 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 70.329999999999998 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.040000000000006 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.310000000000002 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.340000000000003 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.409999999999997 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.584 ' CE1' HG21 ' A' ' 116' ' ' VAL . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.847 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.519999999999996 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.56 ' O ' HD12 ' B' ' 163' ' ' LEU . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 42.130000000000003 112.504 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.420000000000002 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 53.130000000000003 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.582 ' HB3' HD13 ' B' ' 118' ' ' ILE . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 110.928 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' B' ' 167' ' ' MET . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.109999999999999 110.861 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.319999999999993 110.982 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.400000000000006 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.83 ' HB2' HD23 ' B' ' 110' ' ' LEU . 8.0 ptmt -165.51 60.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.886 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.694 ' CB ' HD23 ' B' ' 163' ' ' LEU . 18.8 ptp -53.8 152.77 9.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 75.010000000000005 110.834 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 51.15 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.75 2.3 . . . . 74.510000000000005 112.276 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' B' ' 167' ' ' MET . 0.0 OUTLIER -50.89 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 74.140000000000001 110.967 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -83.13 -0.52 49.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 73.049999999999997 110.822 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.47 22.03 6.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 110.874 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.52 -25.2 60.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.319999999999993 110.88 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.02 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.2 mttp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.861 0.363 . . . . 55.409999999999997 110.837 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -53.72 10.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 75.019999999999996 110.867 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -83.75 153.9 64.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.562 0.696 . . . . 74.230000000000004 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.78 -11.8 31.55 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.662 2.241 . . . . 64.150000000000006 112.284 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER 51.55 67.3 4.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 63.109999999999999 110.925 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.67 2.247 . . . . 61.310000000000002 112.409 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.07 2.53 12.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.310000000000002 110.926 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.587 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.869 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' B' ' 161' ' ' ALA . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.019999999999996 110.929 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.681 HG11 ' CE1' ' B' ' 157' ' ' PHE . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 54.549999999999997 111.158 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.340000000000003 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.129999999999995 111.111 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.230000000000004 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 53.329999999999998 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 71.239999999999995 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 63.030000000000001 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.693 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.588 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 71.430000000000007 110.978 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 151' ' ' PHE . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 71.040000000000006 111.103 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 34.329999999999998 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 129' ' ' VAL . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.219999999999999 111.163 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.843 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.140000000000001 111.097 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' A' ' 129' ' ' VAL . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.89 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.524 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 73.329999999999998 110.934 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' A' ' 147' ' ' ALA . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.530000000000001 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 64.400000000000006 111.089 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.200000000000003 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 41.32 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.010000000000005 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.439999999999998 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.329999999999998 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.150000000000006 110.891 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.129999999999995 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.049999999999997 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 72.420000000000002 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.099999999999994 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' A' ' 133' ' ' THR . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.430000000000007 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.099999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 61.350000000000001 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.703 HD22 ' CG2' ' B' ' 124' ' ' ILE . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.975 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.586 ' HD1' HD11 ' A' ' 126' ' ' ILE . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 110.877 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.409999999999997 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 42.350000000000001 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 HD13 ' A' ' 125' ' ' LEU . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.109999999999999 111.09 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 62.420000000000002 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 62.25 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 64.450000000000003 110.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.310000000000002 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.349999999999994 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 43.509999999999998 111.074 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.654 ' HB3' HD13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.340000000000003 110.874 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.598 HD22 ' NH2' ' B' ' 114' ' ' ARG . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 62.340000000000003 110.956 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.109999999999999 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.454 ' CB ' HD23 ' A' ' 110' ' ' LEU . 1.3 ptmt -142.79 57.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 54.030000000000001 110.925 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 mtm -50.76 142.9 15.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.642 0.734 . . . . 43.310000000000002 110.837 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 54.2 Cg_endo -69.66 48.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.256 . . . . 62.140000000000001 112.396 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 110.999 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.82 -7.82 50.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 63.020000000000003 110.932 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.17 23.52 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -26.13 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 73.420000000000002 110.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.140000000000001 111.054 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.6 mttp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.774 0.321 . . . . 64.510000000000005 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.01 -53.12 10.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 72.340000000000003 110.781 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -84.56 153.67 61.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.561 0.696 . . . . 71.109999999999999 110.851 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -12.28 32.68 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.695 2.263 . . . . 72.219999999999999 112.322 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.6 OUTLIER 51.72 67.18 4.36 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 60.450000000000003 110.854 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.92 -169.17 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 75.129999999999995 112.306 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.63 1.62 14.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 75.349999999999994 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 110.885 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.598 ' NH2' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 62.420000000000002 110.928 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 157' ' ' PHE . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 71.109999999999999 111.077 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 53.340000000000003 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 51.299999999999997 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.350000000000001 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.219999999999999 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 64.219999999999999 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 71.319999999999993 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.703 ' CG2' HD22 ' A' ' 150' ' ' LEU . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.230000000000004 111.134 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 65.409999999999997 110.908 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.556 HD11 ' HD1' ' B' ' 151' ' ' PHE . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 60.140000000000001 111.152 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.520000000000003 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.843 HG11 HG22 ' A' ' 129' ' ' VAL . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 53.420000000000002 111.17 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.823 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 111.11 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' B' ' 129' ' ' VAL . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.929 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.627 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.030000000000001 112.495 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.549 ' HD2' HG12 ' A' ' 128' ' ' VAL . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.120000000000005 110.889 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.722 HG21 ' N ' ' B' ' 147' ' ' ALA . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 71.430000000000007 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.627 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.420000000000002 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.200000000000003 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.340000000000003 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.409999999999997 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.349999999999994 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.839 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.120000000000005 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.340000000000003 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.420000000000002 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.030000000000001 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.722 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 70.010000000000005 111.019 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.219999999999999 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.200000000000003 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.693 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 110.857 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.556 ' HD1' HD11 ' B' ' 126' ' ' ILE . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.916 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 51.340000000000003 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 61.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.425 HG13 HD22 ' B' ' 125' ' ' LEU . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.150000000000006 111.128 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 63.450000000000003 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.329999999999998 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.681 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 65.430000000000007 110.908 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 61.240000000000002 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.310000000000002 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.219999999999999 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.621 ' HB3' HD13 ' B' ' 118' ' ' ILE . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.856 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 64.109999999999999 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.48 ' CB ' HD23 ' B' ' 110' ' ' LEU . 1.4 ptmt -139.92 57.69 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.450000000000003 110.911 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.435 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.2 mtm -49.62 143.36 10.85 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.582 0.706 . . . . 74.019999999999996 110.855 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.435 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 52.9 Cg_endo -69.82 48.44 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 74.140000000000001 112.298 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 62.020000000000003 110.866 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -7.44 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 72.219999999999999 110.863 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.09 23.8 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 74.540000000000006 110.947 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -26.22 64.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.892 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.019 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 54.329999999999998 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -52.83 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 74.439999999999998 110.901 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.84 153.87 47.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 75.340000000000003 110.906 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 -11.36 30.77 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.259 . . . . 63.009999999999998 112.38 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER 51.07 69.35 2.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.559 0.695 . . . . 45.439999999999998 110.918 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.24 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.675 2.25 . . . . 73.230000000000004 112.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.69 1.78 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.219999999999999 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.585 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.439999999999998 110.928 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' CZ ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 70.010000000000005 110.953 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.549999999999997 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' B' ' 157' ' ' PHE . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 111.171 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.126 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.399999999999999 111.162 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 54.130000000000003 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.439999999999998 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.010000000000005 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 111.149 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 154' ' ' ILE . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.93 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.400000000000006 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.310000000000002 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' B' ' 128' ' ' VAL . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 55.140000000000001 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 150' ' ' LEU . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.319999999999993 111.134 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.200000000000003 110.862 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.611 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.549999999999997 112.459 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.329999999999998 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.69 HG21 ' N ' ' A' ' 147' ' ' ALA . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 60.149999999999999 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.611 HG12 ' HA2' ' A' ' 131' ' ' GLY . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.430000000000007 111.105 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.519999999999996 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 43.340000000000003 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 65.329999999999998 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.239999999999995 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.909 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.430000000000007 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.350000000000001 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 72.219999999999999 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 71.329999999999998 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 53.509999999999998 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.69 ' N ' HG21 ' A' ' 133' ' ' THR . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 24.32 111.189 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.409999999999997 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 129' ' ' VAL . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.400000000000006 110.913 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.409999999999997 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.539999999999999 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 111.091 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' B' ' 116' ' ' VAL . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 55.210000000000001 110.875 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 73.230000000000004 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 70.540000000000006 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 63.119999999999997 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.310000000000002 111.131 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.851 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.230000000000004 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.64 HD23 ' NH1' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.886 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.689 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -144.22 57.66 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.340000000000003 110.862 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.426 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.2 mtm -49.95 143.58 11.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.489 0.661 . . . . 73.049999999999997 110.92 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.8 Cg_endo -69.68 48.03 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.682 2.255 . . . . 62.030000000000001 112.327 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -82.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 71.400000000000006 110.953 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -80.26 -1.9 42.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -54.74 -25.98 31.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.974 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 ptt85 -179.32 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 73.510000000000005 110.915 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.25 111.149 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.762 0.315 . . . . 73.430000000000007 110.849 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.48 -52.28 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.52 153.57 48.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 70.120000000000005 110.924 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.85 -11.92 31.68 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.643 2.229 . . . . 74.519999999999996 112.314 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.674 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.6 OUTLIER 51.15 68.53 3.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.692 0.758 . . . . 64.120000000000005 110.935 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.89 -170.46 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.604 2.203 . . . . 73.540000000000006 112.368 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.02 1.48 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 53.210000000000001 110.894 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.49 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 53.140000000000001 110.864 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.64 ' NH1' HD23 ' A' ' 164' ' ' LEU . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 72.219999999999999 110.928 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.653 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 111.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.310000000000002 111.104 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.009999999999998 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 111.133 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.239999999999995 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 41.119999999999997 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.230000000000004 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.621 ' O ' HG23 ' B' ' 128' ' ' VAL . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 54.350000000000001 111.139 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.625 HD22 ' CB ' ' B' ' 154' ' ' ILE . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.420000000000002 110.956 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.510000000000005 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.230000000000004 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' A' ' 128' ' ' VAL . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.239999999999995 111.123 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.661 HG22 HD13 ' B' ' 150' ' ' LEU . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 53.049999999999997 111.117 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.46 ' N ' HG12 ' B' ' 129' ' ' VAL . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.818 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.329999999999998 112.488 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 128' ' ' VAL . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 63.329999999999998 110.963 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' B' ' 147' ' ' ALA . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.420000000000002 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 54.020000000000003 111.124 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 54.229999999999997 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.519999999999996 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 73.409999999999997 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.109999999999999 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 63.149999999999999 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.517 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 55.520000000000003 110.852 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.350000000000001 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.140000000000001 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.540000000000006 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.140000000000001 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 31.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.5 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.661 HD13 HG22 ' B' ' 129' ' ' VAL . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.239999999999995 110.904 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.129999999999995 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 34.409999999999997 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.625 ' CB ' HD22 ' B' ' 125' ' ' LEU . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.219999999999999 111.06 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.200000000000003 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 50.240000000000002 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 116' ' ' VAL . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.519999999999996 110.924 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.150000000000006 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.520000000000003 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.209999999999994 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 114' ' ' ARG . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 35.130000000000003 111.115 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.658 ' HB3' HD13 ' B' ' 118' ' ' ILE . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.871 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.039999999999999 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.674 ' CB ' HD23 ' B' ' 110' ' ' LEU . 0.4 OUTLIER -142.19 58.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.430000000000007 110.921 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.427 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.1 mtm -50.26 144.24 11.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 64.109999999999999 110.844 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.427 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 52.9 Cg_endo -69.77 48.18 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 74.349999999999994 112.311 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 63.439999999999998 110.953 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.56 -1.29 41.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 74.349999999999994 110.924 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -54.85 -25.97 32.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.905 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 ptt85 -179.66 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.854 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.5 111.154 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.716 0.294 . . . . 73.530000000000001 110.878 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -52.42 8.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 73.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 158.38 46.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.709 . . . . 74.400000000000006 110.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -11.57 31.27 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.612 2.208 . . . . 64.109999999999999 112.386 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt 59.37 68.92 1.43 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.597 0.713 . . . . 72.019999999999996 110.952 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -170.65 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 64.040000000000006 112.3 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 116' ' ' VAL . 9.3 mp -113.13 1.24 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 53.509999999999998 110.948 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.574 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 70.310000000000002 110.895 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 51.130000000000003 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.420000000000002 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 112' ' ' LEU . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.109999999999999 111.144 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' B' ' 117' ' ' GLN . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.439999999999998 110.998 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.519999999999996 111.118 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 54.109999999999999 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.019999999999996 111.112 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.010000000000005 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.310000000000002 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 63.32 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.796 HG23 HD22 ' B' ' 150' ' ' LEU . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.768 HD13 HG13 ' A' ' 154' ' ' ILE . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 53.32 110.909 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 72.409999999999997 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.439999999999998 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.932 HG11 HG22 ' B' ' 129' ' ' VAL . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.209999999999994 111.123 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.944 HG22 HG11 ' B' ' 128' ' ' VAL . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.133 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 129' ' ' VAL . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 70.340000000000003 110.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.109999999999999 112.478 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD2' HG12 ' B' ' 128' ' ' VAL . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.439999999999998 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 70.140000000000001 111.189 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 43.149999999999999 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 45.009999999999998 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.439999999999998 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 72.329999999999998 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.340000000000003 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.530000000000001 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 45.240000000000002 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 61.350000000000001 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 43.329999999999998 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.400000000000006 111.085 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 52.450000000000003 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 54.439999999999998 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.802 HD22 HG23 ' B' ' 124' ' ' ILE . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.219999999999999 110.923 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 64.299999999999997 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.430000000000007 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.768 HG13 HD13 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 72.219999999999999 111.18 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.150000000000006 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.109999999999999 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' B' ' 116' ' ' VAL . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.040000000000006 110.924 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.109999999999999 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 63.130000000000003 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.299999999999997 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.239999999999995 111.105 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.659 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.549999999999997 110.856 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 54.0 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -153.22 56.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.909 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.4 mtm -48.76 142.58 8.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.572 0.701 . . . . 72.040000000000006 110.862 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.2 Cg_endo -69.93 48.31 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.530000000000001 112.335 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 62.229999999999997 110.918 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -79.64 -2.27 41.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.907 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -57.3 -23.9 51.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 50.25 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.36 -39.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.329999999999998 110.895 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 62.299999999999997 111.102 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.797 0.332 . . . . 75.439999999999998 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 -52.33 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 63.32 110.805 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.44 158.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.524 0.678 . . . . 72.120000000000005 110.985 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -16.34 37.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.75 2.3 . . . . 74.010000000000005 112.292 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mt 63.81 68.2 0.89 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.7 . . . . 43.240000000000002 110.862 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.669 2.246 . . . . 73.209999999999994 112.323 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 116' ' ' VAL . 9.2 mp -110.3 1.04 18.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.020000000000003 110.938 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 62.240000000000002 110.857 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 63.229999999999997 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 112' ' ' LEU . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.120000000000005 111.058 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 117' ' ' GLN . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.904 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' B' ' 162' ' ' ARG . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 111.074 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.409999999999997 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.118 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.200000000000003 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 73.049999999999997 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.802 HG23 HD22 ' A' ' 150' ' ' LEU . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.844 HD13 HG13 ' B' ' 154' ' ' ILE . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.833 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 129' ' ' VAL . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.510000000000005 111.09 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 128' ' ' VAL . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.239999999999995 111.119 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.413 ' N ' HG12 ' B' ' 129' ' ' VAL . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.129999999999995 110.893 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.63 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.340000000000003 112.57 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 73.109999999999999 110.957 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.120000000000005 111.2 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.63 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 65.239999999999995 111.133 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 70.109999999999999 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 61.030000000000001 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.030000000000001 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 70.530000000000001 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 44.350000000000001 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.120000000000005 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 63.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.299999999999997 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 61.140000000000001 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.349999999999994 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.673 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.129999999999995 111.121 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 54.299999999999997 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 71.310000000000002 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.796 HD22 HG23 ' A' ' 124' ' ' ILE . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 70.219999999999999 110.912 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.439999999999998 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.510000000000005 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.844 HG13 HD13 ' B' ' 125' ' ' LEU . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 44.450000000000003 111.18 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.319999999999993 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 116' ' ' VAL . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 54.240000000000002 110.822 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 51.530000000000001 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.210000000000001 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 64.530000000000001 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 72.450000000000003 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' B' ' 118' ' ' ILE . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.9 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 54.509999999999998 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.477 HD13 ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.903 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.230000000000004 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -150.88 57.55 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.540000000000006 110.886 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.443 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.3 mtm -48.31 143.38 7.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.819 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 54.0 Cg_endo -69.87 48.87 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.537 2.158 . . . . 74.329999999999998 112.373 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -85.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.450000000000003 110.847 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -80.35 -2.2 44.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.129999999999995 110.863 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.74 -24.51 50.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.299999999999997 110.882 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.51 -37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 75.040000000000006 110.934 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 61.109999999999999 111.177 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.465 ' HG2' HD11 ' A' ' 110' ' ' LEU . 1.1 tttm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.762 0.315 . . . . 41.240000000000002 110.931 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -50.88 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 60.299999999999997 110.759 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -52.08 157.18 2.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 73.430000000000007 110.948 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.48 31.87 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 70.439999999999998 112.35 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 106' ' ' LYS . 0.7 OUTLIER 50.23 68.24 3.62 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.581 0.705 . . . . 70.540000000000006 110.932 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -173.02 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 64.549999999999997 112.326 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.7 mp -119.64 0.99 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 54.140000000000001 110.905 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.654 ' CG ' HD22 ' B' ' 164' ' ' LEU . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 110.888 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.510000000000005 111.113 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.583 HD13 ' CB ' ' A' ' 162' ' ' ARG . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 63.030000000000001 111.098 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.140000000000001 111.043 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 55.520000000000003 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.240000000000002 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.349999999999994 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.424 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 64.049999999999997 111.11 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 129' ' ' VAL . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.882 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.129999999999995 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 53.32 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' B' ' 132' ' ' TYR . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.140000000000001 111.053 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 125' ' ' LEU . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 111.076 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 134' ' ' VAL . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 43.25 110.839 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 24.309999999999999 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' B' ' 128' ' ' VAL . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 60.409999999999997 110.93 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.310000000000002 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 130' ' ' LEU . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.420000000000002 111.085 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 60.109999999999999 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.439999999999998 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 42.25 112.532 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.099999999999994 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.150000000000006 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.030000000000001 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 61.450000000000003 110.926 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.130000000000003 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 64.420000000000002 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.239999999999995 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 141' ' ' LEU . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.048 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.209999999999994 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 42.509999999999998 111.095 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.409999999999997 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 70.319999999999993 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 129' ' ' VAL . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.889 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 65.329999999999998 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.439999999999998 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.340000000000003 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.510000000000005 111.104 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 63.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.200000000000003 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.519999999999996 112.529 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.430000000000007 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.319999999999993 111.076 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.583 ' CB ' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.400000000000006 110.852 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 159' ' ' GLY . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 110.935 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.7 HD22 ' CG ' ' B' ' 113' ' ' MET . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 110.883 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -147.09 57.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.150000000000006 110.846 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.447 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 mtm -50.48 143.36 13.91 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.644 0.735 . . . . 73.510000000000005 110.811 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.447 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.3 Cg_endo -69.72 48.25 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.648 2.232 . . . . 72.109999999999999 112.374 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.33 -82.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.917 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -78.75 -2.86 41.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 61.310000000000002 110.913 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.51 -24.16 44.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 72.109999999999999 111.001 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.39 59.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.818 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 62.039999999999999 111.086 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.784 0.326 . . . . 72.219999999999999 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -50.47 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 63.5 110.804 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -52.82 157.31 2.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 70.109999999999999 110.833 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.1 31.11 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.653 2.235 . . . . 70.120000000000005 112.379 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.3 67.7 4.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.647 0.737 . . . . 63.210000000000001 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 65.420000000000002 112.375 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.25 1.19 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 62.32 110.909 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.7 ' CG ' HD22 ' A' ' 164' ' ' LEU . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.239999999999995 110.915 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 161' ' ' ALA . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.129999999999995 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 55.219999999999999 111.11 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' B' ' 162' ' ' ARG . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 111.186 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.136 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.618 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.510000000000005 112.46 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.439999999999998 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 126' ' ' ILE . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 70.140000000000001 110.942 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.618 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' B' ' 123' ' ' LEU . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.219999999999999 111.116 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.319999999999993 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.502 HG23 ' CD2' ' A' ' 132' ' ' TYR . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.140000000000001 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 111.099 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.426 ' N ' HG12 ' B' ' 129' ' ' VAL . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 64.129999999999995 110.95 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.53 ' CD2' HG23 ' A' ' 128' ' ' VAL . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 53.310000000000002 110.899 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.612 ' CB ' ' HB2' ' B' ' 147' ' ' ALA . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.140000000000001 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' B' ' 131' ' ' GLY . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 111.186 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.099999999999994 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.230000000000004 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.519999999999996 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 62.039999999999999 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 52.399999999999999 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' B' ' 145' ' ' VAL . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.931 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 73.299999999999997 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.120000000000005 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.230000000000004 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' VAL . . . . . 0.478 ' HB ' HD11 ' B' ' 141' ' ' LEU . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.2 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 72.230000000000004 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' CB ' ' B' ' 133' ' ' THR . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 70.439999999999998 111.114 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 65.319999999999993 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 70.5 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 124' ' ' ILE . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.450000000000003 110.972 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.219999999999999 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.319999999999993 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 34.149999999999999 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 65.510000000000005 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.433 ' O ' HD13 ' B' ' 163' ' ' LEU . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.510000000000005 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 111.139 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.585 ' CB ' HD13 ' B' ' 118' ' ' ILE . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.872 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.433 HD13 ' O ' ' B' ' 159' ' ' GLY . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 61.340000000000003 110.948 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.654 HD22 ' CG ' ' A' ' 113' ' ' MET . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.450000000000003 110.921 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.420000000000002 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.21 57.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.120000000000005 110.864 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.43 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.2 mtm -50.81 143.93 14.09 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.57 0.7 . . . . 73.409999999999997 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.43 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 54.0 Cg_endo -69.75 48.46 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.643 2.229 . . . . 60.329999999999998 112.415 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 72.420000000000002 110.967 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -79.21 -2.63 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.420000000000002 110.839 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -24.43 48.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 42.420000000000002 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.24 59.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 64.319999999999993 110.848 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 51.539999999999999 111.056 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -52.87 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 42.32 110.884 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.585 ' O ' HD12 ' A' ' 110' ' ' LEU . 2.6 mp0 -51.59 159.89 1.15 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.698 0.761 . . . . 62.310000000000002 110.833 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.62 -27.39 27.2 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.749 2.299 . . . . 65.420000000000002 112.358 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 ' CB ' ' A' ' 166' ' ' LYS . 1.2 mp 49.63 67.58 4.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.565 0.698 . . . . 52.329999999999998 110.854 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -178.56 2.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.694 2.263 . . . . 74.540000000000006 112.381 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.29 -0.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 74.519999999999996 110.901 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.694 ' HG3' HD13 ' B' ' 164' ' ' LEU . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.879 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG21 ' CE1' ' B' ' 157' ' ' PHE . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 54.009999999999998 111.141 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.57 ' HG2' HG22 ' B' ' 118' ' ' ILE . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.510000000000005 110.936 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 111.147 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 50.439999999999998 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.340000000000003 111.094 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.219999999999999 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 50.439999999999998 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.299999999999997 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.536 HG23 HD22 ' B' ' 150' ' ' LEU . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.549999999999997 111.119 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 64.319999999999993 110.893 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.509999999999998 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.924 HG11 HG22 ' B' ' 129' ' ' VAL . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.030000000000001 111.099 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 128' ' ' VAL . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 53.439999999999998 111.087 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' ' 129' ' ' VAL . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 52.32 110.821 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.310000000000002 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.519999999999996 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.219999999999999 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.010000000000005 110.865 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.129999999999995 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.349999999999994 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.120000000000005 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.927 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 53.420000000000002 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.219999999999999 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.439999999999998 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.200000000000003 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.439999999999998 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 62.119999999999997 111.129 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 64.040000000000006 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 63.310000000000002 110.877 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 129' ' ' VAL . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 44.409999999999997 110.922 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 71.530000000000001 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.200000000000003 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 62.530000000000001 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.209999999999994 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.219999999999999 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.030000000000001 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 71.219999999999999 110.886 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.530000000000001 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 54.219999999999999 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 72.430000000000007 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.119999999999997 111.11 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 118' ' ' ILE . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.934 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.714 HD13 ' HG3' ' B' ' 113' ' ' MET . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.040000000000006 110.896 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.329999999999998 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.671 ' CB ' HD23 ' A' ' 110' ' ' LEU . 7.1 ptmm? -148.04 56.94 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.109999999999999 110.921 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.453 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 ttm -50.09 142.9 13.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 72.439999999999998 110.908 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 54.0 Cg_endo -69.65 48.16 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.63 2.22 . . . . 64.310000000000002 112.369 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 63.130000000000003 110.821 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -9.69 54.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.909 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -96.28 22.98 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.834 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.07 -35.35 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 110.855 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 74.120000000000005 111.118 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.871 0.367 . . . . 75.329999999999998 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -53.12 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.876 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLN . . . . . 0.67 ' O ' HD12 ' B' ' 110' ' ' LEU . 2.4 mp0 -52.7 159.56 1.71 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 73.129999999999995 110.908 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -28.36 25.3 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.685 2.257 . . . . 64.209999999999994 112.33 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.67 HD12 ' O ' ' B' ' 108' ' ' GLN . 1.4 mp 49.61 65.54 6.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.589 0.709 . . . . 72.430000000000007 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 179.61 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.601 2.201 . . . . 43.119999999999997 112.352 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.23 0.07 10.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.714 ' HG3' HD13 ' A' ' 164' ' ' LEU . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.099999999999994 110.886 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 61.140000000000001 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 64.530000000000001 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.702 HG21 ' CE1' ' A' ' 157' ' ' PHE . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.181 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLN . . . . . 0.592 ' HG2' HG22 ' A' ' 118' ' ' ILE . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.019999999999996 110.914 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.57 HG22 ' HG2' ' A' ' 117' ' ' GLN . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 63.109999999999999 111.054 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.109999999999999 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 70.319999999999993 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 61.140000000000001 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 150' ' ' LEU . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 54.240000000000002 111.095 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.632 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.349999999999994 110.892 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.439999999999998 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.409999999999997 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 129' ' ' VAL . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.209999999999994 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.924 HG22 HG11 ' A' ' 128' ' ' VAL . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.167 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.477 ' N ' HG12 ' B' ' 129' ' ' VAL . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.966 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 44.210000000000001 112.482 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.109999999999999 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.140000000000001 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 65.230000000000004 111.104 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.439999999999998 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.450000000000003 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 50.350000000000001 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.129999999999995 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.150000000000006 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.52 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 70.310000000000002 110.926 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.009999999999998 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.540000000000006 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.450000000000003 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 71.219999999999999 111.068 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 24.309999999999999 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' LEU . . . . . 0.573 ' O ' HD13 ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.510000000000005 110.958 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' B' ' 147' ' ' ALA . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 110.815 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 52.350000000000001 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.310000000000002 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 72.109999999999999 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 72.310000000000002 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.627 ' CE1' HG21 ' A' ' 116' ' ' VAL . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 60.329999999999998 110.866 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.140000000000001 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.349999999999994 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.420000000000002 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 52.140000000000001 111.122 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.51 ' HB2' HD13 ' B' ' 118' ' ' ILE . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.966 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' B' ' 167' ' ' MET . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 110.814 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.694 HD13 ' HG3' ' A' ' 113' ' ' MET . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 110.829 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.230000000000004 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' B' ' 110' ' ' LEU . 10.9 ptmm? -133.78 57.31 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.92 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.47 ' HE2' ' O ' ' B' ' 163' ' ' LEU . 2.2 ttm -51.58 143.81 19.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.64 0.733 . . . . 73.519999999999996 110.918 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.8 Cg_endo -69.72 49.44 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 75.439999999999998 112.373 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 65.319999999999993 110.902 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -10.0 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 71.420000000000002 110.836 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -95.11 22.11 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.349999999999994 110.868 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -35.28 61.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.458 . . . . 64.150000000000006 110.887 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 63.530000000000001 111.067 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HZ2' ' N ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 44.409999999999997 110.878 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -52.84 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 75.340000000000003 110.837 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . 52.5 tp60 -50.26 108.22 0.97 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.637 0.732 . . . . 73.010000000000005 110.919 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 108' ' ' GLN . 53.5 Cg_endo -69.79 -177.07 1.71 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.717 2.278 . . . . 44.43 112.364 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 110' ' ' LEU . 4.1 mp -127.34 67.1 70.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.599 0.714 . . . . 74.030000000000001 110.961 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 154.8 67.3 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.735 2.29 . . . . 45.210000000000001 112.328 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt -84.12 0.71 47.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 110.921 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.54 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 45.210000000000001 110.965 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 111.187 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 61.420000000000002 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 162' ' ' ARG . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 118' ' ' ILE . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 65.540000000000006 111.057 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 52.340000000000003 111.112 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 43.049999999999997 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 63.200000000000003 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 53.439999999999998 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.621 HG23 HD22 ' B' ' 150' ' ' LEU . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.107 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 110.908 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.319999999999993 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.019999999999996 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.909 HG11 HG22 ' B' ' 129' ' ' VAL . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.219999999999999 111.15 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.87 HG22 HG11 ' B' ' 128' ' ' VAL . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.239999999999995 111.089 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 129' ' ' VAL . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.030000000000001 110.917 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 61.009999999999998 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.030000000000001 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 42.340000000000003 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.130000000000003 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.150000000000006 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 61.200000000000003 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.200000000000003 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 72.239999999999995 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.530000000000001 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 71.430000000000007 110.932 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 52.210000000000001 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.019999999999996 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.350000000000001 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 62.229999999999997 111.068 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.420000000000002 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 149' ' ' LEU . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.140000000000001 110.999 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 129' ' ' VAL . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 63.020000000000003 110.924 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.310000000000002 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.340000000000003 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 53.530000000000001 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.209999999999994 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 64.340000000000003 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.200000000000003 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' B' ' 116' ' ' VAL . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.84 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 71.209999999999994 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 55.229999999999997 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.319999999999993 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 111.149 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' HD12 ' A' ' 118' ' ' ILE . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.519999999999996 110.872 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 54.109999999999999 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' B' ' 113' ' ' MET . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.881 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -161.12 60.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.6 ptp -48.49 153.81 1.28 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.575 0.703 . . . . 63.299999999999997 110.899 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 50.34 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 73.400000000000006 112.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -48.7 -86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.349999999999994 110.94 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.46 -0.5 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 62.109999999999999 110.869 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -54.65 -26.3 32.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 72.420000000000002 110.918 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -178.87 57.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 71.219999999999999 110.871 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 65.230000000000004 111.049 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.547 ' N ' ' HZ2' ' B' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.816 0.341 . . . . 61.439999999999998 110.931 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -52.79 9.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.862 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -51.85 109.91 1.62 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.636 0.731 . . . . 75.040000000000006 110.949 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -167.86 0.25 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.706 2.271 . . . . 73.040000000000006 112.337 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.431 ' N ' HD12 ' B' ' 110' ' ' LEU . 4.0 mp -138.68 64.68 37.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.616 0.722 . . . . 53.229999999999997 110.931 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.29 66.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.243 . . . . 63.420000000000002 112.348 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.5 0.4 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.540000000000006 110.894 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 64.200000000000003 110.87 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 64.420000000000002 111.12 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 61.409999999999997 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 162' ' ' ARG . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 111.093 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.450000000000003 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.114 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.120000000000005 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.219999999999999 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.120000000000005 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.591 HG23 HD22 ' A' ' 150' ' ' LEU . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.030000000000001 111.147 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.65 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 52.25 110.858 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 55.43 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 0.87 HG11 HG22 ' A' ' 129' ' ' VAL . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 73.200000000000003 111.072 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 128' ' ' VAL . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 111.146 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.489 ' N ' HG12 ' B' ' 129' ' ' VAL . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 65.230000000000004 110.965 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.239999999999995 112.5 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.019999999999996 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.439999999999998 111.171 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.420000000000002 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 61.43 112.429 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.430000000000007 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.530000000000001 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 61.340000000000003 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.349999999999994 110.923 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 72.049999999999997 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 51.299999999999997 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.430000000000007 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 63.409999999999997 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.519999999999996 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' B' ' 150' ' ' LEU . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 51.229999999999997 111.147 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 60.310000000000002 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' LEU . . . . . 0.572 HD23 ' O ' ' B' ' 149' ' ' LEU . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 53.119999999999997 110.975 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 124' ' ' ILE . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 110.896 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 72.129999999999995 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 60.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 61.030000000000001 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 72.299999999999997 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.340000000000003 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.219999999999999 110.872 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 52.229999999999997 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 62.009999999999998 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.436 ' HB3' HD12 ' B' ' 118' ' ' ILE . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.9 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.420000000000002 110.91 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.340000000000003 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -161.78 60.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 110.896 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ptp -48.58 153.88 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 71.230000000000004 110.833 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 50.89 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 73.120000000000005 112.344 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' TRP . . . . . 0.418 ' CD1' ' N ' ' B' ' 169' ' ' TRP . 0.0 OUTLIER -48.95 -85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 74.129999999999995 110.875 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.49 -0.11 44.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 110.869 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -55.13 -26.13 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 63.520000000000003 110.935 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -179.32 59.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.409999999999997 110.836 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.039 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.821 0.343 . . . . 63.329999999999998 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -52.73 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 110.832 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -95.91 155.53 38.25 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 51.420000000000002 110.901 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 -21.0 34.64 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.72 2.28 . . . . 63.549999999999997 112.382 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.3 mt 50.61 69.45 2.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.698 . . . . 72.099999999999994 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.634 2.223 . . . . 73.510000000000005 112.378 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.49 1.76 13.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 61.210000000000001 110.885 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.838 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.219999999999999 110.867 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.445 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 61.399999999999999 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.349999999999994 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG21 ' CE1' ' B' ' 157' ' ' PHE . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.230000000000004 111.084 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 52.509999999999998 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.239999999999995 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.229999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.420000000000002 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.439999999999998 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 128' ' ' VAL . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 42.409999999999997 111.156 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.495 HD22 HG23 ' A' ' 129' ' ' VAL . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.894 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.140000000000001 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' B' ' 128' ' ' VAL . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 62.43 111.136 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 147' ' ' ALA . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.159 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.419 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.869 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.430000000000007 112.439 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' B' ' 128' ' ' VAL . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 61.549999999999997 110.985 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 61.340000000000003 111.178 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.095 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.439999999999998 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.539999999999999 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.140000000000001 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.030000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.924 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.230000000000004 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 45.43 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.299999999999997 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 71.549999999999997 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 71.219999999999999 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 71.420000000000002 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 70.129999999999995 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 65.540000000000006 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 64.140000000000001 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 71.200000000000003 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 73.450000000000003 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 43.539999999999999 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.430000000000007 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.340000000000003 111.08 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 54.549999999999997 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.140000000000001 110.902 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.010000000000005 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.18 56.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 110.832 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.454 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.4 mtm -48.8 143.1 8.5 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 74.040000000000006 110.84 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.5 Cg_endo -69.86 49.03 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 71.230000000000004 112.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.402 ' CE2' ' O ' ' A' ' 167' ' ' MET . 0.0 OUTLIER -54.06 -80.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.010000000000005 110.872 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -9.03 55.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 50.509999999999998 110.847 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.0 23.46 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 72.049999999999997 110.916 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -24.62 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.816 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 71.209999999999994 111.139 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -52.85 8.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 61.340000000000003 110.915 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.95 156.59 37.82 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.574 0.702 . . . . 63.539999999999999 110.951 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -25.4 28.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.372 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt 53.9 67.71 3.35 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.629 0.728 . . . . 70.540000000000006 110.986 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -169.43 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.67 2.247 . . . . 71.409999999999997 112.367 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.92 2.1 14.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 71.540000000000006 110.881 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' MET . . . . . 0.765 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.787 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.409999999999997 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.0 111.066 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.445 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 52.439999999999998 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.120000000000005 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.349999999999994 111.106 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 44.130000000000003 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.019999999999996 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.210000000000001 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.65 ' O ' HG23 ' B' ' 128' ' ' VAL . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 70.109999999999999 111.163 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.489 HD22 HG23 ' B' ' 129' ' ' VAL . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 64.209999999999994 110.898 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 61.439999999999998 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.200000000000003 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' A' ' 128' ' ' VAL . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 45.240000000000002 111.169 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.200000000000003 111.12 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.435 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 65.030000000000001 110.935 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.409999999999997 112.497 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 128' ' ' VAL . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.310000000000002 111.094 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 42.439999999999998 111.161 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.439999999999998 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 72.129999999999995 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.540000000000006 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.140000000000001 110.901 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.219999999999999 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.120000000000005 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 70.420000000000002 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.400000000000006 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 70.420000000000002 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 54.420000000000002 111.109 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 53.109999999999999 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.030000000000001 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.349999999999994 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 63.210000000000001 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 70.439999999999998 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 61.439999999999998 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 116' ' ' VAL . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 73.420000000000002 110.855 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.310000000000002 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 61.149999999999999 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 70.25 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 71.540000000000006 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.329999999999998 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 62.340000000000003 110.877 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.399999999999999 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 57.16 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 61.32 110.905 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.451 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.3 mtm -48.75 142.92 8.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.491 0.663 . . . . 71.430000000000007 110.921 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.1 Cg_endo -69.83 49.08 0.69 Allowed 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.72 2.28 . . . . 75.319999999999993 112.282 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' TRP . . . . . 0.403 ' CE2' ' O ' ' B' ' 167' ' ' MET . 0.0 OUTLIER -54.41 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 110.945 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -8.81 54.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.420000000000002 110.961 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.96 23.54 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 64.0 110.932 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -23.97 63.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 71.109999999999999 110.937 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 74.230000000000004 111.054 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.789 0.328 . . . . 64.22 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.779 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.05 110.935 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.41 ' HD3' ' CB ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.833 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.24 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 54.03 111.124 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 62.15 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 42.22 111.14 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.43 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.42 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.2 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.459 ' CG2' HD22 ' B' ' 150' ' ' LEU . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 72.12 111.136 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.699 HD22 HG23 ' A' ' 129' ' ' VAL . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.02 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.1 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' B' ' 128' ' ' VAL . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 61.33 111.139 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 125' ' ' LEU . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.51 111.126 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.429 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 44.21 110.899 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 53.11 112.494 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.24 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.672 ' CB ' ' HB2' ' A' ' 147' ' ' ALA . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 111.098 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.554 HG12 ' HA2' ' A' ' 131' ' ' GLY . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.1 111.153 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 63.02 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 53.44 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.2 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.04 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.903 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 53.42 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.33 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.54 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.13 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 133' ' ' THR . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 43.12 111.102 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.42 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 30.33 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD13 HG22 ' A' ' 129' ' ' VAL . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.1 110.981 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 60.12 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.04 111.128 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 21.11 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.21 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.05 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 30.34 111.086 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 64.33 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.43 110.939 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.831 HD22 ' HB2' ' B' ' 113' ' ' MET . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.878 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CB ' ' HD3' ' A' ' 114' ' ' ARG . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.849 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.01 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.76 0.314 . . . . 65.02 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.831 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.894 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.682 ' NH1' HG23 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.3 110.879 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.22 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 30.15 111.183 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.682 HG23 ' NH1' ' B' ' 114' ' ' ARG . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.157 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.417 ' N ' HG13 ' B' ' 118' ' ' ILE . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 31.13 111.163 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 62.04 111.102 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.556 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 60.12 112.452 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 52.24 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 150' ' ' LEU . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.161 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.922 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 63.55 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 40.53 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 128' ' ' VAL . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 70.32 111.145 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 71.43 111.088 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.425 ' N ' HG12 ' B' ' 129' ' ' VAL . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 61.31 110.909 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.6 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.22 112.439 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.21 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.12 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.6 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 43.23 111.136 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.44 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.54 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.51 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 64.11 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.3 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 72.03 110.954 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.21 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 62.51 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.41 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.42 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.35 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.653 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 63.33 111.076 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 41.33 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.2 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.459 HD22 ' CG2' ' A' ' 124' ' ' ILE . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.23 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 54.41 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.11 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 72.14 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.31 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.45 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.13 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.12 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.666 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 64.11 111.081 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 61.31 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.952 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.53 110.887 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.842 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 72.3 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.705 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.927 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 53.03 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.709 HG11 ' CE1' ' B' ' 157' ' ' PHE . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.24 111.169 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.692 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 73.24 110.968 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.68 HG22 ' HG3' ' B' ' 117' ' ' GLN . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.21 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 118' ' ' ILE . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.32 111.101 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.038 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.583 ' HA2' HD11 ' B' ' 154' ' ' ILE . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.45 112.52 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.33 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.41 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.699 ' CG2' HD22 ' B' ' 150' ' ' LEU . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.22 111.139 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 71.05 110.897 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 62.12 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 62.23 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.788 HG11 HG22 ' B' ' 129' ' ' VAL . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 61.14 111.123 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.796 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.097 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.889 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 43.15 112.462 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.41 110.923 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.7 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 65.32 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.599 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.5 111.057 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.53 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.23 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 43.34 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.44 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 32.13 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 45.04 110.958 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 133' ' ' THR . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 70.01 112.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 71.33 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 61.11 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 64.34 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.7 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.01 111.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.23 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 61.34 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CG2' ' B' ' 124' ' ' ILE . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.967 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.15 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 52.1 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.564 HD11 ' HA2' ' B' ' 121' ' ' GLY . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 74.22 111.088 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.723 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 71.11 110.907 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 55.44 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.04 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 73.45 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.53 111.138 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' HD13 ' A' ' 118' ' ' ILE . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 61.13 110.867 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 62.43 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 61.2 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 72.13 110.929 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.401 ' O ' HG23 ' B' ' 116' ' ' VAL . 95.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.767 0.317 . . . . 51.12 110.888 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.687 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.886 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 65.33 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 53.21 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.723 HG11 ' CE1' ' A' ' 157' ' ' PHE . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.32 111.142 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . 0.68 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.942 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.692 HG22 ' HG3' ' A' ' 117' ' ' GLN . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.175 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.413 ' N ' HD12 ' B' ' 118' ' ' ILE . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.02 111.09 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.53 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 154' ' ' ILE . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 65.4 112.503 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 70.43 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.68 ' CG2' HD22 ' A' ' 150' ' ' LEU . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.44 111.092 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.545 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.958 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 72.14 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 62.13 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.796 HG11 HG22 ' A' ' 129' ' ' VAL . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 54.45 111.05 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.788 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.149 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.443 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.947 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.54 112.433 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.5 ' CD2' HG12 ' A' ' 128' ' ' VAL . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 74.45 110.864 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.679 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 64.31 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 65.14 110.95 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.12 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 71.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 70.24 110.915 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 53.14 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' B' ' 133' ' ' THR . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.44 112.552 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 73.03 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 62.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 62.35 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.679 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 71.02 111.089 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 60.23 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 71.44 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.699 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.33 111.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.3 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 64.22 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.583 HD11 ' HA2' ' A' ' 121' ' ' GLY . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.44 111.141 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 61.21 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.709 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 72.44 110.918 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.35 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 60.23 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.15 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 52.42 111.169 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.631 ' HB2' HD13 ' B' ' 118' ' ' ILE . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.926 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 65.05 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.32 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.21 110.946 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.831 0.348 . . . . 42.32 110.914 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.578 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.836 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 71.21 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' B' ' 157' ' ' PHE . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.145 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 60.23 110.891 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 162' ' ' ARG . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.23 111.156 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.33 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 54.4 111.149 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 55.21 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 42.34 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 73.42 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.526 HG23 HD22 ' B' ' 150' ' ' LEU . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.22 111.217 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.949 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 70.03 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 62.03 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.918 HG11 HG22 ' B' ' 129' ' ' VAL . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.33 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 128' ' ' VAL . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.132 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.04 110.945 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.14 112.543 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 73.34 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.2 111.155 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.61 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 61.25 111.075 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 51.01 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.14 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.21 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.21 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.851 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.14 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.04 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 54.44 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.6 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.33 111.077 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 43.42 110.885 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 129' ' ' VAL . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.925 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 54.32 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 63.11 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.13 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 71.51 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.11 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.2 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' B' ' 116' ' ' VAL . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 71.23 110.916 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 53.3 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 163' ' ' LEU . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.13 112.482 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.44 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 51.44 111.128 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HB3' HD13 ' A' ' 118' ' ' ILE . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.31 110.88 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.963 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.849 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.841 0.353 . . . . 73.12 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 52.21 110.902 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.642 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.089 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . 0.526 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 54.42 110.943 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' B' ' 162' ' ' ARG . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 61.43 111.161 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 72.52 111.136 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.53 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.42 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.23 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.513 HG23 HD22 ' A' ' 150' ' ' LEU . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.092 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.626 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 63.32 110.92 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 63.04 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 50.14 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.911 HG11 HG22 ' A' ' 129' ' ' VAL . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.31 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 128' ' ' VAL . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.04 111.146 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.483 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 51.11 110.923 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.44 112.519 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.34 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.4 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.147 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.21 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.12 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.22 112.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.51 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.925 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 54.04 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.14 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.01 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 45.33 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.591 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 42.31 110.966 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.54 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . 0.568 HD13 ' O ' ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 62.25 110.961 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 124' ' ' ILE . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.23 110.926 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.43 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 70.33 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.04 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.31 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.41 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.584 ' CE1' HG21 ' A' ' 116' ' ' VAL . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.34 110.847 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.52 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.56 ' O ' HD12 ' B' ' 163' ' ' LEU . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.504 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.42 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 53.13 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.582 ' HB3' HD13 ' B' ' 118' ' ' ILE . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 54.41 110.928 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.56 HD12 ' O ' ' B' ' 159' ' ' GLY . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.861 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.982 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.4 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.886 179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.797 0.332 . . . . 73.31 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.587 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.869 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' B' ' 161' ' ' ALA . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.02 110.929 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.681 HG11 ' CE1' ' B' ' 157' ' ' PHE . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 54.55 111.158 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.34 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.13 111.111 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.23 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 53.33 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 63.03 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.693 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.588 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.978 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 151' ' ' PHE . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 71.04 111.103 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 34.33 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 129' ' ' VAL . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.22 111.163 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.843 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.097 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' A' ' 129' ' ' VAL . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.89 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.524 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 73.33 110.934 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' A' ' 147' ' ' ALA . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.53 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 64.4 111.089 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.2 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 41.32 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.01 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.44 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.15 110.891 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.13 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.05 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 72.42 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.1 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' A' ' 133' ' ' THR . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.43 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.1 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 61.35 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.703 HD22 ' CG2' ' B' ' 124' ' ' ILE . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.975 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.586 ' HD1' HD11 ' A' ' 126' ' ' ILE . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.1 110.877 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.41 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 42.35 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 HD13 ' A' ' 125' ' ' LEU . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.11 111.09 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 62.42 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 62.25 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 64.45 110.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.31 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.35 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 43.51 111.074 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.654 ' HB3' HD13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.34 110.874 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.598 HD22 ' NH2' ' B' ' 114' ' ' ARG . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 62.34 110.956 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 54.03 110.925 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.777 0.322 . . . . 75.35 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.885 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.598 ' NH2' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 62.42 110.928 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 157' ' ' PHE . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 71.11 111.077 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 53.34 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 51.3 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.35 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.22 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 64.22 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 71.32 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.703 ' CG2' HD22 ' A' ' 150' ' ' LEU . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.23 111.134 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 65.41 110.908 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.556 HD11 ' HD1' ' B' ' 151' ' ' PHE . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 60.14 111.152 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.52 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.843 HG11 HG22 ' A' ' 129' ' ' VAL . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 53.42 111.17 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.823 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 70.45 111.11 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' B' ' 129' ' ' VAL . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.929 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.627 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.03 112.495 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.549 ' HD2' HG12 ' A' ' 128' ' ' VAL . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.12 110.889 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.722 HG21 ' N ' ' B' ' 147' ' ' ALA . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 71.43 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.627 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.2 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.34 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.41 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.35 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.839 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.12 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.34 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.42 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.03 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.722 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 70.01 111.019 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.22 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.2 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.693 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.857 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.556 ' HD1' HD11 ' B' ' 126' ' ' ILE . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.916 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 51.34 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 61.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.425 HG13 HD22 ' B' ' 125' ' ' LEU . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.15 111.128 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 63.45 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.33 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.681 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 65.43 110.908 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 61.24 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.31 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.22 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.621 ' HB3' HD13 ' B' ' 118' ' ' ILE . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.856 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 64.11 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.45 110.911 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.873 0.368 . . . . 71.22 110.948 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.585 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.928 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.685 ' CZ ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 70.01 110.953 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.55 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' B' ' 157' ' ' PHE . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.22 111.171 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.126 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 63.22 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.4 111.162 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 54.13 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.01 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.33 111.149 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 154' ' ' ILE . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.93 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.31 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' B' ' 128' ' ' VAL . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 55.14 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 150' ' ' LEU . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.134 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.862 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.611 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.55 112.459 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.33 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.69 HG21 ' N ' ' A' ' 147' ' ' ALA . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 60.15 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.611 HG12 ' HA2' ' A' ' 131' ' ' GLY . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.43 111.105 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.52 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 43.34 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 65.33 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.24 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.13 110.909 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.35 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 72.22 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 53.51 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.69 ' N ' HG21 ' A' ' 133' ' ' THR . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 24.32 111.189 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.41 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.22 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 129' ' ' VAL . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.4 110.913 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.41 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.54 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.2 111.091 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' B' ' 116' ' ' VAL . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 55.21 110.875 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 73.23 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 70.54 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 63.12 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.31 111.131 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.851 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.64 HD23 ' NH1' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.34 110.862 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.82 0.343 . . . . 53.21 110.894 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.49 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 53.14 110.864 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.64 ' NH1' HD23 ' A' ' 164' ' ' LEU . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 72.22 110.928 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.653 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.31 111.104 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.01 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.133 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.24 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 41.12 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.23 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.621 ' O ' HG23 ' B' ' 128' ' ' VAL . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 54.35 111.139 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.625 HD22 ' CB ' ' B' ' 154' ' ' ILE . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.42 110.956 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.51 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' A' ' 128' ' ' VAL . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.24 111.123 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.661 HG22 HD13 ' B' ' 150' ' ' LEU . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 53.05 111.117 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.46 ' N ' HG12 ' B' ' 129' ' ' VAL . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 71.32 110.818 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.33 112.488 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 128' ' ' VAL . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 63.33 110.963 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' B' ' 147' ' ' ALA . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.42 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 54.02 111.124 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 62.22 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 54.23 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.52 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 73.41 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.11 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 63.15 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.517 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 55.52 110.852 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.35 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.14 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.14 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 31.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.5 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.661 HD13 HG22 ' B' ' 129' ' ' VAL . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.904 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.24 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 34.41 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.625 ' CB ' HD22 ' B' ' 125' ' ' LEU . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.22 111.06 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.2 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 50.24 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 116' ' ' VAL . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.52 110.924 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.15 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.52 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.21 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 114' ' ' ARG . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 35.13 111.115 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.658 ' HB3' HD13 ' B' ' 118' ' ' ILE . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.871 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.04 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 116' ' ' VAL . 9.3 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.831 0.348 . . . . 53.51 110.948 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.574 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 70.31 110.895 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 51.13 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.42 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 112' ' ' LEU . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.11 111.144 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' B' ' 117' ' ' GLN . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.44 110.998 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.118 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 54.11 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.02 111.112 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.01 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 63.32 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.796 HG23 HD22 ' B' ' 150' ' ' LEU . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.768 HD13 HG13 ' A' ' 154' ' ' ILE . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 53.32 110.909 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 72.41 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.44 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.932 HG11 HG22 ' B' ' 129' ' ' VAL . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.21 111.123 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.944 HG22 HG11 ' B' ' 128' ' ' VAL . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.14 111.133 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 129' ' ' VAL . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 70.34 110.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.478 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD2' HG12 ' B' ' 128' ' ' VAL . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.44 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 70.14 111.189 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 43.15 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 45.01 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.44 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 72.33 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.34 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 45.24 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 61.35 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 53.34 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 43.33 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.4 111.085 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 52.45 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 54.44 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.802 HD22 HG23 ' B' ' 124' ' ' ILE . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.22 110.923 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 64.3 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.43 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.768 HG13 HD13 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 72.22 111.18 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.11 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' B' ' 116' ' ' VAL . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.04 110.924 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.11 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 63.13 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.3 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.24 111.105 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.659 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.856 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 54.0 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 116' ' ' VAL . 9.2 mp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.786 0.327 . . . . 62.02 110.938 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 62.24 110.857 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 63.23 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 112' ' ' LEU . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.058 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 117' ' ' GLN . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.904 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' B' ' 162' ' ' ARG . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.074 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.41 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.118 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.2 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 73.05 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.802 HG23 HD22 ' A' ' 150' ' ' LEU . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.844 HD13 HG13 ' B' ' 154' ' ' ILE . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.833 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 129' ' ' VAL . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.51 111.09 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 128' ' ' VAL . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.24 111.119 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.413 ' N ' HG12 ' B' ' 129' ' ' VAL . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.893 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.63 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.34 112.57 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 73.11 110.957 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.2 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.63 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 65.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.13 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 70.11 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 61.03 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.03 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 70.53 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 44.35 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.12 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 63.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.3 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 61.14 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.35 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.673 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.13 111.121 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 54.3 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 71.31 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.796 HD22 HG23 ' A' ' 124' ' ' ILE . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.912 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . 0.844 HG13 HD13 ' B' ' 125' ' ' LEU . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 44.45 111.18 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 116' ' ' VAL . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 54.24 110.822 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 51.53 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.21 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 64.53 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 72.45 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' B' ' 118' ' ' ILE . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.9 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 54.51 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.477 HD13 ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.903 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.23 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.886 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.7 mp . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.838 0.352 . . . . 54.14 110.905 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.654 ' CG ' HD22 ' B' ' 164' ' ' LEU . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.24 110.888 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.32 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.51 111.113 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.583 HD13 ' CB ' ' A' ' 162' ' ' ARG . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 63.03 111.098 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.11 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.043 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 55.52 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.24 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.35 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.424 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 64.05 111.11 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 129' ' ' VAL . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 70.31 110.882 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.13 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 53.32 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' B' ' 132' ' ' TYR . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.14 111.053 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 125' ' ' LEU . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.21 111.076 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 134' ' ' VAL . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 43.25 110.839 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 24.31 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' B' ' 128' ' ' VAL . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 60.41 110.93 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.31 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 130' ' ' LEU . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.085 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 60.11 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.44 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 42.25 112.532 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.1 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.15 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.03 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 61.45 110.926 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.13 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 64.42 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.24 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 141' ' ' LEU . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.04 111.048 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.21 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 42.51 111.095 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 70.32 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 129' ' ' VAL . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.889 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.51 111.104 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 63.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.52 112.529 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.43 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.32 111.076 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.583 ' CB ' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.4 110.852 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 159' ' ' GLY . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.935 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.7 HD22 ' CG ' ' B' ' 113' ' ' MET . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.883 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.03 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 62.32 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.7 ' CG ' HD22 ' A' ' 164' ' ' LEU . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.24 110.915 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 161' ' ' ALA . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 55.22 111.11 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' B' ' 162' ' ' ARG . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.186 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.136 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.618 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.51 112.46 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 126' ' ' ILE . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 70.14 110.942 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.618 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' B' ' 123' ' ' LEU . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.22 111.116 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.502 HG23 ' CD2' ' A' ' 132' ' ' TYR . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.14 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.33 111.099 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.426 ' N ' HG12 ' B' ' 129' ' ' VAL . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 64.13 110.95 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.53 ' CD2' HG23 ' A' ' 128' ' ' VAL . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 53.31 110.899 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.14 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' B' ' 131' ' ' GLY . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.186 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.1 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.23 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.52 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 62.04 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 52.4 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' B' ' 145' ' ' VAL . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.31 110.931 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 73.3 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.23 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . 0.478 ' HB ' HD11 ' B' ' 141' ' ' LEU . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.2 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 72.23 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 70.44 111.114 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 70.5 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 124' ' ' ILE . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.972 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.22 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.32 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.43 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 34.15 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 65.51 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.433 ' O ' HD13 ' B' ' 163' ' ' LEU . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.51 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.139 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.585 ' CB ' HD13 ' B' ' 118' ' ' ILE . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.35 110.872 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.433 HD13 ' O ' ' B' ' 159' ' ' GLY . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.948 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.654 HD22 ' CG ' ' A' ' 113' ' ' MET . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.45 110.921 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.42 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.12 110.864 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 74.52 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.694 ' HG3' HD13 ' B' ' 164' ' ' LEU . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.879 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG21 ' CE1' ' B' ' 157' ' ' PHE . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 54.01 111.141 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.57 ' HG2' HG22 ' B' ' 118' ' ' ILE . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.51 110.936 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.147 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 50.44 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.34 111.094 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.22 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 50.44 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.3 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.536 HG23 HD22 ' B' ' 150' ' ' LEU . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.55 111.119 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.893 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.51 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.924 HG11 HG22 ' B' ' 129' ' ' VAL . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.03 111.099 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 128' ' ' VAL . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 53.44 111.087 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' ' 129' ' ' VAL . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 52.32 110.821 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.31 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.52 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.865 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.35 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.12 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.927 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 53.42 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.22 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.44 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.2 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.44 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 62.12 111.129 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 64.04 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 63.31 110.877 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 129' ' ' VAL . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 44.41 110.922 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 71.53 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.2 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 62.53 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.21 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.22 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.03 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 71.22 110.886 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.53 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 54.22 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 72.43 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.12 111.11 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 118' ' ' ILE . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.934 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.24 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.714 HD13 ' HG3' ' B' ' 113' ' ' MET . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.04 110.896 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.921 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.798 0.332 . . . . 74.2 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.714 ' HG3' HD13 ' A' ' 164' ' ' LEU . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.1 110.886 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 64.53 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.702 HG21 ' CE1' ' A' ' 157' ' ' PHE . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 62.44 111.181 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . 0.592 ' HG2' HG22 ' A' ' 118' ' ' ILE . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.02 110.914 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.57 HG22 ' HG2' ' A' ' 117' ' ' GLN . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 63.11 111.054 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.11 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 70.32 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 61.14 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 150' ' ' LEU . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 54.24 111.095 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.632 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.892 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.44 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.41 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 129' ' ' VAL . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.21 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.924 HG22 HG11 ' A' ' 128' ' ' VAL . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.167 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.477 ' N ' HG12 ' B' ' 129' ' ' VAL . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.966 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 44.21 112.482 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.11 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.14 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 65.23 111.104 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.44 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.45 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 50.35 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.13 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.15 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.52 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 70.31 110.926 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.01 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.33 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.45 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 71.22 111.068 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 24.31 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.51 110.958 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' B' ' 147' ' ' ALA . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.815 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.1 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 52.35 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.31 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 72.11 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 72.31 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.627 ' CE1' HG21 ' A' ' 116' ' ' VAL . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 60.33 110.866 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.42 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 52.14 111.122 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.51 ' HB2' HD13 ' B' ' 118' ' ' ILE . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.966 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.694 HD13 ' HG3' ' A' ' 113' ' ' MET . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.14 110.829 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.23 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.92 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.883 0.373 . . . . 73.51 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.54 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 45.21 110.965 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.45 111.187 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 61.42 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 162' ' ' ARG . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 118' ' ' ILE . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 65.54 111.057 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 52.34 111.112 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 43.05 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 63.2 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 53.44 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.621 HG23 HD22 ' B' ' 150' ' ' LEU . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.107 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.32 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.02 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.909 HG11 HG22 ' B' ' 129' ' ' VAL . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.22 111.15 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.87 HG22 HG11 ' B' ' 128' ' ' VAL . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.089 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 129' ' ' VAL . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.03 110.917 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 61.01 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.03 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 42.34 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.15 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 61.2 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.2 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 72.24 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 71.43 110.932 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 52.21 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.02 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.34 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.35 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 62.23 111.068 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.42 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 149' ' ' LEU . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.14 110.999 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 129' ' ' VAL . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 63.02 110.924 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.31 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.34 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 53.53 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.21 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 64.34 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.2 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' B' ' 116' ' ' VAL . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.52 110.84 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 71.21 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 55.23 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.32 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.24 111.149 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' HD12 ' A' ' 118' ' ' ILE . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.872 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 54.11 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' B' ' 113' ' ' MET . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.881 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.917 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 72.54 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 64.2 110.87 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.44 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 64.42 111.12 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 61.41 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 162' ' ' ARG . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.093 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.45 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.114 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.12 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.12 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.591 HG23 HD22 ' A' ' 150' ' ' LEU . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.147 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.65 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 52.25 110.858 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 55.43 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 0.87 HG11 HG22 ' A' ' 129' ' ' VAL . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 73.2 111.072 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 128' ' ' VAL . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.146 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.489 ' N ' HG12 ' B' ' 129' ' ' VAL . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 65.23 110.965 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.24 112.5 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.02 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.171 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.42 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 61.43 112.429 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.43 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.53 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 61.34 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.35 110.923 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 72.05 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 51.3 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.43 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 63.41 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.52 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' B' ' 150' ' ' LEU . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 51.23 111.147 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 60.31 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . 0.572 ' O ' HD23 ' B' ' 149' ' ' LEU . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 53.12 110.975 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 124' ' ' ILE . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.896 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 60.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 61.03 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 72.3 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.34 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.22 110.872 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 52.23 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 62.01 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.436 ' HB3' HD12 ' B' ' 118' ' ' ILE . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.9 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.91 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.896 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 61.21 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.838 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.22 110.867 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.445 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 61.4 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.35 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG21 ' CE1' ' B' ' 157' ' ' PHE . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.084 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 52.51 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.24 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.23 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.42 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.44 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 128' ' ' VAL . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 42.41 111.156 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.495 HD22 HG23 ' A' ' 129' ' ' VAL . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.894 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.14 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' B' ' 128' ' ' VAL . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 62.43 111.136 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 147' ' ' ALA . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.159 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.419 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.869 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.43 112.439 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' B' ' 128' ' ' VAL . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 61.55 110.985 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 61.34 111.178 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.095 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.44 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.54 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.14 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.924 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 45.43 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.21 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.3 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 71.55 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 71.22 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 71.42 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 70.13 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 65.54 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.41 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 64.14 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 71.2 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 73.45 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 43.54 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.43 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.34 111.08 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 54.55 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.14 110.902 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.11 110.832 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.736 0.303 . . . . 71.54 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' MET . . . . . 0.765 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.787 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.41 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.0 111.066 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.445 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 52.44 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.12 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.35 111.106 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 44.13 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.02 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.21 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.65 ' O ' HG23 ' B' ' 128' ' ' VAL . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 70.11 111.163 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.489 HD22 HG23 ' B' ' 129' ' ' VAL . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.898 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 61.44 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.2 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' A' ' 128' ' ' VAL . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 45.24 111.169 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.2 111.12 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.435 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 65.03 110.935 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.41 112.497 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 128' ' ' VAL . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.31 111.094 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 42.44 111.161 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.42 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 72.13 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.13 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.14 110.901 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.12 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 70.42 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 70.42 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 54.42 111.109 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 53.11 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.03 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.35 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 63.21 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 70.44 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 61.44 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 116' ' ' VAL . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 73.42 110.855 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.31 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 61.15 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 70.25 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 62.34 110.877 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.4 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 61.32 110.905 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.856 0.36 . . . . 63.21 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -53.77 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.868 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -111.16 153.68 43.86 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 72.23 110.885 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 -8.93 24.84 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.625 2.216 . . . . 55.24 112.311 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.744 HD23 ' CB ' ' A' ' 166' ' ' LYS . 1.0 OUTLIER 50.9 67.09 4.64 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.689 0.757 . . . . 74.11 110.865 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -171.07 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.646 2.23 . . . . 62.3 112.437 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.15 0.45 10.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 64.22 110.889 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.779 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -72.38 -16.44 61.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 70.05 110.935 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.41 ' HD3' ' CB ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -116.52 -40.96 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.833 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -52.38 -27.82 17.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 73.24 110.88 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 27.0 m -77.95 -31.12 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 54.03 111.124 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 tp60 -74.89 -41.25 60.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.874 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.69 -39.48 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.092 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.42 -56.88 4.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 62.15 111.101 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.82 -38.26 76.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 42.22 111.14 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.18 88.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 75.43 112.449 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.39 -49.1 40.67 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.752 -0.737 . . . . 73.42 112.501 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mt -63.72 -55.7 21.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 75.2 110.917 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.459 ' CG2' HD22 ' B' ' 150' ' ' LEU . 76.6 mt -54.8 -50.1 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 72.12 111.136 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.699 HD22 HG23 ' A' ' 129' ' ' VAL . 2.7 tm? -52.16 -52.14 53.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.831 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.1 mt -51.77 -49.6 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.02 111.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.88 -62.0 5.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 71.1 112.483 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' B' ' 128' ' ' VAL . 7.6 p -51.12 -25.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 61.33 111.139 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.699 HG23 HD22 ' A' ' 125' ' ' LEU . 2.1 t -75.88 -56.25 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 75.51 111.126 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.429 ' N ' HG12 ' A' ' 129' ' ' VAL . 1.4 tt -53.94 -27.52 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 44.21 110.899 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.554 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.76 -48.82 4.8 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.663 -0.78 . . . . 53.11 112.494 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -62.92 -21.71 66.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 74.24 110.919 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.672 ' CB ' ' HB2' ' A' ' 147' ' ' ALA . 54.6 m -93.15 -41.2 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 111.098 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.554 HG12 ' HA2' ' A' ' 131' ' ' GLY . 3.8 p -77.39 -7.01 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 73.1 111.153 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -41.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.858 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.47 0.5 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 63.02 110.857 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.02 -23.9 12.53 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.718 . . . . 53.44 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.47 -15.89 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 74.2 110.843 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.33 -44.37 12.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.901 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.68 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.04 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.518 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.84 -85.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.903 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 t -125.44 -41.61 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.846 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.36 23.36 2.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 53.42 112.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -123.48 -38.63 2.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 74.33 110.844 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.8 t -65.66 -39.78 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 61.54 111.058 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.99 2.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.687 -0.768 . . . . 72.13 112.526 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 133' ' ' THR . . . -59.51 -32.19 70.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 43.12 111.102 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.69 -56.44 11.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.781 -0.723 . . . . 74.42 112.55 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -35.62 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 30.33 110.926 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD13 HG22 ' A' ' 129' ' ' VAL . 16.8 mt -66.64 -47.28 73.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.1 110.981 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -58.94 -53.03 63.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.875 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.63 76.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.115 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.98 -66.25 2.8 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.733 -0.746 . . . . 60.12 112.518 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.57 -21.29 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.362 . . . . 73.04 111.128 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.2 m -68.99 -63.17 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.839 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -34.93 89.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 21.11 112.573 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -65.81 -58.51 5.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 74.41 110.906 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -54.19 -42.74 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 54.21 110.847 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 -49.34 79.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.777 -0.725 . . . . 71.54 112.457 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -34.4 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.307 . . . . 74.05 110.85 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.05 -48.46 29.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 30.34 111.086 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.14 -31.1 66.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 64.33 110.878 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.569 HD23 ' HG2' ' A' ' 167' ' ' MET . 0.2 OUTLIER -80.15 -44.68 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.43 110.939 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.831 HD22 ' HB2' ' B' ' 113' ' ' MET . 1.4 tp -63.92 -18.62 64.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.156 -0.475 . . . . 74.51 110.878 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CB ' ' HD3' ' A' ' 114' ' ' ARG . 13.6 t70 -101.62 -50.29 3.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.849 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.744 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -132.24 56.84 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.01 110.892 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.569 ' HG2' HD23 ' A' ' 163' ' ' LEU . 2.2 ttm -50.2 144.54 11.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.599 0.714 . . . . 72.25 110.944 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.7 Cg_endo -69.83 48.24 0.63 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.73 2.287 . . . . 63.25 112.345 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -84.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.994 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -79.28 -2.56 41.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.35 110.934 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -56.5 -24.27 45.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.894 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -142.22 38.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.765 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 52.44 111.073 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.776 0.322 . . . . 73.43 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -53.6 10.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.832 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -111.61 153.33 44.32 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.572 0.701 . . . . 73.21 110.941 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -10.99 29.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.746 2.297 . . . . 61.02 112.304 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.9 OUTLIER 52.12 67.66 3.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.592 0.711 . . . . 74.24 110.987 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.578 2.185 . . . . 71.25 112.455 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp -113.59 1.04 14.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 65.02 110.902 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.831 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -82.36 -5.69 58.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.894 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.682 ' NH1' HG23 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -117.34 -47.1 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.3 110.879 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -55.45 -31.46 61.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 75.22 110.919 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 35.1 m -75.18 -30.65 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 30.15 111.183 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -72.62 -42.07 64.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.941 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.682 HG23 ' NH1' ' B' ' 114' ' ' ARG . 27.8 pt -77.76 -39.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.157 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.417 ' N ' HG13 ' B' ' 118' ' ' ILE . . . -70.9 -56.49 6.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 31.13 111.163 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.28 -40.48 70.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 62.04 111.102 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.556 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -67.37 -42.79 89.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 60.12 112.452 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.31 32.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.494 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.81 -57.29 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.337 . . . . 52.24 110.958 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 150' ' ' LEU . 75.0 mt -51.64 -51.5 26.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.01 111.161 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.2 mm? -51.73 -56.26 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.468 . . . . 75.22 110.922 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 21.4 mt -46.43 -51.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 63.55 111.089 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.64 -65.16 3.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.74 . . . . 40.53 112.503 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 128' ' ' VAL . 8.3 p -50.33 -25.87 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 70.32 111.145 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.6 t -72.07 -61.19 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 71.43 111.088 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.425 ' N ' HG12 ' B' ' 129' ' ' VAL . 1.4 tt -53.22 -28.34 26.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 61.31 110.909 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.6 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.54 -49.42 5.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.739 -0.744 . . . . 74.22 112.439 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -62.34 -22.37 66.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.993 0.425 . . . . 72.21 110.996 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 85.2 m -92.79 -39.49 11.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 73.12 111.147 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.6 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -77.94 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 43.23 111.136 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.44 -39.5 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 70.44 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.55 0.94 14.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.63 -24.01 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 73.54 112.501 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.65 -15.57 58.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.813 0.34 . . . . 74.51 110.857 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.19 -44.86 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 64.11 110.949 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.88 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 72.3 110.924 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.508 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.56 -85.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 72.03 110.954 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 13.4 t -125.49 -41.02 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.21 110.868 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.03 23.1 2.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 62.51 112.534 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -123.23 -38.49 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.373 . . . . 70.41 110.864 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.71 -39.51 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 71.42 111.144 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.76 -68.11 1.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 70.35 112.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.653 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.76 -31.76 69.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 63.33 111.076 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.12 14.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.724 -0.75 . . . . 41.33 112.459 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -35.5 72.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.37 . . . . 73.2 111.009 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.459 HD22 ' CG2' ' A' ' 124' ' ' ILE . 53.7 mt -66.19 -46.8 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.911 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -60.25 -49.73 76.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.441 . . . . 71.23 110.928 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.2 82.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 54.41 111.129 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.98 -63.4 4.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 54.11 112.53 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 16.0 mm -57.34 -23.36 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 72.14 111.07 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 3.3 m -69.55 -62.72 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.839 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.6 -36.23 88.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 71.31 112.472 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -66.15 -56.33 11.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 74.45 110.883 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 68.7 m -54.52 -42.67 71.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.878 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.79 -52.87 50.38 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.658 -0.782 . . . . 50.13 112.52 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -35.62 71.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 72.12 110.928 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.666 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -72.14 -47.98 46.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 64.11 111.081 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -58.17 -29.32 65.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 61.31 110.87 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.496 HD23 ' HG2' ' B' ' 167' ' ' MET . 0.2 OUTLIER -78.42 -47.9 16.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.952 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.779 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.34 -15.75 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 75.53 110.887 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -101.0 -47.07 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.854 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.716 ' CB ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -141.16 58.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.842 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.496 ' HG2' HD23 ' B' ' 163' ' ' LEU . 2.1 mtm -49.61 143.95 10.07 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 73.41 110.903 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.0 Cg_endo -69.9 48.11 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.744 2.296 . . . . 74.34 112.267 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.885 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -80.15 -2.02 42.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 71.32 110.873 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.48 -23.48 57.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.24 110.998 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -143.84 41.68 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 53.33 110.915 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 75.32 111.104 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.54 ' N ' ' HZ2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.864 0.364 . . . . 74.34 110.882 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.92 -53.37 9.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 63.53 110.814 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -53.32 153.14 7.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.568 0.699 . . . . 73.11 110.959 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.58 -18.22 37.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.704 2.269 . . . . 74.31 112.42 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 49.24 68.07 3.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 75.02 110.934 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.0 11.67 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.72 2.28 . . . . 75.45 112.328 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.15 1.07 10.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.3 110.847 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.705 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 12.1 mmt -89.28 -6.67 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.33 110.927 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -110.26 -47.74 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.915 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -31.2 65.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 53.03 110.953 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.709 HG11 ' CE1' ' B' ' 157' ' ' PHE . 85.4 t -77.52 -28.03 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.24 111.169 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.692 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -72.52 -43.33 63.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 73.24 110.968 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.68 HG22 ' HG3' ' B' ' 117' ' ' GLN . 2.4 pp -76.18 -39.74 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 71.21 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 118' ' ' ILE . . . -70.87 -56.97 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 73.32 111.101 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.0 -39.04 76.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.038 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.583 ' HA2' HD11 ' B' ' 154' ' ' ILE . . . -66.57 -41.52 94.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 73.45 112.52 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.82 -48.38 49.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.756 . . . . 73.33 112.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.58 -58.9 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.329 . . . . 72.41 110.942 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.699 ' CG2' HD22 ' B' ' 150' ' ' LEU . 32.5 mm -50.25 -51.45 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.22 111.139 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.561 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -55.1 -51.75 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 71.05 110.897 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mt -47.73 -43.3 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 62.12 111.231 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.94 -63.94 3.4 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 62.23 112.474 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.788 HG11 HG22 ' B' ' 129' ' ' VAL . 25.6 m -56.12 -21.19 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 61.14 111.123 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.796 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -76.34 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.097 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.89 -28.62 51.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.889 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.54 -50.09 5.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 43.15 112.462 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.9 t80 -61.33 -23.42 65.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 72.41 110.923 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.7 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 4.0 m -91.27 -38.06 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 65.32 111.197 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.599 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.7 p -81.13 -6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.5 111.057 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.18 -35.68 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 73.53 110.865 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.87 1.22 10.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 71.23 110.814 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -100.04 -23.49 10.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 43.34 112.415 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -17.8 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 73.44 110.867 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -46.81 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.852 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.41 -80.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 32.13 110.878 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.35 -85.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 45.04 110.958 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.45 -41.57 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 62.4 110.888 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 133' ' ' THR . . . 121.41 25.1 2.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 70.01 112.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.77 -36.5 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 71.33 110.848 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.22 -39.43 85.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 61.11 111.066 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.29 -69.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 64.34 112.51 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.7 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.1 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.752 0.31 . . . . 74.01 111.073 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.86 10.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.668 -0.777 . . . . 73.23 112.503 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.84 -36.83 70.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 61.34 110.957 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CG2' ' B' ' 124' ' ' ILE . 92.8 mt -66.83 -44.82 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.967 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -59.65 -51.03 71.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.15 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 74.15 111.095 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -58.82 -64.1 4.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 52.1 112.501 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.564 HD11 ' HA2' ' B' ' 121' ' ' GLY . 13.6 mm -59.17 -22.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 74.22 111.088 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -62.42 1.46 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.847 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.15 -34.94 91.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.758 . . . . 74.25 112.579 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.723 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.7 m-85 -67.74 -55.85 11.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 71.11 110.907 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 66.3 m -54.95 -45.07 74.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 55.44 110.832 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.36 -47.86 88.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.754 -0.736 . . . . 64.04 112.474 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 6.8 mmt -61.16 -35.25 76.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.781 0.324 . . . . 73.45 110.887 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.09 -46.04 45.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 45.53 111.138 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.636 ' HB2' HD13 ' A' ' 118' ' ' ILE . 69.1 ttt180 -58.34 -34.53 70.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 61.13 110.867 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.99 -47.14 19.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 62.43 110.917 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -13.98 62.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.966 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.65 -45.46 6.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 61.2 110.815 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.76 59.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 72.13 110.929 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.2 ptp -51.52 153.74 3.68 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.518 0.675 . . . . 71.22 110.866 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 53.56 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.601 2.201 . . . . 74.52 112.357 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -83.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.907 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -80.84 -1.21 42.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 61.43 110.925 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -95.02 23.47 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.885 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -25.89 64.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 63.43 110.838 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 71.42 111.07 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.518 ' N ' ' HZ2' ' B' ' 106' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.743 0.306 . . . . 53.43 110.841 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -53.33 10.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 74.14 110.8 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -52.77 153.6 5.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.637 0.732 . . . . 73.41 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -21.72 32.71 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.585 2.19 . . . . 64.53 112.41 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.44 67.54 4.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.625 0.726 . . . . 74.21 110.9 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 177.1 5.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.638 2.225 . . . . 63.42 112.381 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.401 ' O ' HG23 ' B' ' 116' ' ' VAL . 95.3 mt -120.15 0.97 10.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 51.12 110.888 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.687 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 12.9 mmt -89.9 -5.59 56.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.886 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -109.86 -47.69 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 65.33 110.869 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -32.93 67.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 53.21 110.884 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.723 HG11 ' CE1' ' A' ' 157' ' ' PHE . 59.0 t -76.81 -30.25 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.32 111.142 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . 0.68 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -68.29 -45.54 72.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 70.32 110.942 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.692 HG22 ' HG3' ' A' ' 117' ' ' GLN . 2.4 pp -76.72 -39.15 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 74.51 111.175 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.413 ' N ' HD12 ' B' ' 118' ' ' ILE . . . -70.23 -57.47 4.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 72.02 111.09 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.03 -39.33 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.53 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 154' ' ' ILE . . . -66.21 -41.67 94.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.756 . . . . 65.4 112.503 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.58 44.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 72.1 112.508 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.92 -59.46 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.788 0.327 . . . . 70.43 110.856 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.68 ' CG2' HD22 ' A' ' 150' ' ' LEU . 33.4 mm -49.93 -52.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 70.44 111.092 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.545 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.95 -53.12 57.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.958 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 30.9 mt -46.66 -43.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 72.14 111.135 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.76 -64.85 2.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 62.13 112.503 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.796 HG11 HG22 ' A' ' 129' ' ' VAL . 23.0 m -55.32 -21.69 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 54.45 111.05 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.788 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.3 -63.03 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 73.22 111.149 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.443 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -53.61 -29.24 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.947 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.81 -49.29 6.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.78 -0.724 . . . . 65.54 112.433 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.5 ' CD2' HG12 ' A' ' 128' ' ' VAL . 5.8 t80 -61.69 -24.52 66.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.026 0.441 . . . . 74.45 110.864 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.679 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 3.8 m -90.48 -37.81 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.501 . . . . 74.22 111.167 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.5 p -81.09 -6.85 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.305 -0.407 . . . . 64.31 111.123 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -122.98 -35.52 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 65.14 110.95 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.41 1.28 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 71.52 110.857 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.36 -22.57 11.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 71.41 112.575 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -17.62 53.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 74.12 110.878 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -46.92 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.946 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.83 -80.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 71.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 70.24 110.915 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -125.36 -41.28 2.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 53.14 110.854 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' B' ' 133' ' ' THR . . . 121.05 24.86 2.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.721 -0.752 . . . . 71.44 112.552 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -123.62 -36.28 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.967 0.413 . . . . 73.03 110.913 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 90.3 t -65.01 -39.57 86.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 62.0 111.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.27 -69.39 1.4 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.718 -0.753 . . . . 62.35 112.535 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.679 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -58.99 -30.75 68.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 71.02 111.089 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.67 -56.69 10.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.685 -0.769 . . . . 60.23 112.509 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.09 -36.74 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 71.44 110.903 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.699 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.3 mt -66.97 -44.74 79.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 75.33 111.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.83 -51.2 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.878 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.94 83.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 72.3 111.058 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.06 -64.34 4.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.744 . . . . 64.22 112.448 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.583 HD11 ' HA2' ' A' ' 121' ' ' GLY . 13.0 mm -58.91 -22.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 72.44 111.141 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -62.27 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.896 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.98 -35.1 91.62 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.74 -0.743 . . . . 61.21 112.503 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.709 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.0 m-85 -68.04 -54.56 17.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.889 0.376 . . . . 72.44 110.918 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -55.07 -46.07 75.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 74.35 110.822 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -48.02 88.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 60.23 112.46 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 6.7 mmt -60.45 -36.04 77.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.749 0.309 . . . . 72.15 110.788 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.79 -45.49 51.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 52.42 111.169 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.631 ' HB2' HD13 ' B' ' 118' ' ' ILE . 69.2 ttt180 -58.03 -33.83 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.926 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.33 -47.81 16.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 65.05 110.876 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -14.98 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.329 -0.396 . . . . 65.32 110.882 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -97.26 -47.44 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.828 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.42 60.37 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.21 110.946 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.3 ptp -52.01 153.62 4.49 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 70.14 110.865 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.87 53.5 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.613 2.209 . . . . 61.45 112.383 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -83.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 62.51 110.927 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -81.03 -1.09 42.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 73.42 110.938 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -94.98 23.42 5.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.914 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -25.69 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.899 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 65.42 111.114 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 73.32 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -53.73 11.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 42.14 110.9 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -131.71 153.79 81.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.31 110.932 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -7.8 22.01 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.62 2.213 . . . . 64.43 112.382 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 166' ' ' LYS . 1.0 OUTLIER 52.08 65.77 5.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.649 0.738 . . . . 64.03 110.961 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -173.13 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.653 2.235 . . . . 61.54 112.405 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.32 1.87 10.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 42.32 110.914 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.578 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -77.36 -20.14 55.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.836 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 -47.34 3.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 71.21 110.905 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.61 -27.9 59.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.33 110.902 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' B' ' 157' ' ' PHE . 7.6 p -77.28 -30.46 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.145 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.551 ' HG3' HG22 ' B' ' 118' ' ' ILE . 0.0 OUTLIER -73.5 -42.26 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 60.23 110.891 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 162' ' ' ARG . 2.0 pp -75.87 -39.74 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.23 111.156 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.19 -56.87 5.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 72.33 111.113 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.41 -39.6 74.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 54.4 111.149 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -41.77 91.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.771 . . . . 55.21 112.521 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.4 -48.59 50.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 42.34 112.484 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.15 -60.04 3.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.747 0.308 . . . . 73.42 110.964 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.526 HG23 HD22 ' B' ' 150' ' ' LEU . 37.9 mm -51.6 -52.23 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.22 111.217 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -50.55 -55.36 16.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.949 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 40.3 mt -49.7 -40.93 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 70.03 111.11 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.34 -65.26 2.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 62.03 112.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.918 HG11 HG22 ' B' ' 129' ' ' VAL . 16.6 m -53.91 -22.47 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.33 111.125 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 128' ' ' VAL . 1.8 t -76.56 -55.4 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.33 111.132 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.3 OUTLIER -55.86 -30.15 61.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.04 110.945 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.37 -48.06 6.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.753 . . . . 73.14 112.543 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -61.81 -24.22 66.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 73.34 110.891 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 58.0 m -90.7 -38.27 13.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.2 111.155 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.61 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.6 p -81.38 -6.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 61.25 111.075 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -123.15 -36.26 2.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.24 110.936 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.1 0.76 10.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 51.01 110.874 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.6 -25.39 12.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.667 -0.778 . . . . 74.14 112.465 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.07 -17.1 56.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 73.21 110.87 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -76.03 -49.88 16.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 61.21 110.899 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.6 mt -52.19 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.934 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.23 -84.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 75.11 110.851 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.55 -41.49 2.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.84 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.72 25.35 2.15 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.658 -0.782 . . . . 54.14 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -123.45 -36.46 2.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.909 0.385 . . . . 74.04 110.867 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.58 -38.53 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 54.44 111.242 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.95 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.495 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.6 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.98 -31.49 69.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 72.33 111.077 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.09 -57.19 11.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.5 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -58.23 -35.91 72.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 43.42 110.885 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 129' ' ' VAL . 11.8 mt -66.61 -42.65 86.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.925 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -62.52 -49.21 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 54.32 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.81 -46.32 84.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 63.11 111.11 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.89 -61.1 7.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 73.13 112.525 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.6 -23.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 71.51 111.115 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.32 -61.9 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 75.11 110.861 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.39 -34.85 90.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.732 -0.747 . . . . 70.2 112.478 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' HG21 ' B' ' 116' ' ' VAL . 11.8 m-85 -66.16 -60.66 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 71.23 110.916 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.1 m -53.7 -42.11 67.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 53.3 110.9 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 163' ' ' LEU . . . -59.44 -47.74 89.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.763 -0.732 . . . . 71.13 112.482 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 82.5 mmm -64.47 -32.3 73.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.318 . . . . 72.44 110.886 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.25 -53.64 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 51.44 111.128 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.611 ' HB3' HD13 ' A' ' 118' ' ' ILE . 42.4 ptt85 -57.24 -31.19 65.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.31 110.88 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 167' ' ' MET . 0.2 OUTLIER -76.39 -49.65 16.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.963 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.4 OUTLIER -65.88 -14.71 61.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -94.86 -43.96 7.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.858 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.746 ' HB2' HD23 ' A' ' 110' ' ' LEU . 9.1 ptmt -165.18 59.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.849 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.697 ' HB2' HD23 ' A' ' 163' ' ' LEU . 18.4 ptp -54.37 152.91 10.81 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.475 0.655 . . . . 75.15 110.924 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 50.97 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 71.31 112.304 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.927 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.83 -0.5 48.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.52 110.799 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.75 21.99 6.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 62.25 110.99 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.9 -25.06 59.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.869 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 64.45 111.019 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.802 0.334 . . . . 51.01 110.929 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -53.57 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.86 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -131.58 153.67 81.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.544 0.688 . . . . 74.44 110.851 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -11.97 31.94 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.695 2.263 . . . . 64.24 112.323 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.83 HD23 ' HB2' ' B' ' 166' ' ' LYS . 1.1 mp 56.2 65.45 4.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.54 0.686 . . . . 61.32 110.893 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -171.78 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.643 2.229 . . . . 70.33 112.322 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.1 1.34 10.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.586 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -77.3 -18.61 57.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 52.21 110.902 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.9 -46.77 3.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.926 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -53.94 -32.25 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.921 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.642 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.3 p -76.69 -30.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.089 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . 0.526 ' HG3' HG22 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -68.55 -44.87 73.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 54.42 110.943 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.582 HD13 ' HB3' ' B' ' 162' ' ' ARG . 2.0 pp -77.16 -38.75 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 61.43 111.161 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.37 -57.18 5.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.132 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.04 -39.69 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 72.52 111.136 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.26 -42.25 90.87 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.53 112.417 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.49 48.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.42 112.414 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.54 -60.66 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.711 0.291 . . . . 75.23 110.974 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.513 HG23 HD22 ' A' ' 150' ' ' LEU . 38.1 mm -51.31 -52.69 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.092 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.626 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.02 -55.72 13.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 63.32 110.92 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.73 -41.19 16.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 63.04 111.196 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.03 -65.47 2.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 50.14 112.535 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.911 HG11 HG22 ' A' ' 129' ' ' VAL . 17.0 m -53.73 -22.71 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 71.31 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 128' ' ' VAL . 1.9 t -75.76 -56.69 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.04 111.146 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.483 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.3 OUTLIER -55.36 -30.9 61.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 51.11 110.923 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.78 -47.32 6.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 44.44 112.519 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.45 -25.2 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.997 0.427 . . . . 74.34 110.905 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 66.6 m -90.09 -37.65 14.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.4 111.121 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -81.19 -6.67 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.147 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -122.94 -35.7 2.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 72.21 110.891 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.26 0.7 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.12 110.896 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.93 -24.99 11.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.22 112.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.97 -17.2 56.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 71.51 110.895 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -76.08 -49.92 16.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.953 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -51.84 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.987 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.03 -84.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.925 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 -41.27 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 70.5 110.903 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.36 25.29 2.23 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.712 -0.756 . . . . 54.04 112.449 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -123.38 -36.4 2.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 74.14 110.861 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.59 -38.63 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 74.01 111.107 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.19 -69.17 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.734 . . . . 45.33 112.483 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.591 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.79 -31.14 69.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 42.31 110.966 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.35 -57.39 10.43 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.656 -0.783 . . . . 65.54 112.503 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . 0.568 HD13 ' O ' ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.79 -36.02 71.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.861 0.362 . . . . 62.25 110.961 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 124' ' ' ILE . 12.0 mt -66.47 -42.91 86.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.23 110.926 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -62.49 -48.87 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.43 110.853 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.8 -46.91 83.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 70.33 111.077 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.5 -61.24 7.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 70.04 112.493 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.55 -23.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.31 111.098 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -68.65 -61.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.891 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.23 -35.17 91.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.73 . . . . 75.41 112.474 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.584 ' CE1' HG21 ' A' ' 116' ' ' VAL . 13.5 m-85 -66.92 -55.95 12.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.34 110.847 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 70.1 m -55.77 -42.27 75.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 74.52 110.855 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.56 ' O ' HD12 ' B' ' 163' ' ' LEU . . . -61.52 -46.1 95.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.504 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.94 -33.87 77.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 71.42 110.873 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.94 -53.16 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 53.13 111.166 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.582 ' HB3' HD13 ' B' ' 118' ' ' ILE . 43.0 ptt85 -57.42 -30.69 65.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 54.41 110.928 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' B' ' 167' ' ' MET . 0.2 OUTLIER -76.08 -50.05 15.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.861 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.2 OUTLIER -65.21 -16.02 63.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.982 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.77 -45.08 8.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 70.4 110.851 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.83 ' HB2' HD23 ' B' ' 110' ' ' LEU . 8.0 ptmt -165.51 60.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.886 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.694 ' CB ' HD23 ' B' ' 163' ' ' LEU . 18.8 ptp -53.8 152.77 9.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 75.01 110.834 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 51.15 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.75 2.3 . . . . 74.51 112.276 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' B' ' 167' ' ' MET . 0.0 OUTLIER -50.89 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.967 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -83.13 -0.52 49.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 73.05 110.822 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.47 22.03 6.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.874 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -73.52 -25.2 60.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.32 110.88 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.51 111.02 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.2 mttp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.861 0.363 . . . . 55.41 110.837 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -53.72 10.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 75.02 110.867 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -83.75 153.9 64.58 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.562 0.696 . . . . 74.23 110.909 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.78 -11.8 31.55 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.662 2.241 . . . . 64.15 112.284 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER 51.55 67.3 4.3 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 63.11 110.925 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.39 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.67 2.247 . . . . 61.31 112.409 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.07 2.53 12.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.926 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.587 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -80.07 -11.63 59.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.869 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' B' ' 161' ' ' ALA . 0.8 OUTLIER -115.52 -48.86 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 74.02 110.929 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -30.61 48.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.946 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.681 HG11 ' CE1' ' B' ' 157' ' ' PHE . 73.7 t -77.9 -32.47 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 54.55 111.158 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -70.35 -42.56 71.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.34 110.888 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.5 pp -76.12 -39.83 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 73.13 111.111 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -56.19 6.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.23 111.077 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.4 -39.23 74.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.0 -42.18 94.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 53.33 112.548 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.53 51.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.98 -59.11 4.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 63.03 110.994 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.693 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.5 mm -50.44 -52.98 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.25 111.13 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.588 HD11 ' CG2' ' B' ' 124' ' ' ILE . 1.3 tt -53.94 -53.09 57.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.978 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 151' ' ' PHE . 7.9 mm -47.36 -43.04 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 71.04 111.103 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.65 -64.82 2.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.661 -0.781 . . . . 34.33 112.487 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG22 ' B' ' 129' ' ' VAL . 19.5 m -56.08 -21.12 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 62.22 111.163 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.843 HG22 HG11 ' B' ' 128' ' ' VAL . 2.7 t -75.92 -62.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.14 111.097 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' A' ' 129' ' ' VAL . 5.1 tt -54.9 -28.61 51.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.89 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -80.39 -48.37 6.39 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 43.5 112.541 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.524 ' HD2' HG12 ' B' ' 128' ' ' VAL . 7.0 t80 -62.61 -23.12 66.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.015 0.436 . . . . 73.33 110.934 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' A' ' 147' ' ' ALA . 10.7 p -92.04 -37.56 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 71.53 111.205 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -80.59 -6.98 10.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 64.4 111.089 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.35 -35.65 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.93 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.13 0.75 10.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 71.2 110.849 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.33 -25.33 14.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 41.32 112.514 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.65 -18.07 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 74.01 110.898 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.57 -51.76 13.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 74.44 110.89 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.65 -79.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.889 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -85.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 72.15 110.891 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.827 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.86 24.69 2.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 72.13 112.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -123.15 -36.56 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 74.05 110.935 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.21 -38.77 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 72.42 111.081 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.03 -67.47 1.91 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.671 -0.776 . . . . 73.1 112.432 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' A' ' 133' ' ' THR . . . -58.65 -31.11 67.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.95 0.405 . . . . 71.43 111.173 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.18 -57.1 9.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 72.1 112.482 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.64 -36.88 70.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 61.35 110.926 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.703 HD22 ' CG2' ' B' ' 124' ' ' ILE . 94.2 mt -66.49 -43.62 84.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.975 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.586 ' HD1' HD11 ' A' ' 126' ' ' ILE . 4.6 t80 -60.13 -52.56 64.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.472 . . . . 74.1 110.877 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.34 80.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.41 111.044 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.7 -64.63 4.04 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.696 -0.764 . . . . 42.35 112.515 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG13 HD13 ' A' ' 125' ' ' LEU . 15.6 mm -58.75 -22.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.841 0.353 . . . . 74.11 111.09 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -67.1 -62.87 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 62.42 110.891 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.38 -34.38 89.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 62.25 112.503 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.721 ' CE1' HG11 ' B' ' 116' ' ' VAL . 13.4 m-85 -68.12 -55.63 11.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 64.45 110.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.0 m -55.95 -44.61 78.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.81 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.84 -48.6 85.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.31 112.454 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 73.35 110.836 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -73.57 -53.77 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 43.51 111.074 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.654 ' HB3' HD13 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -58.81 -28.26 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 70.34 110.874 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.38 -47.69 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.598 HD22 ' NH2' ' B' ' 114' ' ' ARG . 0.1 OUTLIER -67.89 -15.5 63.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 62.34 110.956 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.38 -46.06 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.906 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.454 ' CB ' HD23 ' A' ' 110' ' ' LEU . 1.3 ptmt -142.79 57.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.513 . . . . 54.03 110.925 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 mtm -50.76 142.9 15.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.642 0.734 . . . . 43.31 110.837 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 54.2 Cg_endo -69.66 48.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.256 . . . . 62.14 112.396 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.999 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.82 -7.82 50.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 63.02 110.932 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.17 23.52 6.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -26.13 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 73.42 110.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.054 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.6 mttp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.774 0.321 . . . . 64.51 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.01 -53.12 10.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 72.34 110.781 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -84.56 153.67 61.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.561 0.696 . . . . 71.11 110.851 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -12.28 32.68 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.695 2.263 . . . . 72.22 112.322 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.6 OUTLIER 51.72 67.18 4.36 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 60.45 110.854 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.92 -169.17 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.66 2.24 . . . . 75.13 112.306 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.63 1.62 14.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 75.35 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -84.27 -6.38 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.885 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.598 ' NH2' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.76 -46.26 2.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 62.42 110.928 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -32.57 72.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.721 HG11 ' CE1' ' A' ' 157' ' ' PHE . 72.1 t -75.85 -32.7 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 71.11 111.077 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.62 -44.35 74.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 53.34 110.918 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.6 pp -76.92 -39.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 51.3 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.33 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 43.35 111.101 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.93 -39.07 76.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 73.25 111.057 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.98 -42.61 94.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.67 -0.776 . . . . 73.22 112.446 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.84 -47.85 45.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 64.22 112.491 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 tp -64.77 -59.7 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.797 0.332 . . . . 71.32 110.977 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.703 ' CG2' HD22 ' A' ' 150' ' ' LEU . 34.5 mm -50.33 -53.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.23 111.134 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.566 HD11 ' CG2' ' A' ' 124' ' ' ILE . 1.2 tt -53.74 -54.3 39.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 65.41 110.908 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.556 HD11 ' HD1' ' B' ' 151' ' ' PHE . 8.7 mm -46.46 -43.45 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 60.14 111.152 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.16 -65.65 2.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 62.52 112.467 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.843 HG11 HG22 ' A' ' 129' ' ' VAL . 20.1 m -55.66 -21.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.9 0.381 . . . . 53.42 111.17 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.823 HG22 HG11 ' A' ' 128' ' ' VAL . 2.8 t -75.23 -63.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 70.45 111.11 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.446 ' N ' HG12 ' B' ' 129' ' ' VAL . 5.1 tt -54.05 -29.12 42.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.929 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.627 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -79.95 -47.2 7.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.814 -0.708 . . . . 75.03 112.495 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.549 ' HD2' HG12 ' A' ' 128' ' ' VAL . 5.7 t80 -63.41 -24.34 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.973 0.416 . . . . 72.12 110.889 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.722 HG21 ' N ' ' B' ' 147' ' ' ALA . 10.2 p -91.02 -37.21 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 71.43 111.186 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.627 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -80.54 -7.22 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.154 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.16 -35.56 2.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.905 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.37 1.01 10.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 74.2 110.879 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -95.65 -25.04 14.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.747 -0.739 . . . . 63.34 112.494 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -60.39 -18.28 49.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.907 0.384 . . . . 71.41 110.89 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.6 -52.25 12.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 75.35 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mp -51.67 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.4 -85.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.839 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.71 -41.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.891 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.95 24.88 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 74.12 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -123.33 -36.46 2.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 74.34 110.852 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.29 -39.21 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 73.42 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -67.44 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.03 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.722 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.04 68.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 70.01 111.019 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.1 -57.21 9.82 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 44.22 112.448 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.55 -36.97 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.803 0.335 . . . . 63.2 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.693 HD22 ' CG2' ' A' ' 124' ' ' ILE . 90.9 mt -66.6 -43.52 84.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.192 -0.458 . . . . 71.31 110.857 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.556 ' HD1' HD11 ' B' ' 126' ' ' ILE . 4.1 t80 -60.13 -52.53 64.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.916 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.47 -44.56 80.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 51.34 111.18 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.46 -65.32 3.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 61.25 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.425 HG13 HD22 ' B' ' 125' ' ' LEU . 16.9 mm -58.02 -22.51 19.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 74.15 111.128 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.1 m -66.93 -62.68 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 63.45 110.822 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.03 -35.03 91.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 64.33 112.512 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.681 ' CE1' HG11 ' A' ' 116' ' ' VAL . 15.5 m-85 -67.87 -53.4 26.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 65.43 110.908 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.6 m -57.05 -43.19 81.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 72.32 110.854 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.85 -48.13 87.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 61.24 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -32.92 74.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 71.31 110.871 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.63 -54.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 70.22 111.104 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.621 ' HB3' HD13 ' B' ' 118' ' ' ILE . 0.2 OUTLIER -57.35 -29.46 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.856 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.97 -47.33 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -15.77 63.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 64.11 110.847 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.32 -48.85 4.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.885 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.48 ' CB ' HD23 ' B' ' 110' ' ' LEU . 1.4 ptmt -139.92 57.69 1.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.45 110.911 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.435 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.2 mtm -49.62 143.36 10.85 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.582 0.706 . . . . 74.02 110.855 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.435 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 52.9 Cg_endo -69.82 48.44 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.678 2.252 . . . . 74.14 112.298 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 62.02 110.866 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -7.44 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 72.22 110.863 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -96.09 23.8 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 74.54 110.947 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -26.22 64.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.892 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.019 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 54.33 110.917 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -52.83 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 74.44 110.901 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -89.84 153.87 47.59 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 75.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 -11.36 30.77 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.259 . . . . 63.01 112.38 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD23 ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER 51.07 69.35 2.62 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.559 0.695 . . . . 45.44 110.918 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.24 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.675 2.25 . . . . 73.23 112.369 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.69 1.78 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.948 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.585 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -84.02 -12.27 55.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.928 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.685 ' CZ ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -111.66 -47.29 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 70.01 110.953 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -31.01 67.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 70.55 110.931 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' B' ' 157' ' ' PHE . 9.2 p -76.86 -29.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.22 111.171 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -73.46 -43.72 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.865 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 162' ' ' ARG . 1.2 pp -76.08 -38.08 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.126 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.77 -56.4 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 63.22 111.104 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.94 -38.9 72.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 62.4 111.162 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.31 -40.55 87.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.742 . . . . 54.13 112.456 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.17 -47.97 41.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.761 -0.733 . . . . 75.44 112.452 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.84 -55.08 21.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.786 0.327 . . . . 74.01 110.888 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.7 mm -53.96 -54.15 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 71.33 111.149 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 154' ' ' ILE . 1.1 tt -53.46 -48.81 68.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.93 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 mt -50.3 -59.11 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.167 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.69 9.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 60.31 112.509 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' B' ' 128' ' ' VAL . 39.8 t -51.15 -27.6 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 55.14 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 150' ' ' LEU . 2.2 t -73.21 -57.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.134 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.427 ' N ' HG12 ' A' ' 129' ' ' VAL . 28.6 mt -54.39 -26.72 31.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.862 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.611 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -84.13 -48.26 5.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.55 112.459 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -63.33 -20.88 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 75.33 110.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.69 HG21 ' N ' ' A' ' 147' ' ' ALA . 19.6 p -94.54 -38.87 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 60.15 111.118 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.611 HG12 ' HA2' ' A' ' 131' ' ' GLY . 5.1 p -76.94 -9.24 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 71.43 111.105 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.31 -40.12 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.52 110.921 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.55 0.97 15.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.823 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -99.1 -24.45 10.42 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 43.34 112.531 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.04 -17.72 53.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 65.33 110.895 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -78.28 -44.88 24.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.08 -80.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.24 110.855 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.46 -85.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.13 110.909 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.6 m -125.67 -41.91 1.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.787 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.92 23.65 2.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 62.35 112.435 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -123.16 -38.76 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 72.22 110.918 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.82 -40.61 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.147 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.3 -65.08 2.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.805 -0.712 . . . . 53.51 112.462 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.69 ' N ' HG21 ' A' ' 133' ' ' THR . . . -59.3 -31.55 69.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 24.32 111.189 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.13 -56.15 15.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.745 . . . . 72.41 112.587 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.71 -35.45 72.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 75.22 110.886 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 129' ' ' VAL . 45.3 mt -66.02 -45.55 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.4 110.913 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -60.1 -51.98 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.98 77.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 73.41 111.105 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -61.58 6.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 44.54 112.452 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -59.74 -21.8 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 74.2 111.091 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -69.52 -61.93 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.829 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.51 91.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' B' ' 116' ' ' VAL . 13.8 m-85 -67.73 -58.16 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 55.21 110.875 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.6 m -53.96 -43.26 69.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 73.23 110.852 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.21 -48.87 84.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.746 -0.74 . . . . 70.54 112.464 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -32.21 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.322 . . . . 63.12 110.92 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.36 -54.29 7.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.31 111.131 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.3 ptm180 -58.65 -26.49 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.851 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.58 -48.89 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 75.23 111.021 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.64 HD23 ' NH1' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -67.89 -14.47 62.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 73.55 110.886 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.95 -44.66 5.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.808 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.689 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -144.22 57.66 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.34 110.862 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.426 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.2 mtm -49.95 143.58 11.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.489 0.661 . . . . 73.05 110.92 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.8 Cg_endo -69.68 48.03 0.59 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.682 2.255 . . . . 62.03 112.327 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -82.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 71.4 110.953 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -80.26 -1.9 42.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -54.74 -25.98 31.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.974 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.1 ptt85 -179.32 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.915 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.25 111.149 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.762 0.315 . . . . 73.43 110.849 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.48 -52.28 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -89.52 153.57 48.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.578 0.704 . . . . 70.12 110.924 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.85 -11.92 31.68 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.643 2.229 . . . . 74.52 112.314 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.674 HD23 ' CB ' ' B' ' 166' ' ' LYS . 0.6 OUTLIER 51.15 68.53 3.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.692 0.758 . . . . 64.12 110.935 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.89 -170.46 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.604 2.203 . . . . 73.54 112.368 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.02 1.48 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 53.21 110.894 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.49 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -84.55 -8.75 58.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 53.14 110.864 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.64 ' NH1' HD23 ' A' ' 164' ' ' LEU . 6.1 mpt_? -115.65 -47.77 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 72.22 110.928 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.9 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.653 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.5 p -75.66 -29.42 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -69.29 -46.0 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 54.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' B' ' 162' ' ' ARG . 1.1 pp -76.82 -37.56 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.285 -0.416 . . . . 74.31 111.104 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.67 -56.86 5.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 53.01 111.072 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -71.36 -39.24 71.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.133 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.83 -40.92 89.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 75.24 112.49 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.53 35.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 41.12 112.507 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.88 -55.2 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 74.23 110.923 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.621 ' O ' HG23 ' B' ' 128' ' ' VAL . 29.6 mm -54.2 -56.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 54.35 111.139 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.625 HD22 ' CB ' ' B' ' 154' ' ' ILE . 0.9 OUTLIER -51.66 -48.98 63.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 61.42 110.956 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 27.4 mt -50.29 -59.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 65.51 111.09 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.81 -58.2 15.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.92 HG12 HG12 ' A' ' 128' ' ' VAL . 24.1 t -53.47 -26.25 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.824 0.345 . . . . 74.24 111.123 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.661 HG22 HD13 ' B' ' 150' ' ' LEU . 2.1 t -72.59 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 53.05 111.117 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.46 ' N ' HG12 ' B' ' 129' ' ' VAL . 30.1 mt -55.53 -29.47 58.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 71.32 110.818 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.88 -45.17 7.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.732 -0.747 . . . . 53.33 112.488 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 128' ' ' VAL . 9.1 t80 -64.96 -23.56 67.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.044 0.45 . . . . 63.33 110.963 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.707 HG21 ' N ' ' B' ' 147' ' ' ALA . 20.5 p -92.65 -37.86 12.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.513 . . . . 74.42 111.194 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -79.95 -7.49 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 54.02 111.124 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.08 -35.68 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 62.22 110.864 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.57 1.55 11.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 54.23 110.883 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -100.59 -22.95 10.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 73.52 112.517 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -60.02 -18.26 44.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 73.41 110.952 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -79.22 -42.78 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.079 -0.51 . . . . 62.11 110.902 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mp -56.49 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 63.15 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.517 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -85.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 55.52 110.852 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 37.8 m -125.59 -41.98 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.908 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.87 23.91 2.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.777 -0.725 . . . . 63.35 112.574 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -123.3 -38.89 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.944 0.402 . . . . 72.14 110.877 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.58 -41.17 91.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 74.54 111.114 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.0 -64.99 2.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.742 . . . . 62.14 112.508 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.707 ' N ' HG21 ' B' ' 133' ' ' THR . . . -58.95 -31.52 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.966 0.412 . . . . 31.41 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.08 -56.32 14.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.661 -0.781 . . . . 63.25 112.513 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -35.4 72.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 72.5 110.867 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.661 HD13 HG22 ' B' ' 129' ' ' VAL . 45.7 mt -66.14 -46.08 78.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.904 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.74 -51.75 68.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.24 110.881 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.17 77.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.116 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -61.26 7.13 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.7 -0.762 . . . . 34.41 112.528 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.625 ' CB ' HD22 ' B' ' 125' ' ' LEU . 0.3 OUTLIER -59.69 -22.23 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.701 0.286 . . . . 64.22 111.06 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.3 m -69.13 -62.25 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.04 0.448 . . . . 71.2 110.799 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.86 92.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 50.24 112.468 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 116' ' ' VAL . 14.1 m-85 -67.79 -56.76 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 75.52 110.924 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 45.6 m -54.59 -43.71 72.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 65.15 110.89 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.08 -48.83 84.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 54.52 112.545 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -32.7 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.767 0.318 . . . . 64.21 110.909 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.685 ' HB1' ' CZ ' ' A' ' 114' ' ' ARG . . . -74.37 -55.78 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 35.13 111.115 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.658 ' HB3' HD13 ' B' ' 118' ' ' ILE . 1.2 ptm180 -56.27 -26.81 53.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.52 -49.22 12.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.972 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -66.16 -14.72 62.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.871 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.58 -45.83 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 53.04 110.902 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.674 ' CB ' HD23 ' B' ' 110' ' ' LEU . 0.4 OUTLIER -142.19 58.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.921 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.427 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.1 mtm -50.26 144.24 11.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 64.11 110.844 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.427 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 52.9 Cg_endo -69.77 48.18 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.655 2.237 . . . . 74.35 112.311 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 63.44 110.953 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -80.56 -1.29 41.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 74.35 110.924 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -54.85 -25.97 32.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.905 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 ptt85 -179.66 -40.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.854 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.5 111.154 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.716 0.294 . . . . 73.53 110.878 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -52.42 8.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 73.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 158.38 46.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.709 . . . . 74.4 110.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.64 -11.57 31.27 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.612 2.208 . . . . 64.11 112.386 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.3 mt 59.37 68.92 1.43 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.597 0.713 . . . . 72.02 110.952 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -170.65 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.711 2.274 . . . . 64.04 112.3 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 116' ' ' VAL . 9.3 mp -113.13 1.24 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 53.51 110.948 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.574 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -62.33 -16.67 55.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 70.31 110.895 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -120.42 -38.01 2.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 51.13 110.88 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -58.35 -32.82 68.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 64.42 110.871 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 112' ' ' LEU . 16.3 m -77.73 -28.0 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 72.11 111.144 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' B' ' 117' ' ' GLN . 28.0 tp60 -73.72 -42.39 61.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 71.44 110.998 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.3 pp -76.21 -39.15 35.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.118 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.6 -55.84 6.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 54.11 111.096 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.27 -38.53 71.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.02 111.112 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.6 -42.26 93.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 74.01 112.56 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.34 -48.79 43.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.455 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.65 -58.38 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.782 0.325 . . . . 63.32 110.874 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.796 HG23 HD22 ' B' ' 150' ' ' LEU . 92.5 mt -51.62 -54.27 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.768 HD13 HG13 ' A' ' 154' ' ' ILE . 3.7 tt -50.57 -55.07 17.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 53.32 110.909 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.0 mt -48.22 -41.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 72.41 111.176 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.08 -66.52 2.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.742 . . . . 42.44 112.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.932 HG11 HG22 ' B' ' 129' ' ' VAL . 15.7 m -54.32 -22.08 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 74.21 111.123 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.944 HG22 HG11 ' B' ' 128' ' ' VAL . 3.3 t -75.4 -62.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 73.14 111.133 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HG12 ' A' ' 129' ' ' VAL . 26.5 tp -53.68 -28.42 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 70.34 110.969 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.605 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -81.04 -49.28 5.67 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.478 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD2' HG12 ' B' ' 128' ' ' VAL . 5.8 t80 -61.32 -23.46 65.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.966 0.412 . . . . 70.44 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.666 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 95.0 m -91.63 -39.73 11.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 70.14 111.189 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.605 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.8 p -77.99 -7.43 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 43.15 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.19 -43.34 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 45.01 110.899 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.32 1.09 18.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.837 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.23 -21.06 10.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.735 . . . . 71.44 112.517 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.88 -22.21 24.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 72.33 110.847 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -80.81 -34.46 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.893 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.73 -165.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.34 110.854 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -39.75 -82.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.097 -0.501 . . . . 74.53 110.877 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.98 -38.74 2.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.94 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.36 22.42 4.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.702 -0.761 . . . . 45.24 112.433 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.43 -33.57 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 61.35 110.84 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.76 -35.91 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 53.34 111.127 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.7 -70.68 1.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.661 -0.781 . . . . 43.33 112.533 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -60.63 -32.09 71.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.769 0.318 . . . . 72.4 111.085 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.18 -57.33 8.62 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 52.45 112.402 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -37.34 68.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.772 0.32 . . . . 54.44 110.906 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.802 HD22 HG23 ' B' ' 124' ' ' ILE . 89.7 mt -67.16 -44.25 80.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.493 . . . . 73.22 110.923 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -58.93 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.884 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.11 77.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 64.3 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -66.74 2.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 75.43 112.43 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.768 HG13 HD13 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -58.83 -21.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 72.22 111.18 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 m -68.5 -62.63 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.857 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.58 91.82 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.753 -0.737 . . . . 53.11 112.508 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' B' ' 116' ' ' VAL . 13.9 m-85 -65.59 -57.46 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.853 0.358 . . . . 71.04 110.924 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.1 p -55.5 -45.61 77.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 61.11 110.887 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.31 -48.56 74.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.668 -0.777 . . . . 63.13 112.45 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -33.53 75.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 72.3 110.85 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.79 -48.65 36.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 75.24 111.105 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.659 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -59.72 -32.64 70.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.55 110.856 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.9 -46.36 30.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.926 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -11.64 60.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.928 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.69 -43.2 8.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.264 -0.426 . . . . 54.0 110.9 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -153.22 56.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.4 mtm -48.76 142.58 8.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.572 0.701 . . . . 72.04 110.862 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.2 Cg_endo -69.93 48.31 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 73.53 112.335 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -84.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 62.23 110.918 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -79.64 -2.27 41.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.907 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -57.3 -23.9 51.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 50.25 110.883 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.36 -39.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 65.33 110.895 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 62.3 111.102 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.797 0.332 . . . . 75.44 110.883 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.88 -52.33 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 63.32 110.805 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.44 158.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.524 0.678 . . . . 72.12 110.985 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -16.34 37.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.75 2.3 . . . . 74.01 112.292 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 mt 63.81 68.2 0.89 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.7 . . . . 43.24 110.862 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.669 2.246 . . . . 73.21 112.323 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.529 ' O ' HG22 ' B' ' 116' ' ' VAL . 9.2 mp -110.3 1.04 18.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.938 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -63.88 -15.35 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 62.24 110.857 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.23 -39.72 2.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 63.23 110.868 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -56.44 -33.0 65.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.529 HG22 ' O ' ' B' ' 112' ' ' LEU . 16.5 m -78.79 -28.86 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.058 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 117' ' ' GLN . 0.9 OUTLIER -70.57 -40.52 73.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.904 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' B' ' 162' ' ' ARG . 1.2 pp -80.97 -38.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 75.34 111.074 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.27 -54.84 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.257 -0.429 . . . . 60.41 111.134 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -73.02 -39.17 66.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.32 111.118 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 -42.98 93.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.747 . . . . 72.2 112.486 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.81 -49.09 37.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 53.43 112.416 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.69 -59.35 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.857 0.36 . . . . 73.05 110.961 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.802 HG23 HD22 ' A' ' 150' ' ' LEU . 92.6 mt -50.98 -55.73 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.0 111.13 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.844 HD13 HG13 ' B' ' 154' ' ' ILE . 3.5 tt -49.38 -57.64 6.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.833 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 46.8 mt -46.51 -42.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.076 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.39 -68.09 1.77 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 73.0 112.555 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.944 HG11 HG22 ' A' ' 129' ' ' VAL . 14.2 m -53.41 -22.5 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 73.51 111.09 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 128' ' ' VAL . 3.7 t -74.22 -63.95 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 65.24 111.119 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.413 ' N ' HG12 ' B' ' 129' ' ' VAL . 27.1 tp -52.61 -29.08 24.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.893 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.63 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.37 -48.23 6.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.753 -0.737 . . . . 62.34 112.57 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.9 t80 -61.81 -24.26 66.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.994 0.426 . . . . 73.11 110.957 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.673 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 87.2 m -91.09 -39.52 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.2 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.63 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.7 p -78.03 -7.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 65.24 111.133 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -42.78 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 73.13 110.809 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.05 1.43 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.946 0.403 . . . . 70.11 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.48 10.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 61.03 112.46 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.92 -22.23 24.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 74.03 110.874 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.83 -34.38 33.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.918 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 26.0 mt -61.68 -166.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 70.53 110.869 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.467 ' N ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -39.53 -82.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 44.35 110.943 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.99 -38.55 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 65.12 110.786 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.12 22.17 5.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.712 -0.756 . . . . 63.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.19 -33.62 3.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.3 110.786 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.94 -35.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 61.14 111.074 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.96 -70.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.801 -0.714 . . . . 75.35 112.485 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.673 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.75 -31.96 71.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.818 0.342 . . . . 65.13 111.121 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.32 -57.27 8.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 54.3 112.513 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -37.15 68.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.817 0.341 . . . . 71.31 110.883 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.796 HD22 HG23 ' A' ' 124' ' ' ILE . 89.9 mt -67.47 -43.73 80.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.912 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -59.78 -54.51 45.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.84 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.104 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.77 -66.14 2.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.439 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.844 HG13 HD13 ' B' ' 125' ' ' LEU . 0.4 OUTLIER -58.94 -20.85 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 44.45 111.18 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 2.4 m -68.92 -62.75 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.83 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.27 -36.43 92.42 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.465 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.406 ' CD1' HG21 ' A' ' 116' ' ' VAL . 15.0 m-85 -65.63 -53.4 42.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 54.24 110.822 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p -56.65 -48.19 78.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 51.53 110.807 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.75 -46.87 81.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.21 112.505 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -34.81 78.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 64.53 110.891 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -72.72 -47.66 45.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.254 -0.43 . . . . 72.45 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.649 ' HB2' HD13 ' B' ' 118' ' ' ILE . 0.8 OUTLIER -60.35 -32.52 71.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.9 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.79 -47.04 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 54.51 110.933 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.477 HD13 ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -71.59 -12.63 61.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.903 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.13 -46.33 7.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 64.23 110.813 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -150.88 57.55 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.443 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.3 mtm -48.31 143.38 7.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.608 0.718 . . . . 74.14 110.819 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.443 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 54.0 Cg_endo -69.87 48.87 0.69 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.537 2.158 . . . . 74.33 112.373 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -85.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.847 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -80.35 -2.2 44.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.13 110.863 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.74 -24.51 50.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.3 110.882 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -179.51 -37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 75.04 110.934 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 61.11 111.177 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.465 ' HG2' HD11 ' A' ' 110' ' ' LEU . 1.1 tttm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.762 0.315 . . . . 41.24 110.931 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -50.88 9.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 60.3 110.759 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -52.08 157.18 2.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 73.43 110.948 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -22.48 31.87 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 70.44 112.35 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 106' ' ' LYS . 0.7 OUTLIER 50.23 68.24 3.62 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.581 0.705 . . . . 70.54 110.932 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -173.02 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 64.55 112.326 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.7 mp -119.64 0.99 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 54.14 110.905 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.654 ' CG ' HD22 ' B' ' 164' ' ' LEU . 21.6 mmt -86.62 -7.01 58.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.24 110.888 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.6 -45.73 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.83 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -29.71 67.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.32 110.929 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 26.9 m -76.28 -28.78 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.51 111.113 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -73.18 -44.28 60.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.924 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.583 HD13 ' CB ' ' A' ' 162' ' ' ARG . 1.4 pp -75.6 -38.23 38.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 63.03 111.098 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.08 -57.02 4.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 61.11 111.103 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.71 -38.81 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.043 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.4 87.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 55.52 112.456 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.49 -48.53 36.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 52.24 112.452 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -55.75 23.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.769 0.319 . . . . 73.35 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.424 ' CG2' HD22 ' B' ' 150' ' ' LEU . 33.3 mm -55.15 -49.18 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 64.05 111.11 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.711 HD22 HG23 ' A' ' 129' ' ' VAL . 2.6 tm? -53.34 -52.89 57.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 70.31 110.882 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 mt -50.88 -51.59 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.13 111.141 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.87 -62.74 4.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 53.32 112.487 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.53 HG23 ' CD2' ' B' ' 132' ' ' TYR . 10.0 p -50.93 -25.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.14 111.053 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 125' ' ' LEU . 1.9 t -74.95 -56.26 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.21 111.076 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 134' ' ' VAL . 34.9 tp -53.74 -30.04 42.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 43.25 110.839 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.03 -46.52 7.03 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 24.31 112.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' B' ' 128' ' ' VAL . 0.4 OUTLIER -66.36 -19.44 65.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 60.41 110.93 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 52.9 m -90.22 -43.07 10.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 64.31 111.134 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 130' ' ' LEU . 16.4 m -81.8 -4.84 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.085 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.48 -36.9 2.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 60.11 110.854 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.28 0.59 10.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.259 -0.428 . . . . 65.44 110.873 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.79 -23.98 10.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 42.25 112.532 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -17.58 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.1 110.934 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -74.58 -46.87 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 75.15 110.961 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.7 mt -54.35 -82.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 75.03 110.933 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -122.12 -86.9 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 61.45 110.926 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.71 -41.84 2.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 54.13 110.852 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 126.26 31.71 0.77 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.629 -0.796 . . . . 64.42 112.48 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -122.94 -38.83 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.989 0.423 . . . . 75.24 110.916 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 141' ' ' LEU . 71.3 t -66.56 -38.33 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 74.04 111.048 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.18 -67.04 2.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 71.21 112.551 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -61.24 -29.87 70.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 42.51 111.095 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.0 -56.37 10.97 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.64 -35.61 74.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.371 . . . . 70.32 110.921 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 129' ' ' VAL . 18.4 mt -67.04 -48.26 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.889 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.19 -52.79 64.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.826 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.1 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -59.47 -65.6 3.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.454 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 125' ' ' LEU . 0.4 OUTLIER -60.7 -20.56 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.51 111.104 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.8 m -67.82 -62.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.821 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.12 -34.9 91.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.517 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -66.17 -57.83 6.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 63.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 97.6 p -55.28 -44.19 75.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.863 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 163' ' ' LEU . . . -57.76 -49.38 74.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 74.52 112.529 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 12.9 mmt -63.09 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 65.43 110.953 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' B' ' 114' ' ' ARG . . . -74.35 -54.77 6.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 72.32 111.076 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.583 ' CB ' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -58.71 -26.35 63.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 73.4 110.852 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 159' ' ' GLY . 2.4 mp -78.64 -49.14 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.935 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.7 HD22 ' CG ' ' B' ' 113' ' ' MET . 0.4 OUTLIER -69.96 -12.16 61.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.883 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -100.49 -44.37 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.03 110.834 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -147.09 57.03 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.846 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.447 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 mtm -50.48 143.36 13.91 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.644 0.735 . . . . 73.51 110.811 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.447 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.3 Cg_endo -69.72 48.25 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.648 2.232 . . . . 72.11 112.374 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.33 -82.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.917 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.75 -2.86 41.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 61.31 110.913 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.51 -24.16 44.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 72.11 111.001 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.39 59.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.818 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 62.04 111.086 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.784 0.326 . . . . 72.22 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -50.47 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 63.5 110.804 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -52.82 157.31 2.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.723 . . . . 70.11 110.833 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -23.1 31.11 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.653 2.235 . . . . 70.12 112.379 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.3 67.7 4.12 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.647 0.737 . . . . 63.21 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -173.93 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 65.42 112.375 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.7 mp -118.25 1.19 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 62.32 110.909 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.7 ' CG ' HD22 ' A' ' 164' ' ' LEU . 16.2 mmt -85.07 -7.0 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 73.24 110.915 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 161' ' ' ALA . 16.1 tpp180 -114.1 -45.31 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -33.81 59.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.951 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 33.0 m -76.35 -30.1 19.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 55.22 111.11 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -68.37 -45.6 72.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.893 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' B' ' 162' ' ' ARG . 1.4 pp -77.1 -37.73 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.186 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.99 -57.94 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.11 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.47 -39.05 74.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.136 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.618 ' O ' HD23 ' B' ' 125' ' ' LEU . . . -68.19 -41.21 87.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.699 -0.763 . . . . 71.51 112.46 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.78 -49.15 44.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.504 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 126' ' ' ILE . 0.1 OUTLIER -62.29 -55.52 27.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 70.14 110.942 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 28.6 mm -53.27 -46.04 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.105 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.618 HD23 ' O ' ' B' ' 121' ' ' GLY . 2.3 mm? -56.7 -54.02 50.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' B' ' 123' ' ' LEU . 16.4 mt -48.25 -52.63 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.22 111.116 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.35 -63.97 4.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.499 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.502 HG23 ' CD2' ' A' ' 132' ' ' TYR . 9.1 p -51.33 -25.02 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.378 . . . . 72.14 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.4 t -72.68 -59.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.33 111.099 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.426 ' N ' HG12 ' B' ' 129' ' ' VAL . 31.0 tp -53.66 -28.11 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 64.13 110.95 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.06 -48.74 5.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.49 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.53 ' CD2' HG23 ' A' ' 128' ' ' VAL . 7.3 t80 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 53.31 110.899 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 60.4 m -93.47 -40.41 10.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.14 111.164 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' B' ' 131' ' ' GLY . 6.5 p -73.9 -9.59 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.186 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.13 -45.69 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.885 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 0.83 25.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 72.1 110.905 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -98.07 -25.05 10.74 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 71.23 112.556 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -63.22 -16.15 59.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.925 0.393 . . . . 74.52 110.873 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.18 -50.15 17.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.073 -0.512 . . . . 62.04 110.983 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.8 mt -52.05 -82.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 52.4 110.905 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.478 HD11 ' HB ' ' B' ' 145' ' ' VAL . 0.1 OUTLIER -122.08 -85.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 65.31 110.931 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.65 -40.91 2.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 73.3 110.859 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.61 31.2 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.477 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -123.02 -38.34 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.23 110.833 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . 0.478 ' HB ' HD11 ' B' ' 141' ' ' LEU . 61.4 t -66.15 -39.21 83.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.41 111.2 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.27 -67.85 1.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 72.23 112.449 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -60.48 -31.21 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 70.44 111.114 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.68 -56.21 14.09 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.474 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.16 -35.32 73.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.833 0.349 . . . . 70.5 110.939 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 124' ' ' ILE . 43.2 mt -66.24 -45.83 79.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.972 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.06 -49.15 78.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.816 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.08 85.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.22 111.1 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.99 -61.53 6.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.763 -0.732 . . . . 75.32 112.491 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 mm -60.04 -23.05 25.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.812 0.339 . . . . 74.43 111.107 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.9 m -68.6 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.859 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -61.35 -35.35 90.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 34.15 112.538 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -66.33 -59.02 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 65.51 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 91.9 p -53.4 -45.44 69.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.915 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.433 ' O ' HD13 ' B' ' 163' ' ' LEU . . . -57.94 -47.54 88.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.82 -0.705 . . . . 40.43 112.422 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.72 -32.16 73.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.331 . . . . 71.51 110.87 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -74.88 -53.6 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.139 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.585 ' CB ' HD13 ' B' ' 118' ' ' ILE . 0.1 OUTLIER -58.85 -25.62 63.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.35 110.872 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.433 HD13 ' O ' ' B' ' 159' ' ' GLY . 2.3 mp -80.16 -50.9 9.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.948 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.654 HD22 ' CG ' ' A' ' 113' ' ' MET . 0.4 OUTLIER -68.43 -12.5 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.45 110.921 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.16 -44.39 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 73.42 110.91 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.21 57.37 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.12 110.864 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.43 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.2 mtm -50.81 143.93 14.09 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.57 0.7 . . . . 73.41 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.43 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 54.0 Cg_endo -69.75 48.46 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.643 2.229 . . . . 60.33 112.415 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.46 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 72.42 110.967 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -79.21 -2.63 41.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.839 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -24.43 48.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 42.42 110.875 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.24 59.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 64.32 110.848 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 51.54 111.056 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.835 0.35 . . . . 74.43 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -52.87 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 42.32 110.884 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.585 ' O ' HD12 ' A' ' 110' ' ' LEU . 2.6 mp0 -51.59 159.89 1.15 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.698 0.761 . . . . 62.31 110.833 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.62 -27.39 27.2 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.749 2.299 . . . . 65.42 112.358 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 ' CB ' ' A' ' 166' ' ' LYS . 1.2 mp 49.63 67.58 4.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.565 0.698 . . . . 52.33 110.854 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -178.56 2.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.694 2.263 . . . . 74.54 112.381 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.29 -0.43 10.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.901 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.694 ' HG3' HD13 ' B' ' 164' ' ' LEU . 25.4 mmt -87.08 -10.04 53.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.879 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -45.15 4.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 73.31 110.826 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -60.42 -28.37 68.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.906 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG21 ' CE1' ' B' ' 157' ' ' PHE . 11.4 p -77.26 -31.05 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 54.01 111.141 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.57 ' HG2' HG22 ' B' ' 118' ' ' ILE . 33.3 tp60 -74.35 -41.53 60.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 75.51 110.936 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.637 HD13 ' HB2' ' A' ' 162' ' ' ARG . 1.8 pp -75.18 -39.63 43.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.147 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.83 -57.52 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 50.44 111.076 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -69.32 -39.16 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 63.34 111.094 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.27 -41.62 91.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.22 112.463 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.16 -48.65 51.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 50.44 112.521 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.16 -59.83 3.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.3 110.886 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.536 HG23 HD22 ' B' ' 150' ' ' LEU . 73.0 mt -51.39 -52.39 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.55 111.119 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -51.11 -55.24 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 64.32 110.893 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.8 mt -49.37 -40.62 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 75.31 111.188 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.84 -65.5 2.69 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 45.51 112.521 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.924 HG11 HG22 ' B' ' 129' ' ' VAL . 17.1 m -53.62 -22.77 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 71.03 111.099 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 128' ' ' VAL . 1.7 t -76.68 -54.91 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 53.44 111.087 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' ' 129' ' ' VAL . 38.1 tp -56.3 -29.84 61.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 52.32 110.821 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -82.08 -47.84 5.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.509 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.36 -23.58 66.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 74.31 110.912 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 73.8 m -91.58 -39.03 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 74.52 111.123 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.5 p -79.71 -7.23 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.22 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -123.07 -38.48 2.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.865 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.81 1.07 12.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.865 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 133' ' ' THR . . . -97.25 -25.3 11.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.371 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.34 -17.57 54.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.93 0.395 . . . . 75.35 110.902 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -76.52 -49.8 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 75.12 110.889 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 65.7 mt -51.79 -79.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.911 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.21 -85.19 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.927 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 t -125.66 -41.33 2.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.094 -0.503 . . . . 53.42 110.718 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.59 2.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.785 . . . . 52.22 112.502 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -123.48 -36.58 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 73.44 110.872 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.19 -39.51 85.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.2 111.123 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.49 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 71.44 112.52 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.28 -31.33 69.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.843 0.354 . . . . 62.12 111.129 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.44 -57.06 10.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 64.04 112.5 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -57.66 -36.12 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 63.31 110.877 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 129' ' ' VAL . 10.3 mt -66.47 -42.78 87.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 44.41 110.922 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.14 -50.59 71.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 71.53 110.901 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.92 -46.1 82.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.2 111.031 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.11 -63.01 5.29 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 62.53 112.473 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.93 -23.21 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 72.21 111.066 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 m -69.2 -62.47 1.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.22 110.815 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.2 -35.91 89.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 73.03 112.482 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.7 m-85 -67.1 -56.8 8.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 71.22 110.886 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m -52.25 -46.4 65.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 74.53 110.917 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.25 -45.14 96.62 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.708 -0.758 . . . . 54.22 112.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.7 -34.14 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 72.43 110.878 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.62 -50.08 27.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 61.12 111.11 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.637 ' HB2' HD13 ' A' ' 118' ' ' ILE . 42.1 ttp180 -59.52 -30.16 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.934 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -47.03 21.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.24 110.913 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.714 HD13 ' HG3' ' B' ' 113' ' ' MET . 0.7 OUTLIER -70.78 -13.39 62.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 70.04 110.896 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -97.78 -44.21 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.845 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.671 ' CB ' HD23 ' A' ' 110' ' ' LEU . 7.1 ptmm? -148.04 56.94 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 75.11 110.921 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.453 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.3 ttm -50.09 142.9 13.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 72.44 110.908 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 54.0 Cg_endo -69.65 48.16 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.63 2.22 . . . . 64.31 112.369 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -79.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 63.13 110.821 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.19 -9.69 54.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.909 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -96.28 22.98 7.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.12 110.834 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.07 -35.35 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.855 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 74.12 111.118 179.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.871 0.367 . . . . 75.33 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -53.12 10.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.876 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . 0.67 ' O ' HD12 ' B' ' 110' ' ' LEU . 2.4 mp0 -52.7 159.56 1.71 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.618 0.723 . . . . 73.13 110.908 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -28.36 25.3 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.685 2.257 . . . . 64.21 112.33 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.67 HD12 ' O ' ' B' ' 108' ' ' GLN . 1.4 mp 49.61 65.54 6.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.589 0.709 . . . . 72.43 110.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 179.61 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.601 2.201 . . . . 43.12 112.352 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.23 0.07 10.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.714 ' HG3' HD13 ' A' ' 164' ' ' LEU . 25.2 mmt -81.05 -4.07 53.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 74.1 110.886 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.91 -38.36 2.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.839 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -51.62 -35.34 41.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 64.53 110.922 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.702 HG21 ' CE1' ' A' ' 157' ' ' PHE . 13.1 p -78.05 -27.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 62.44 111.181 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . 0.592 ' HG2' HG22 ' A' ' 118' ' ' ILE . 32.6 tp60 -71.49 -45.61 62.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 65.02 110.914 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.57 HG22 ' HG2' ' A' ' 117' ' ' GLN . 1.6 pp -76.29 -38.55 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 62.0 111.131 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.41 -59.25 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.094 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -69.43 -38.36 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 63.11 111.054 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.52 -42.04 93.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 65.11 112.436 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.94 -48.69 46.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 70.32 112.503 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.07 -60.03 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 61.14 110.974 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 150' ' ' LEU . 72.9 mt -51.22 -52.74 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 54.24 111.095 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.632 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -50.63 -55.6 15.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.892 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mt -49.41 -40.97 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.44 111.129 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.55 -65.49 2.72 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.75 -0.738 . . . . 54.41 112.519 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.891 HG11 HG22 ' A' ' 129' ' ' VAL . 17.5 m -53.6 -22.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 74.21 111.169 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.924 HG22 HG11 ' A' ' 128' ' ' VAL . 1.8 t -75.91 -56.12 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.167 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.477 ' N ' HG12 ' B' ' 129' ' ' VAL . 38.7 tp -55.92 -30.88 62.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.966 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.625 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -80.85 -46.9 6.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 44.21 112.482 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -63.37 -24.62 67.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.93 0.395 . . . . 64.11 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 91.2 m -90.53 -37.79 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 75.14 111.092 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.625 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.91 -7.21 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 65.23 111.104 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -123.0 -35.61 2.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 70.44 110.963 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.97 1.11 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.45 110.794 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' B' ' 133' ' ' THR . . . -97.88 -24.09 12.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.834 -0.698 . . . . 50.35 112.578 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -17.22 56.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.869 0.366 . . . . 72.13 110.869 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.83 -49.47 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.8 mt -51.84 -79.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 71.15 110.93 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.52 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.12 -85.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 70.31 110.926 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.3 t -125.6 -41.06 2.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.01 110.885 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.05 24.73 2.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.713 -0.756 . . . . 73.41 112.42 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -123.57 -36.61 2.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.831 0.348 . . . . 74.33 110.84 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.03 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.211 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.55 -69.04 1.47 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 74.45 112.531 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.01 -31.49 68.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 71.22 111.068 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.41 -57.34 10.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.736 . . . . 24.31 112.494 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 149' ' ' LEU . 0.4 OUTLIER -57.26 -36.09 70.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.857 0.36 . . . . 72.51 110.958 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' B' ' 147' ' ' ALA . 10.3 mt -66.67 -42.58 86.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 74.03 110.815 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -62.35 -50.83 70.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.25 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.31 83.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.1 111.135 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.13 -63.05 5.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.781 -0.723 . . . . 52.35 112.518 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.9 mm -57.34 -23.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.926 0.393 . . . . 74.31 111.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.5 m -69.19 -62.56 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 72.11 110.789 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.41 -35.23 88.14 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 72.31 112.481 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.627 ' CE1' HG21 ' A' ' 116' ' ' VAL . 15.4 m-85 -67.57 -56.88 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.333 . . . . 60.33 110.866 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.2 m -52.13 -48.04 65.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.854 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.85 -45.93 94.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.545 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -34.41 73.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 73.42 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.37 -48.19 36.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 52.14 111.122 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.51 ' HB2' HD13 ' B' ' 118' ' ' ILE . 40.6 ttp180 -58.7 -30.51 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.966 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' B' ' 167' ' ' MET . 0.3 OUTLIER -79.55 -46.51 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.814 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.694 HD13 ' HG3' ' A' ' 113' ' ' MET . 0.4 OUTLIER -64.15 -18.02 64.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.14 110.829 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -100.35 -50.22 4.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 74.23 110.874 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . 0.577 ' HB3' HD23 ' B' ' 110' ' ' LEU . 10.9 ptmm? -133.78 57.31 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.92 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.47 ' HE2' ' O ' ' B' ' 163' ' ' LEU . 2.2 ttm -51.58 143.81 19.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.64 0.733 . . . . 73.52 110.918 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.8 Cg_endo -69.72 49.44 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 75.44 112.373 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -81.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 65.32 110.902 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -10.0 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.836 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -95.11 22.11 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.868 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -35.28 61.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.458 . . . . 64.15 110.887 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 63.53 111.067 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' N ' ' HZ2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 44.41 110.878 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.65 -52.84 9.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 75.34 110.837 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . 52.5 tp60 -50.26 108.22 0.97 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.637 0.732 . . . . 73.01 110.919 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 108' ' ' GLN . 53.5 Cg_endo -69.79 -177.07 1.71 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.717 2.278 . . . . 44.43 112.364 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 110' ' ' LEU . 4.1 mp -127.34 67.1 70.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.599 0.714 . . . . 74.03 110.961 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 154.8 67.3 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.735 2.29 . . . . 45.21 112.328 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.7 mt -84.12 0.71 47.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.51 110.921 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.54 ' O ' ' HB2' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -76.9 -14.06 59.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 45.21 110.965 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -118.83 -46.01 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.825 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.14 -34.27 70.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.918 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 53.7 t -73.49 -30.71 30.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.45 111.187 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -72.53 -38.96 67.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 61.42 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 162' ' ' ARG . 21.3 pt -76.43 -40.24 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' N ' HG13 ' A' ' 118' ' ' ILE . . . -73.63 -54.89 7.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 65.54 111.057 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -71.54 -41.73 68.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 52.34 111.112 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.07 -43.22 91.1 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 43.05 112.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.88 -48.84 45.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.72 . . . . 63.2 112.466 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 tp -63.56 -60.16 3.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.342 . . . . 53.44 110.897 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.621 HG23 HD22 ' B' ' 150' ' ' LEU . 36.6 mm -51.35 -54.55 11.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.107 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.644 HD22 HG23 ' A' ' 129' ' ' VAL . 2.4 tm? -49.59 -55.31 14.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -49.63 -41.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.32 111.181 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.26 -64.77 3.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 74.02 112.513 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.909 HG11 HG22 ' B' ' 129' ' ' VAL . 19.2 m -53.77 -22.73 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.22 111.15 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.87 HG22 HG11 ' B' ' 128' ' ' VAL . 1.9 t -76.88 -54.58 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.089 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 129' ' ' VAL . 14.4 mt -56.79 -29.94 63.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.03 110.917 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.14 -44.92 7.31 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.687 -0.768 . . . . 61.01 112.463 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -65.93 -22.7 66.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.899 0.38 . . . . 71.03 110.901 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 39.9 m -91.75 -38.56 12.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 51.43 111.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 134' ' ' VAL . 71.8 t -82.02 -8.5 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 42.34 111.159 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.06 -35.07 3.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.937 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.23 0.58 10.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.15 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.48 -23.48 11.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.785 -0.722 . . . . 61.2 112.481 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.21 -16.12 59.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 73.2 110.819 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -78.59 -49.19 13.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 72.24 110.878 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 76.9 mt -51.71 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 75.53 110.903 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.19 -85.02 0.66 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.266 -0.424 . . . . 71.43 110.932 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.38 -41.05 2.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.829 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.01 24.85 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 52.21 112.496 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.19 -36.48 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.02 110.809 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.96 -38.12 81.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.34 111.095 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -69.09 1.46 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 61.35 112.536 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.597 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -58.96 -31.5 68.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 62.23 111.068 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.6 -57.06 10.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 64.42 112.481 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 149' ' ' LEU . 5.0 tt -56.89 -36.89 70.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.872 0.368 . . . . 73.14 110.999 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 129' ' ' VAL . 9.0 mt -65.88 -43.28 88.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 63.02 110.924 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -61.6 -48.93 78.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.31 110.895 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.96 81.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 71.34 111.109 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.82 5.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 53.53 112.491 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 mm -55.86 -24.1 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 72.21 111.17 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -60.95 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 64.34 110.88 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.1 -37.25 92.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 71.2 112.5 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CE1' HG11 ' B' ' 116' ' ' VAL . 23.2 m-85 -64.22 -56.97 10.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 74.52 110.84 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -55.1 -40.07 70.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 71.21 110.835 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.29 -49.21 80.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.697 -0.763 . . . . 55.23 112.542 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -30.88 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.715 0.293 . . . . 74.32 110.819 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -74.03 -50.74 18.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 75.24 111.149 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' HD12 ' A' ' 118' ' ' ILE . 29.3 ptt180 -60.66 -30.13 69.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.872 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -50.16 14.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 54.11 110.964 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' B' ' 113' ' ' MET . 0.5 OUTLIER -69.62 -14.33 62.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.881 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.33 -45.32 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.822 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -161.12 60.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.6 ptp -48.49 153.81 1.28 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.575 0.703 . . . . 63.3 110.899 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 50.34 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 73.4 112.324 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -48.7 -86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 70.35 110.94 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.46 -0.5 46.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 62.11 110.869 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -54.65 -26.3 32.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.918 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -178.87 57.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 71.22 110.871 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 65.23 111.049 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.547 ' N ' ' HZ2' ' B' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.816 0.341 . . . . 61.44 110.931 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -52.79 9.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.11 110.862 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -51.85 109.91 1.62 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.636 0.731 . . . . 75.04 110.949 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -167.86 0.25 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.706 2.271 . . . . 73.04 112.337 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.431 HD12 ' N ' ' B' ' 110' ' ' LEU . 4.0 mp -138.68 64.68 37.2 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.616 0.722 . . . . 53.23 110.931 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.29 66.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.243 . . . . 63.42 112.348 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.5 0.4 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.894 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.606 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 64.2 110.87 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' B' ' 161' ' ' ALA . 0.0 OUTLIER -117.92 -45.65 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 74.44 110.864 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -54.99 -35.21 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' B' ' 120' ' ' ALA . 90.7 t -75.71 -30.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 64.42 111.12 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -69.09 -40.76 78.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 61.41 110.867 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' B' ' 162' ' ' ARG . 20.5 pt -78.27 -40.24 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.093 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.02 -55.74 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.45 111.063 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -72.06 -41.88 66.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.114 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.7 91.42 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.698 -0.763 . . . . 71.12 112.444 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.68 43.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 73.22 112.505 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.01 -60.92 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.771 0.32 . . . . 75.12 110.862 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.591 HG23 HD22 ' A' ' 150' ' ' LEU . 38.0 mm -51.15 -55.25 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.147 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.65 HD22 HG23 ' B' ' 129' ' ' VAL . 2.4 tm? -48.78 -56.4 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 52.25 110.858 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.9 mt -49.13 -41.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.112 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.53 -65.08 2.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 55.43 112.505 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 0.87 HG11 HG22 ' A' ' 129' ' ' VAL . 19.9 m -53.38 -22.88 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 73.2 111.072 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.909 HG22 HG11 ' A' ' 128' ' ' VAL . 2.0 t -76.15 -57.69 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.146 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.489 ' N ' HG12 ' B' ' 129' ' ' VAL . 13.5 mt -54.36 -30.6 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 65.23 110.965 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -81.26 -46.33 7.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 75.24 112.5 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -64.03 -23.81 67.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 74.02 110.907 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 47.7 m -91.58 -37.18 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.54 111.218 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.2 p -80.91 -7.74 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.171 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 -35.25 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.53 0.9 11.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 75.42 110.93 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.91 -23.98 11.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 61.43 112.429 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.92 -15.44 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.43 110.893 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -78.53 -49.43 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.53 110.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.81 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 61.34 110.99 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.519 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.18 -84.99 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.35 110.923 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.23 -41.2 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 72.05 110.805 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.25 24.61 2.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 51.3 112.439 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -123.19 -36.47 2.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 75.43 110.868 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.8 -38.46 82.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 63.41 111.092 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.86 -69.09 1.46 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 71.52 112.539 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' B' ' 150' ' ' LEU . . . -58.61 -32.2 68.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.95 0.405 . . . . 51.23 111.147 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 -57.38 10.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 60.31 112.47 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . 0.572 ' O ' HD23 ' B' ' 149' ' ' LEU . 5.0 tt -55.95 -37.24 68.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 53.12 110.975 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.621 HD22 HG23 ' A' ' 124' ' ' ILE . 8.8 mt -65.49 -43.39 90.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.896 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.57 -48.25 81.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.87 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.79 80.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 60.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.09 -62.21 6.3 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 54.25 112.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 5.2 mm -56.35 -24.09 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.894 0.378 . . . . 61.03 111.145 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -60.38 2.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 72.3 110.845 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.84 91.52 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.801 -0.714 . . . . 70.34 112.541 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.497 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.6 m-85 -65.44 -52.02 56.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.22 110.872 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 69.5 m -57.25 -41.32 79.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 52.23 110.831 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.88 -48.63 85.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.698 -0.763 . . . . 62.01 112.615 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.6 72.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.774 0.321 . . . . 53.43 110.874 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -73.89 -50.29 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.143 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.436 ' HB3' HD12 ' B' ' 118' ' ' ILE . 28.2 ptt180 -60.78 -29.5 69.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.9 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -51.41 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.23 110.921 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -68.81 -14.65 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.91 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -95.26 -45.18 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.896 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -161.78 60.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 71.32 110.896 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ptp -48.58 153.88 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 71.23 110.833 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.71 50.89 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 73.12 112.344 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . 0.418 ' CD1' ' N ' ' B' ' 169' ' ' TRP . 0.0 OUTLIER -48.95 -85.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 74.13 110.875 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -82.49 -0.11 44.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 72.34 110.869 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -55.13 -26.13 36.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 63.52 110.935 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -179.32 59.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.41 110.836 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 63.23 111.039 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.821 0.343 . . . . 63.33 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -52.73 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 64.45 110.832 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -95.91 155.53 38.25 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 51.42 110.901 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 -21.0 34.64 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.72 2.28 . . . . 63.55 112.382 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.3 mt 50.61 69.45 2.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.698 . . . . 72.1 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.634 2.223 . . . . 73.51 112.378 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.49 1.76 13.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 61.21 110.885 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.838 ' HB2' HD22 ' B' ' 164' ' ' LEU . 0.0 OUTLIER -76.9 -18.67 58.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.22 110.867 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.445 HH22 ' N ' ' B' ' 118' ' ' ILE . 1.7 tpm_? -110.02 -48.23 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.293 -0.412 . . . . 61.4 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -56.05 -29.25 60.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.35 110.981 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG21 ' CE1' ' B' ' 157' ' ' PHE . 8.0 p -74.94 -29.5 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.084 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.8 -42.04 61.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.906 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -39.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 74.12 111.132 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.84 -55.75 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 52.51 111.095 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 116' ' ' VAL . . . -70.49 -42.39 71.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 70.24 111.087 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.07 96.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 62.23 112.52 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.65 -49.29 44.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 71.42 112.452 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -58.59 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 72.44 110.932 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 128' ' ' VAL . 33.8 mm -51.61 -51.08 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 42.41 111.156 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.495 HD22 HG23 ' A' ' 129' ' ' VAL . 3.1 tm? -53.2 -49.09 67.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.894 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.7 mt -50.58 -57.59 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.184 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -59.43 -58.29 15.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 51.14 112.478 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' B' ' 128' ' ' VAL . 25.8 t -51.69 -30.22 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.849 0.356 . . . . 62.43 111.136 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 147' ' ' ALA . 2.2 t -69.38 -57.17 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.159 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.419 ' N ' HG12 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.35 -28.66 44.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.869 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 134' ' ' VAL . . . -83.39 -48.45 5.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.752 -0.737 . . . . 74.43 112.439 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' B' ' 128' ' ' VAL . 13.4 t80 -61.76 -23.1 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.046 0.451 . . . . 61.55 110.985 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 147' ' ' ALA . 89.9 m -92.26 -38.68 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 61.34 111.178 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.615 HG12 ' HA2' ' A' ' 131' ' ' GLY . 4.3 p -80.35 -6.39 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.095 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -123.1 -36.03 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.44 110.905 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.77 0.16 10.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.831 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -97.43 -26.46 10.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 53.54 112.452 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -61.69 -17.2 54.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.932 0.396 . . . . 74.14 110.892 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -80.73 -46.69 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 60.03 110.882 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.86 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.879 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -122.52 -84.67 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.924 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.57 -41.06 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.56 2.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.493 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -123.72 -37.67 2.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 45.43 110.857 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.28 -38.96 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.21 111.087 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.39 -68.76 1.55 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 73.3 112.47 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.617 ' HB2' ' OG1' ' A' ' 133' ' ' THR . . . -59.55 -29.86 68.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 65.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.59 -57.78 8.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 71.55 112.502 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.49 -35.91 72.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.801 0.334 . . . . 74.5 110.88 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.72 -43.73 83.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 71.22 110.916 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -62.22 -50.49 71.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 71.42 110.869 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.59 -46.67 80.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 70.13 111.159 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.32 -63.62 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 65.54 112.431 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 mm -57.26 -22.91 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.41 111.136 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 m -68.12 -61.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 64.14 110.844 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.9 -36.49 92.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 71.2 112.543 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG21 ' B' ' 116' ' ' VAL . 16.9 m-85 -65.64 -54.75 23.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 73.45 110.866 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.4 m -55.12 -46.43 75.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.917 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.52 -49.23 70.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 43.54 112.513 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -33.81 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.757 0.313 . . . . 72.43 110.861 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' B' ' 113' ' ' MET . . . -72.86 -46.17 54.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.34 111.08 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -60.55 -33.99 73.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.855 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.25 -47.19 29.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 54.55 110.941 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.765 HD22 ' HB2' ' B' ' 113' ' ' MET . 0.3 OUTLIER -73.29 -10.87 60.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 74.14 110.902 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -94.5 -44.72 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.823 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.18 56.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.11 110.832 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.454 ' HG2' ' HD2' ' A' ' 168' ' ' PRO . 2.4 mtm -48.8 143.1 8.5 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 74.04 110.84 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 167' ' ' MET . 53.5 Cg_endo -69.86 49.03 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 71.23 112.334 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.402 ' CE2' ' O ' ' A' ' 167' ' ' MET . 0.0 OUTLIER -54.06 -80.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.01 110.872 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.48 -9.03 55.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 50.51 110.847 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.0 23.46 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.916 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -24.62 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 74.1 110.816 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 71.21 111.139 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.843 0.354 . . . . 74.21 110.958 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.85 -52.85 8.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 61.34 110.915 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -94.95 156.59 37.82 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.574 0.702 . . . . 63.54 110.951 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -25.4 28.94 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.711 2.274 . . . . 75.44 112.372 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt 53.9 67.71 3.35 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.629 0.728 . . . . 70.54 110.986 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -169.43 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.67 2.247 . . . . 71.41 112.367 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.92 2.1 14.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 71.54 110.881 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' MET . . . . . 0.765 ' HB2' HD22 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -76.97 -19.65 57.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.787 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -48.61 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 74.41 110.922 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -55.96 -29.48 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.882 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 157' ' ' PHE . 8.4 p -75.18 -29.62 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.0 111.066 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -73.56 -41.59 62.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.887 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.445 ' N ' HH22 ' A' ' 114' ' ' ARG . 0.0 OUTLIER -76.63 -39.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 52.44 111.11 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -55.76 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.12 111.105 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 116' ' ' VAL . . . -70.99 -43.55 67.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.35 111.106 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.98 -42.15 96.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.781 -0.724 . . . . 44.13 112.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.34 -49.47 45.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.789 -0.719 . . . . 65.02 112.461 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -59.55 4.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.763 0.316 . . . . 54.21 110.943 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.65 ' O ' HG23 ' B' ' 128' ' ' VAL . 35.6 mm -51.15 -51.79 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 70.11 111.163 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.489 HD22 HG23 ' B' ' 129' ' ' VAL . 3.1 tm? -52.42 -49.52 64.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.898 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 25.9 mt -50.7 -57.76 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 61.44 111.075 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.95 -57.09 21.74 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.738 -0.744 . . . . 65.2 112.46 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . 1.06 HG12 HG12 ' A' ' 128' ' ' VAL . 24.6 t -53.21 -30.27 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.903 0.382 . . . . 45.24 111.169 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' B' ' 147' ' ' ALA . 2.3 t -68.18 -58.75 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.2 111.12 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.435 ' N ' HG12 ' B' ' 129' ' ' VAL . 0.7 OUTLIER -54.11 -30.18 47.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 65.03 110.935 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . 0.634 ' HA2' HG12 ' B' ' 134' ' ' VAL . . . -82.18 -47.31 6.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.41 112.497 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 128' ' ' VAL . 7.9 t80 -62.55 -23.92 67.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 74.25 110.876 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' B' ' 147' ' ' ALA . 93.5 m -91.92 -38.11 12.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.31 111.094 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.634 HG12 ' HA2' ' B' ' 131' ' ' GLY . 4.3 p -80.2 -6.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 42.44 111.161 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -123.32 -35.93 2.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.04 0.68 10.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.42 110.892 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . -98.57 -25.01 10.32 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.46 -16.76 57.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 72.13 110.821 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -81.12 -46.67 14.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.54 110.866 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.57 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 61.13 110.884 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 141' ' ' LEU . 0.0 OUTLIER -122.33 -84.72 0.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 73.14 110.901 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' SER . . . . . . . . . . . . . 2.2 t -125.28 -40.44 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.855 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.42 24.43 2.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.634 -0.793 . . . . 64.12 112.503 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.48 -37.49 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.833 0.349 . . . . 70.42 110.889 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.34 -39.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.214 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.13 -68.14 1.73 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.727 . . . . 70.42 112.515 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HB2' ' OG1' ' B' ' 133' ' ' THR . . . -59.71 -30.06 68.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 54.42 111.109 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.61 -57.63 8.78 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 53.11 112.472 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.41 -35.93 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.903 0.382 . . . . 74.03 110.958 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.99 -43.22 83.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.35 110.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.75 -50.6 70.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 63.21 110.797 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.22 -47.22 78.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 70.44 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -60.22 -63.04 5.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 61.44 112.487 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.58 -22.9 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 73.25 111.159 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 1.2 m -68.33 -61.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.803 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -60.72 -36.36 91.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.811 -0.709 . . . . 70.0 112.45 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 116' ' ' VAL . 17.3 m-85 -66.39 -51.55 55.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.756 0.312 . . . . 73.42 110.855 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.3 m -56.92 -46.28 82.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.852 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.94 -48.86 79.66 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 75.31 112.507 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.48 77.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.775 0.321 . . . . 61.15 110.983 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 113' ' ' MET . . . -71.82 -45.35 61.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 70.25 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.73 -34.19 74.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 mp -74.49 -47.31 33.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.872 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 113' ' ' MET . 0.4 OUTLIER -73.07 -11.46 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 62.34 110.877 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -93.58 -43.85 8.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.4 110.86 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 57.16 0.67 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 61.32 110.905 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.451 ' HG2' ' HD2' ' B' ' 168' ' ' PRO . 2.3 mtm -48.75 142.92 8.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.491 0.663 . . . . 71.43 110.921 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' B' ' 167' ' ' MET . 53.1 Cg_endo -69.83 49.08 0.69 Allowed 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 122.72 2.28 . . . . 75.32 112.282 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' TRP . . . . . 0.403 ' CE2' ' O ' ' B' ' 167' ' ' MET . 0.0 OUTLIER -54.41 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.945 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.71 -8.81 54.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.961 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.96 23.54 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 64.0 110.932 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -23.97 63.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 71.11 110.937 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 74.23 111.054 179.982 . . . . . . . . 0 0 . 1 stop_ save_